EurekaMag Full Text Articles Chapter 51,948

Rigby-Jones, A.; Sneyd, J.R. 2008: Cardiovascular changes after achieving constant effect site concentration of propofol. Anaesthesia 63(7): 780; Author Reply 780-1

Casoni, D.; Spadavecchia, C.; Adami, C. 2014: Cardiovascular changes after administration of aerosolized salbutamol in horses: five cases. Acta Veterinaria Scandinavica 56: 49

Spiriev, T.; Kondoff, S.; Schaller, B. 2011: Cardiovascular changes after subarachnoid hemorrhage initiated by the trigeminocardiac reflex-first description of a case series. Journal of Neurosurgical Anesthesiology 23(4): 379-380

Babu-Narayan, S.V.; Mohiaddin, R.H.; Cannell, T.M.; Muhll, I.V.; Dimopoulos, K.; Mullen, M.J. 2011: Cardiovascular changes after transcatheter endovascular stenting of adult aortic coarctation. International Journal of Cardiology 149(2): 157-163

Horacek, J.M.; Jebavy, L.; Jakl, M.; Zak, P.; Mericka, P.; Maly, J. 2009: Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide. Experimental Oncology 31(2): 121-122

Kok, R.; Nolen, W.; Heeren, T. 2007: Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry 15(8): 725; author reply 726

Marabotti, C.; Scalzini, A.; Menicucci, D.; Passera, M.; Bedini, R.; L'Abbate, A. 2013: Cardiovascular changes during SCUBA diving: an underwater Doppler echocardiographic study. Acta Physiologica 209(1): 62-68

Drozdz, D.; Kawecka-Jaszcz, K. 2014: Cardiovascular changes during chronic hypertensive states. Pediatric Nephrology 29(9): 1507-1516

Swoap, S.J.; Gutilla, M.J. 2009: Cardiovascular changes during daily torpor in the laboratory mouse. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 297(3): R769-R774

Chan, V.; Fenning, A.; Levick, S.P.; Loch, D.; Chunduri, P.; Iyer, A.; Teo, Y.L.; Hoey, A.; Wilson, K.; Burstow, D.; Brown, L. 2011: Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology 57(4): 469-478

Guaraldi, P.; Serra, M.; Barletta, G.; Pierangeli, G.; Terlizzi, R.; Calandra-Buonaura, G.; Cialoni, D.; Cortelli, P. 2009: Cardiovascular changes during maximal breath-holding in elite divers. Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society 19(6): 363-366

Breskovic, T.; Uglesic, L.; Zubin, P.; Kuch, B.; Kraljevic, J.; Zanchi, J.; Ljubkovic, M.; Sieber, A.; Dujic, Z. 2011: Cardiovascular changes during underwater static and dynamic breath-hold dives in trained divers. Journal of Applied Physiology 111(3): 673-678

Kumarathasan, P.; Vincent, R.; Blais, E.; Saravanamuthu, A.; Gupta, P.; Wyatt, H.; Mitchel, R.; Hannan, M.; Trivedi, A.; Whitman, S. 2013: Cardiovascular changes in atherosclerotic ApoE-deficient mice exposed to Co60 (γ) radiation. Plos one 8(6): E65486

Kwok, K.-l.; Ng, D.K.; Chan, C.-h. 2008: Cardiovascular changes in children with snoring and obstructive sleep apnoea. Annals of the Academy of Medicine Singapore 37(8): 715-721

Al-Hamoudi, W.K. 2010: Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 16(3): 145-153

Hemingway, A. 1945: Cardiovascular changes in motion sickness. Journal of Aviation Medicine 16: 417-421

Delière, Q.; Migeotte, P.-F.; Neyt, X.; Funtova, I.; Baevsky, R.M.; Tank, J.; Pattyn, N. 2013: Cardiovascular changes in parabolic flights assessed by ballistocardiography. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 3801-3804

Bernini, G.; Bacca, A.; Carli, V.; Carrara, D.; Materazzi, G.; Berti, P.; Miccoli, P.; Pisano, R.; Tantardini, V.; Bernini, M.; Taddei, S. 2012: Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment. Journal of Endocrinological Investigation 35(3): 274-280

Gómez-Roso, M.; Montero, M.J.; Carrón, R.; Sevilla, M.A. 2009: Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril. British Journal of Pharmacology 158(8): 1911-1921

Gupta, R.; Varma, Y.; Yadav, B.S.; Gupta, R.; Gupta, S.; Gupta, N. 2006: Cardiovascular changes in thyroid disorder. Journal of the Indian Medical Association 104(10): 574; 576-578

Bortkiewicz, A.; Gadzicka, E.żb.; Stroszejn-Mrowca, G.ży.; Szyjkowska, A.; Szymczak, W.ła.; Koszada-Włodarczyk, W.ła.; Szadkowska-Stańczyk, I. 2014: Cardiovascular changes in workers exposed to fine particulate dust. International Journal of Occupational Medicine and Environmental Health 27(1): 78-92

Zhang, L.-F.; Cheng, J.-H.; Liu, X.; Wang, S.; Liu, Y.; Lu, H.-B.; Ma, J. 2008: Cardiovascular changes of conscious rats after simulated microgravity with and without daily -Gx gravitation. Journal of Applied Physiology 105(4): 1134-1145

Bispo, G.S.; de Lima Lopes, J.; de Barros, A.L.B.L. 2013: Cardiovascular changes resulting from sexual activity and sexual dysfunction after myocardial infarction: integrative review. Journal of Clinical Nursing 22(23-24): 3522-3531

De Backer, J. 2009: Cardiovascular characteristics in Marfan syndrome and their relation to the genotype. Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 71(6): 335-371

Capaldo, B.; Di Bonito, P.; Iaccarino, M.; Roman, M.J.; Lee, E.T.; Devereux, R.B.; Riccardi, G.; Howard, B.V.; de Simone, G. 2013: Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study. Diabetes Care 36(4): 992-997

Carré, F.ço. 2013: Cardiovascular clearance for competitive sport in aging people. Presse Medicale 42(6 Part 1): 1028-1031

Nicolau, Jé.C.; Corbalan, R.; Diaz, R.; Bahit, C.; Armstrong, P.W.; Granger, C.B.; Lopes, R.D. 2013: Cardiovascular clinical research in South America. American Heart Journal 165(6): 848-853

Solomon, S.D. 2010: Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study. Circulation 121(22): 2453-2455

Amundsen, M.O.; Engdahl, B.; Berg, C.; Nordeng, H. 2010: Cardiovascular co-medication among users of antiobesity drugs: a population-based study. Pharmacy World and Science: Pws 32(6): 752-758

Handa, R. 2010: Cardiovascular co-morbidity in Asians with lupus: theoretical concern or clinical reality?. Lupus 19(12): 1447-1451

Alani, H.; Tamimi, A.; Tamimi, N. 2014: Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World Journal of Nephrology 3(4): 156-168

John, H.; Kitas, G.; Toms, T.; Goodson, N. 2009: Cardiovascular co-morbidity in early rheumatoid arthritis. Best Practice and Research. Clinical Rheumatology 23(1): 71-82

Turesson, C.; Jacobsson, L.T.H.; Matteson, E.L. 2008: Cardiovascular co-morbidity in rheumatic diseases. Vascular Health and Risk Management 4(3): 605-614

LeVan, P.; Stevenson, J.; Develi, N.; Frey, K. 2008: Cardiovascular collapse after femoral venous cannula placement for robotic-assisted mitral valve repair and patent foramen ovale closure. Journal of Cardiothoracic and Vascular Anesthesia 22(4): 590-591

Wang, D.; Su, L.; Fan, X. 2014: Cardiovascular collapse and disseminated intravascular coagulation as complications of ethanol embolization of arteriovenous malformations in the upper lip: case report and literature review. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 72(2): 346-351

Jonkam, C.C.; Lange, M.; Traber, D.L.; Maybauer, D.M.; Maybauer, M.O.; Bansal, K.; Hamahata, A.; Zhu, Y.; Esechie, A.; Traber, L.D.; Sousse, L.; Rehberg, S.; Herndon, D.N.; Enkhbaatar, P. 2009: Cardiovascular collapse and vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis. Shock 32(6): 621-625

Jo, J.Young.; Chin, J-Hyun.; Park, P.Hwan.; Ku, S.Woo. 2014: Cardiovascular collapse due to right heart failure following ethanol sclerotherapy: a case report. Korean Journal of Anesthesiology 66(5): 388-391

Pradhan, B. 2007: Cardiovascular collapse during induction of general anesthesia. Jnma; Journal of the Nepal Medical Association 46(167): 130-132

Nemergut, E.C.; Mintz, P.D.; Clark, P.; Sawyer, R.G.; Pruett, T.L. 2007: Cardiovascular collapse during living-directed orthotopic liver transplantation associated with the transfusion of contaminated red blood cells. Journal of Cardiothoracic and Vascular Anesthesia 21(6): 870-872

Ramaswamykanive, H.; Nanavati, Z.; Mackie, J.; Linderman, R.; Lavee, O. 2011: Cardiovascular collapse following povidone-iodine wash. Anaesthesia and Intensive Care 39(1): 127-130

Wilson, W.M.; Spratt, J.C.; Lombardi, W.L. 2015: Cardiovascular collapse post chronic total occlusion percutaneous coronary intervention due to a compressive left atrial hematoma managed with percutaneous drainage. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 86(3): 407-411

Kesarwani, M.; Perez, A.; Lopez, V.A.; Wong, N.D.; Franklin, S.S. 2009: Cardiovascular comorbidities and blood pressure control in stroke survivors. Journal of Hypertension 27(5): 1056-1063

Kerola, A.M.; Kerola, T.; Kauppi, M.J.; Kautiainen, H.; Virta, L.J.; Puolakka, K.; Nieminen, T.V.M. 2013: Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. Annals of the Rheumatic Diseases 72(11): 1826-1829

Pocoski, J.; Ma, A.; Kessler, C.M.; Boklage, S.; Humphries, T.J. 2014: Cardiovascular comorbidities are increased in U.S. patients with haemophilia A: a retrospective database analysis. Haemophilia: the Official Journal of the World Federation of Hemophilia 20(4): 472-478

Szmit, S.; Zaborowska, M.; Waśko-Grabowska, A.; Żołnierek, J.; Nurzyński, P.ł; Filipiak, K.J.; Opolski, G.; Szczylik, C. 2012: Cardiovascular comorbidities for prediction of progression-free survival in patients with metastatic renal cell carcinoma treated with sorafenib. Kidney and Blood Pressure Research 35(6): 468-476

Muniz Caldas, C.A.; Freire de Carvalho, J.él. 2013: Cardiovascular comorbidities in antiphospholipid syndrome. Expert Review of Clinical Immunology 9(10): 987-990

Torres, T.; Machado, S.; Mendonça, D.; Selores, M. 2014: Cardiovascular comorbidities in childhood psoriasis. European Journal of Dermatology: Ejd 24(2): 229-235

Kellner, H. 2009: Cardiovascular comorbidities in rheumatic diseases. MMW Fortschritte der Medizin 151(48): 48

Chilton, R.; Wyatt, J.; Nandish, S.; Oliveros, R.; Lujan, M. 2011: Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide-1-based therapies. American Journal of Medicine 124(1 Suppl): S35-S53

Singh, G.; Aneja, S.P.S. 2011: Cardiovascular comorbiditiy in psoriasis. Indian Journal of Dermatology 56(5): 553-556

Kleinert, S.; Krueger, K. 2011: Cardiovascular comorbidity and its risk factors in rheumatoid arthritis. Zeitschrift für Rheumatologie 70(6): 464-472

Nguyen, P.L.; Chen, M.-H.; Hoffman, K.E.; Chen, R.C.; Hu, J.C.; Bennett, C.L.; Kattan, M.W.; Sartor, O.; Stein, K.; D'Amico, A.V. 2012: Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. Bju International 110(2): 201-205

Cataluña, J.J.é S.; García, M.A.M.ín. 2009: Cardiovascular comorbidity in COPD. Archivos de Bronconeumologia 45(Suppl 4): 18-23

Müllerova, H.; Agusti, A.; Erqou, S.; Mapel, D.W. 2013: Cardiovascular comorbidity in COPD: systematic literature review. Chest 144(4): 1163-1178

Wright, K.; Crowson, C.S.; Gabriel, S.E. 2014: Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Failure Clinics 10(2): 339-352

Goleń, D.; Kuśmierczyk Droszcz, B.; Demkow, M.; Bilińska, Z.T. 2012: Cardiovascular complication of cocaine abuse. Kardiologia Polska 70(5): 517-521

Furlan, J.C.; Fehlings, M.G. 2008: Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management. Neurosurgical Focus 25(5): E13

Gillis, K.A.; Patel, R.K.; Jardine, A.G. 2014: Cardiovascular complications after transplantation: treatment options in solid organ recipients. Transplantation Reviews 28(2): 47-55

Boccara, F. 2008: Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. Aids 22(Suppl 3): S19-S26

Schneider, M.; Müller-Ladner, U. 2010: Cardiovascular complications and therapeutic strategy. Zeitschrift für Rheumatologie 69(8): 678-679

Wysocki, P.J.; Wysocki, H. 2008: Cardiovascular complications associated with biological therapies for breast cancer. Expert Opinion on Biological Therapy 8(10): 1551-1559

Muneuchi, J.; Ohga, S.; Ishimura, M.; Ikeda, K.; Yamaguchi, K.; Nomura, A.; Takada, H.; Abe, Y.; Hara, T. 2009: Cardiovascular complications associated with chronic active Epstein-Barr virus infection. Pediatric Cardiology 30(3): 274-281

Suárez, C.; Castillo, J.é; Esmatjes, E.; Sala, J.; Cairols, M.; Montoto, C.; Barberá, G.; Abeytua Jimenez, M.; Dolores Adarriaga, M.; Agarrado Luna, A.; Jesus Alias Linares, E.; Almagro Mugica, F.; Alonso Garcia, G.; Alonso Martin, J.; Alonso Martinez, J.L.; Alvarenga Recalde, N.M.; Alvarez Aunon, A.; Alvarez Fernandez, J.; Andres Novales, J.; Andreu Alvarez, J.; Anton Serra, J.A.; Arias Castano, J.C.; Sanchez de Rojas, I.A.; Baldo Perez, E.C.; Barrios, A.; Bautista Prados, J.G.; Bellera Gotarda, M.N.; Bello Lopez, J.; Beloqui Ruiz, O.; Bermudez Garcia, J.M.; Blanco Gonzalez, M.; Blasco, A.; Bohorquez Sierra, J.C.; Bolanos Diaz, A.; Brossa Loidi, V.; Bruguera Cortada, J.; Cabarcos Cazon, A.; Cacabelos Perez, P.ón.; Cairols Castellote, M 2009: Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. on behalf of Spain's REACH Registry. Medicina Clinica 132(14): 537-544

Engi, S.A.; Cruz, F.áb.C.; Leão, R.M.; Spolidorio, L.ís.C.; Planeta, C.S.; Crestani, C.C. 2014: Cardiovascular complications following chronic treatment with cocaine and testosterone in adolescent rats. Plos one 9(8): E105172

Harrison, A.; Abolhoda, A.; Ahsan, C. 2009: Cardiovascular complications in Behçet syndrome: acute myocardial infarction with late stent thrombosis and coronary, ventricular, and femoral pseudoaneurysms. Texas Heart Institute Journal 36(5): 498-500

Aberg, J.A. 2009: Cardiovascular complications in HIV management: past, present, and future. Journal of Acquired Immune Deficiency Syndromes 50(1): 54-64

Guaraldi, G. 2006: Cardiovascular complications in HIV-infected individuals. Current Opinion in HIV and Aids 1(6): 507-513

Lambert, V. 2008: Cardiovascular complications in Kawasaki syndrome. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 15(5): 829-831

Herdy, G.V.H.; Lopes, V.ân.G.S.; Olivaes, M.C.íl.; Mota, I.C.; Vasconcelos, M.M. 2007: Cardiovascular complications in a child with chronic renal failure. Arquivos Brasileiros de Cardiologia 88(2): E32-E35

Stirban, A.O.; Tschoepe, D. 2008: Cardiovascular complications in diabetes: targets and interventions. Diabetes Care 31(Suppl 2): S215-S221

Patel, T.; Charytan, D.M. 2010: Cardiovascular complications in diabetic kidney disease. Seminars in Dialysis 23(2): 169-177

Al-Thani, H.; Shabana, A.; Hussein, A.; Sadek, A.; Sharaf, A.; Koshy, V.; El-Menyar, A. 2015: Cardiovascular complications in diabetic patients undergoing regular hemodialysis: a 5-year observational study. Angiology 66(3): 225-230

Finckh, A. 2013: Cardiovascular complications in immune mediated diseases. Revue Medicale Suisse 9(377): 549

Okello, E.; Wanzhu, Z.; Musoke, C.; Twalib, A.; Kakande, B.; Lwabi, P.; Wilson, N.B.; Mondo, C.K.; Odoi-Adome, R.; Freers, J. 2013: Cardiovascular complications in newly diagnosed rheumatic heart disease patients at Mulago Hospital, Uganda. Cardiovascular Journal of Africa 24(3): 80-85

Głowińska, I.; Grochowski, J.; Małyszko, J. 2008: Cardiovascular complications in patients with diabetic nephropathy receiving pharmacological versus renal replacement therapy. Polskie Archiwum Medycyny Wewnetrznej 118(7-8): 404-412

Sweety, S.A.; Arzu, J.; Rahman, M.; Salim, M.A.; Mahmood, M. 2014: Cardiovascular complications in patients with end stage renal disease on maintenance haemodialysis. Mymensingh Medical Journal: Mmj 23(2): 329-334

Júnior, E.d.C.; Cardinalli-Neto, A.; Albaneze Borim, A.; Bestetti, R.B. 2012: Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dória operation. Acta Tropica 122(2): 219-223

Galetta, F.; Franzoni, F.; Bernini, G.; Poupak, F.; Carpi, A.; Cini, G.; Tocchini, L.; Antonelli, A.; Santoro, G. 2010: Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomedicine and PharmacoTherapy 64(7): 505-509

Piraino, B. 2009: Cardiovascular complications in peritoneal dialysis patients. Contributions to Nephrology 163: 102-109

Barbaro, G.; Silva, E.F.R.d. 2009: Cardiovascular complications in the acquired immunodeficiency syndrome. Revista da Associacao Medica Brasileira 55(5): 621-630

Brindisi, M.-C.; Bouillet, B.; Vergès, B.; Halimi, S. 2010: Cardiovascular complications in type 1 diabetes mellitus. Diabetes and Metabolism 36(5): 341-344

Lekakis, J.; Ikonomidis, I. 2010: Cardiovascular complications of AIDS. Current Opinion in Critical Care 16(5): 408-412

Law, M.G. 2006: Cardiovascular complications of HIV: an overview of risk and a novel approach to prevention - the HIV polypill study. Current Opinion in HIV and Aids 1(6): 482-487

Hibbert, B.; Costiniuk, C.; Hibbert, R.; Joseph, P.; Alanazi, H.; Simard, T.; Dennie, C.; Angel, J.B.; O'Brien, E.R. 2010: Cardiovascular complications of Salmonella enteritidis infection. Canadian Journal of Cardiology 26(8): 323-325

Le Corguillé, M.; Pochmalicki, G.; Eugène, C. 2007: Cardiovascular complications of alpha interferon. Gastroenterologie Clinique et Biologique 31(12): 1081-1084

Swain, S.M. 2008: Cardiovascular complications of breast cancer therapy. Clinical Advances in Hematology and Oncology: H&o 6(4): 247-248; 282

Shenoy, C.; Klem, I.; Crowley, A.L.; Patel, M.R.; Winchester, M.A.; Owusu, C.; Kimmick, G.G. 2011: Cardiovascular complications of breast cancer therapy in older adults. Oncologist 16(8): 1138-1143

Genovesi, S.; Gallieni, M. 2014: Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?. Expert Opinion on Drug Safety 13(9): 1143-1148

Yeh, E.T.H.; Bickford, C.L. 2009: Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. Journal of the American College of Cardiology 53(24): 2231-2247

Hellerstein, H.K.; Feil, H. 1949: Cardiovascular complications of cardiac and noncardiac surgery. Journal of the American Association of Nurse Anesthetists 17(3): 207-223

Tovena, D.M.; Inzoli, A.; Donato, G.; Gazzaniga, P.; Bianchessi, C. 2012: Cardiovascular complications of chemotherapy. Giornale Italiano di Cardiologia 13(10 Suppl 2: 165s-170s

Ross, L.; Banerjee, D. 2013: Cardiovascular complications of chronic kidney disease. International Journal of Clinical Practice 67(1): 4-5

Roy, G.C.; Sutradhar, S.R.; Barua, U.K.; Datta, N.C.; Debnath, C.R.; Hoque, M.M.; Hossain, A.S.; Haider, M.S.; Das, M. 2012: Cardiovascular complications of chronic renal failure - an updated review. Mymensingh Medical Journal: Mmj 21(3): 573-579

Restrepo, C.S.; Rojas, C.A.; Martinez, S.; Riascos, R.; Marmol-Velez, A.; Carrillo, J.; Vargas, D. 2009: Cardiovascular complications of cocaine: imaging findings. Emergency Radiology 16(1): 11-19

Roussin, I.; Sheppard, M.N.; Rubens, M.; Kaddoura, S.; Pepper, J.; Mohiaddin, R.H. 2011: Cardiovascular complications of cutis laxa syndrome: successful diagnosis and surgical management. Circulation 124(1): 100-102

Lau, D.C.W.; Shen, G.X. 2013: Cardiovascular complications of diabetes. Canadian Journal of Diabetes 37(5): 279-281

Bogdanov, V.Y.; Osterud, B. 2010: Cardiovascular complications of diabetes mellitus: the Tissue Factor perspective. Thrombosis Research 125(2): 112-118

Pálsson, R.; Patel, U.D. 2014: Cardiovascular complications of diabetic kidney disease. Advances in Chronic Kidney Disease 21(3): 273-280

Cabanelas, N.; Ferreira, Pícia.; Roxo, F. 2009: Cardiovascular complications of highly active antiretroviral therapy: case report. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(6): 749-758

Bloomgarden, Z.T. 2005: Cardiovascular complications of insulin resistance. Metabolic Syndrome and Related Disorders 3(4): 305-315

Afolabi, B.A.; Novaro, G.M.; Szomstein, S.; Rosenthal, R.J.; Asher, C.R. 2009: Cardiovascular complications of obesity surgery in patients with increased preoperative cardiac risk. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 5(6): 653-656

Ramar, K.; Guilleminault, C. 2008: Cardiovascular complications of obstructive sleep apnea. Expert Review of Respiratory Medicine 2(1): 63-74

Bhattacharjee, R.; Kheirandish-Gozal, L.; Pillar, G.; Gozal, D. 2009: Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children. Progress in Cardiovascular Diseases 51(5): 416-433

Dworzański, W.; Jaskólska, A.; Szumiło, M.ł; Switalska, A.; Burdan, F. 2011: Cardiovascular complications of phosphodiesterase-5 inhibitors. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(176): 139-142

Finch, W.; Shamsa, K.; Lee, M.S. 2014: Cardiovascular complications of radiation exposure. Reviews in Cardiovascular Medicine 15(3): 232-244

Lee, M.S.; Finch, W.; Mahmud, E. 2013: Cardiovascular complications of radiotherapy. American Journal of Cardiology 112(10): 1688-1696

Kaplan, M.J. 2010: Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheumatic Diseases Clinics of North America 36(2): 405-426

Badran, M.; Ayas, N.; Laher, I. 2014: Cardiovascular complications of sleep apnea: role of oxidative stress. Oxidative Medicine and Cellular Longevity 2014: 985258

Hagen, E.M.; Rekand, T.; Grønning, M.; Færestrand, S. 2012: Cardiovascular complications of spinal cord injury. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 132(9): 1115-1120

Mukerji, S.; Aloka, F.; Farooq, M.U.; Kassab, M.Y.; Abela, G.S. 2009: Cardiovascular complications of the Guillain-Barré syndrome. American Journal of Cardiology 104(10): 1452-1455

Gazoni, F.Martins.; Truffa, A.A.M.; Kawamura, C.; Guimarães, Hélio.Penna.; Lopes, R.Delascio.; Sandre, Lícia.Vendrame.; Lopes, A.Carlos. 2006: Cardiovascular complications related to cocaine use: case report. Revista Brasileira de Terapia Intensiva 18(4): 427-432

Brune, K. 2010: Cardiovascular complications with cyclooxygenase inhibitors : Myths and facts. Zeitschrift für Rheumatologie 69(8): 712; 714-718

Babaei, A.; Mittal, R.K. 2011: Cardiovascular compression of the esophagus and spread of gastro-esophageal reflux. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 23(1): 45-51 E3

Gopal, A.; Silvet, H.; Foster, G.P. 2010: Cardiovascular computed tomographic angiography evaluation following unsuccessful invasive angiography: the clinical utility of 3D volume rendering. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 75(5): 753-756

Shinbane, J.S. 2008: Cardiovascular computed tomographic angiography in patients with atrial fibrillation: challenges of anatomy, physiology, and electrophysiology. Journal of Cardiovascular Computed Tomography 2(3): 181-182

Voros, S.; Joshi, P.H.; Vazquez, G.; Roth, G.; Murrieta, L.; Rinehart, S.; Qian, Z.; Miller, J. 2010: Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study. Journal of Cardiovascular Computed Tomography 4(3): 164-172

Raman, S.V.; Cook, S.C. 2007: Cardiovascular computed tomography and MRi in clinical practice: aortopathy. Journal of Cardiovascular Medicine 8(7): 535-540

Klink, T.; Müller, Götz.; Weil, J.; Dodge-Khatami, A.; Adam, G.; Bley, T.Alexander. 2012: Cardiovascular computed tomography angiography in newborns and infants with suspected congenital heart disease: retrospective evaluation of low-dose scan protocols. Clinical Imaging 36(6): 746-753

Mehta, S.; Pereira, S.; Janzen, S.; Mays, R.; Viana, R.; Lobo, L.; Teasell, R.W. 2012: Cardiovascular conditioning for comfortable gait speed and total distance walked during the chronic stage of stroke: a meta-analysis. Topics in Stroke Rehabilitation 19(6): 463-470

Herbst, J.; Winskog, C.; Byard, R.W. 2010: Cardiovascular conditions and the evaluation of the heart in pregnancy-associated autopsies. Journal of Forensic Sciences 55(6): 1528-1533

Holmberg, B.; Stegmayr, B.G. 2009: Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. Hemodialysis International. International Symposium on Home Hemodialysis 13(1): 27-31

Larsen, S.ør.L.; Lyngeraa, T.S.; Maschmann, C.P.; Van Lieshout, J.J.; Pott, F.C. 2014: Cardiovascular consequence of reclining vs. sitting beach-chair body position for induction of anesthesia. Frontiers in Physiology 5: 187

Fava, C.; Ohlsson, T.; Sjögren, M.; Tagetti, A.; Almgren, P.; Engström, G.; Nilsson, P.; Hedblad, B.; Minuz, P.; Melander, O. 2014: Cardiovascular consequences of a polygenetic component of blood pressure in an urban-based longitudinal study: the Malmö diet and cancer. Journal of Hypertension 32(7): 1424-8; Discussion 1428

Trivelloni, P.; Berrettini, U. 2010: Cardiovascular consequences of aerobic maneuvers. Giornale Italiano di Cardiologia 11(10 Suppl 1: 126s-129s

Bhaskaran, K.; Wilkinson, P.; Smeeth, L. 2011: Cardiovascular consequences of air pollution: what are the mechanisms?. Heart 97(7): 519-520

Koroglu, O.A.; Yalaz, M.; Levent, E.; Akisu, M.; Kültürsay, N. 2013: Cardiovascular consequences of bronchopulmonary dysplasia in prematurely born preschool children. Neonatology 104(4): 283-289

Scott, J.M.; Esch, B.T.A.; Shave, R.; Warburton, D.E.R.; Gaze, D.; George, K. 2009: Cardiovascular consequences of completing a 160-km ultramarathon. Medicine and Science in Sports and Exercise 41(1): 26-34

Steendijk, P. 2011: Cardiovascular consequences of cooling in critical care. Critical Care 15(1): 119

Ban, K.; Hui, S.; Drucker, D.J.; Husain, M. 2009: Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies. Journal of the American Society of Hypertension: Jash 3(4): 245-259

McEniery, C.M.; Bolton, C.E.; Fawke, J.; Hennessy, E.; Stocks, J.; Wilkinson, I.B.; Cockcroft, J.R.; Marlow, N. 2011: Cardiovascular consequences of extreme prematurity: the EPICure study. Journal of Hypertension 29(7): 1367-1373

Grobe, J.L.; Dickson, M.E.; Park, S.; Davis, D.R.; Born, E.J.; Sigmund, C.D. 2010: Cardiovascular consequences of genetic variation at -6/235 in human angiotensinogen using "humanized" gene-targeted mice. Hypertension 56(5): 981-987

Scott, J.M.; Esch, B.T.A.; Goodman, L.S.; Bredin, S.S.D.; Haykowsky, M.J.; Warburton, D.E.R. 2007: Cardiovascular consequences of high-performance aircraft maneuvers: implications for effective countermeasures and laboratory-based simulations. Applied Physiology Nutrition and Metabolism 32(2): 332-339

Wauters, R.P.; Cosio, F.G.; Suarez Fernandez, M.L.; Kudva, Y.; Shah, P.; Torres, V.E. 2012: Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation. Transplantation 94(4): 377-382

Ramar, K.; Caples, S.M. 2010: Cardiovascular consequences of obese and nonobese obstructive sleep apnea. Medical Clinics of North America 94(3): 465-478

Purcell, H. 2013: Cardiovascular consequences of obesity: how will the UK cope?. Drugs in Context 2013: 212247

Kuniyoshi, F.H.Sert.; Pusalavidyasagar, S.; Singh, P.; Somers, V.K. 2010: Cardiovascular consequences of obstructive sleep apnoea. Indian Journal of Medical Research 131: 196-205

McCrindle, B.W. 2007: Cardiovascular consequences of paediatric obesity: will there be a future epidemic of premature cardiovascular disease?. Paediatrics and Child Health 12(3): 175-177

Grassi, G.; Seravalle, G.; Mancia, G. 2011: Cardiovascular consequences of poor compliance to antihypertensive therapy. Blood Pressure 20(4): 196-203

Bauldoff, G.S.; Housten-Harris, T.; Nunley, D.R. 2008: Cardiovascular consequences of pulmonary hypertension. Nursing Clinics of North America 43(1): 17-36; V

Foucher, A. 2007: Cardiovascular consequences of sleep apnea. Nephrologie and Therapeutique 3(7): 463-473

Golbidi, S.; Badran, M.; Ayas, N.; Laher, I. 2012: Cardiovascular consequences of sleep apnea. Lung 190(2): 113-132

Celen, Y.T.; Peker, Y.ük. 2010: Cardiovascular consequences of sleep apnea: i -epidemiology. Anadolu Kardiyoloji Dergisi: Akd 10(1): 75-80

Turgut Celen, Y.; Peker, Y.ük. 2010: Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms. Anadolu Kardiyoloji Dergisi: Akd 10(2): 168-175

Turgut Celen, Y.; Peker, Yüksel. 2010: Cardiovascular consequences of sleep apnea: III-impact of continuous positive airway pressure treatment. Anadolu Kardiyoloji Dergisi: Akd 10(3): 274-280

Dematteis, M.; Godin-Ribuot, D.; Arnaud, C.; Ribuot, C.; Stanke-Labesque, F.ço.; Pépin, J.-L.; Lévy, P. 2009: Cardiovascular consequences of sleep-disordered breathing: contribution of animal models to understanding the human disease. Ilar Journal 50(3): 262-281

Ladenson, P.W. 2008: Cardiovascular consequences of subclinical thyroid dysfunction: more smoke but no fire. Annals of Internal Medicine 148(11): 880-881

Rudolph, V.; Freeman, B.A. 2009: Cardiovascular consequences when nitric oxide and lipid signaling converge. Circulation Research 105(6): 511-522

Craft, M.K.; Reed, M.J. 2010: Cardiovascular considerations in critically ill obese patients. Critical Care Clinics 26(4): 603-605

Reamy, B.V.; Ledford, C.C. 2013: Cardiovascular considerations in middle-aged athletes at risk for coronary artery disease. Current Sports Medicine Reports 12(2): 70-76

Ross, C.; Frishman, W.H.; Peterson, S.J.; Lebovics, E. 2008: Cardiovascular considerations in patients undergoing gastrointestinal endoscopy. Cardiology in Review 16(2): 76-81

Zemtsovskiĭ, E.V. 2012: Cardiovascular continuum in Marfan syndrome. Klinicheskaia Meditsina 90(11): 4-9

Gorokhova, S.G. 2011: Cardiovascular continuum: possibilities of coenzyme-q in correction of oxidative stress. Kardiologiia 51(10): 61-67

Wieser, M.; Gisler, S.; Sarabadani, A.; Ruest, R.M.; Buetler, L.; Vallery, H.; Klamroth-Marganska, V.; Hund-Georgiadis, M.; Felder, M.; Schoenberger, J.L.; Gutknecht, C.; Riener, R. 2014: Cardiovascular control and stabilization via inclination and mobilization during bed rest. Medical and Biological Engineering and Computing 52(1): 53-64

Porta, A.; Castiglioni, P.; Di Rienzo, M.; Bassani, T.; Bari, V.; Faes, L.; Nollo, G.; Cividjan, A.; Quintin, L. 2013: Cardiovascular control and time domain Granger causality: insights from selective autonomic blockade. Philosophical Transactions. Series A Mathematical Physical and Engineering Sciences 371(1997): 20120161

Horne, R.S.C.; Witcombe, N.B.; Yiallourou, S.R.; Scaillet, S.; Thiriez, G.ér.; Franco, P. 2010: Cardiovascular control during sleep in infants: Implications for Sudden Infant Death Syndrome. Sleep Medicine 11(7): 615-621

Trinder, J. 2008: Cardiovascular control during sleep: "Sleep-dependent changes in the coupling between heart period and blood pressure in human subjects," by Silvani et al. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 294(5): R1684-R1685

Hainsworth, R. 2014: Cardiovascular control from cardiac and pulmonary vascular receptors. Experimental Physiology 99(2): 312-319

Morita, H.; Abe, C.; Tanaka, K. 2008: Cardiovascular control in space: Arterial pressure regulation under gravitational stress. Masui. Japanese Journal of Anesthesiology 57 Suppl: S66-S76

West, C.R.; Gee, C.M.; Voss, C.; Hubli, M.; Currie, K.D.; Schmid, J.; Krassioukov, A.V. 2015: Cardiovascular control, autonomic function, and elite endurance performance in spinal cord injury. Scandinavian Journal of Medicine and Science in Sports 25(4): 476-485

Urban, P.; Shreshta, N.; Karki, P.; Zimmermann, M.; Cook, S.; Pilgrim, T.; Meier, B. 2013: Cardiovascular cooperation with the BPKIHS Hospital, in Dharan Bazar, Nepal. Revue Medicale Suisse 9(376): 498-501

Kidambi, S.; Kotchen, J.M.; Krishnaswami, S.; Grim, C.E.; Kotchen, T.A. 2011: Cardiovascular correlates of insulin resistance in normotensive and hypertensive African Americans. Metabolism, Clinical and Experimental 60(6): 835-842

Roberts, N.A.; Levenson, R.W.; Gross, J.J. 2008: Cardiovascular costs of emotion suppression cross ethnic lines. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 70(1): 82-87

Schapkin, S.A.; Freude, G. 2013: Cardiovascular costs of working memory performance: effects of age and performance feedback. Industrial Health 51(4): 386-397

Schulz, S.; Tupaika, N.; Berger, S.; Haueisen, J.; Bär, K.-J.ür.; Voss, A. 2013: Cardiovascular coupling analysis with high-resolution joint symbolic dynamics in patients suffering from acute schizophrenia. Physiological Measurement 34(8): 883-901

Bae, J.Young.; Woo, C-Ho.; Kim, S.Hoon.; Kwak, I-Suk.; Mun, S.Ha.; Kim, K-Min. 2010: Cardiovascular crisis after small dose local infiltration of epinephrine in patient with asymptomatic subarachnoid hemorrhage -A case report-. Korean Journal of Anesthesiology 59 Suppl: S53-S57

Patil, H.R.; O'Keefe, J.H.; Lavie, C.J.; Magalski, A.; Vogel, R.A.; McCullough, P.A. 2012: Cardiovascular damage resulting from chronic excessive endurance exercise. Missouri Medicine 109(4): 312-321

Berthoux, F.; Mariat, C. 2010: Cardiovascular death after renal transplantation remains the first cause despite significant quantitative and qualitative changes. Transplantation 89(7): 806

Messerli, F.H.; Bangalore, S. 2012: Cardiovascular death and cancer death--competing risk?. American Journal of Cardiology 109(11): 1687

Marcucci, R.; Gori, A.Maria.; Paniccia, R.; Giusti, B.; Valente, S.; Giglioli, C.; Buonamici, P.; Antoniucci, D.; Abbate, R.; Gensini, G.Franco. 2009: Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 119(2): 237-242

Sniderman, A.D.; Solhpour, A.; Alam, A.; Williams, K.; Sloand, J.A. 2010: Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Clinical Journal of the American Society of Nephrology: Cjasn 5(2): 335-340

Opelz, G.; Döhler, B. 2014: Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. Transplantation 97(3): 310-315

Kuehn, B.M. 2012: Cardiovascular death risk linked to azithromycin use. JAMA 307(22): 2361

Eanes, R.H.; McGILL, K.H.; Clark, M.L. 1946: Cardiovascular defects in Selective Service registrants. American Heart Journal 32(4): 504-514

Kumari, U.; Heese, K. 2010: Cardiovascular dementia - a different perspective. Open Biochemistry Journal 4: 29-52

Wagner, J.G.; Allen, K.; Yang, H.-y.; Nan, B.; Morishita, M.; Mukherjee, B.; Dvonch, J.T.; Spino, C.; Fink, G.D.; Rajagopalan, S.; Sun, Q.; Brook, R.D.; Harkema, J.R. 2014: Cardiovascular depression in rats exposed to inhaled particulate matter and ozone: effects of diet-induced metabolic syndrome. Environmental Health Perspectives 122(1): 27-33

De Sutter, J.; Struyf, S.; Van de Veire, N.R.; Philippé, J.; De Buyzere, M.; Van Damme, J. 2010: Cardiovascular determinants and prognostic significance of CC Chemokine Ligand-18 (CCL18/PARC) in patients with stable coronary artery disease. Journal of Molecular and Cellular Cardiology 49(5): 894-896

Périard, J.D. 2013: Cardiovascular determinants involved in pacing under heat stress. Sports Medicine 43(7): 643-645

Shi, Y.; Camici, G.G.; Lüscher, T.F. 2010: Cardiovascular determinants of life span. Pflugers Archiv: European Journal of Physiology 459(2): 315-324

Bringard, A.él.; Pogliaghi, S.; Adami, A.; De Roia, G.; Lador, F.éd.ér.; Lucini, D.; Pizzinelli, P.; Capelli, C.; Ferretti, G. 2010: Cardiovascular determinants of maximal oxygen consumption in upright and supine posture at the end of prolonged bed rest in humans. Respiratory Physiology and Neurobiology 172(1-2): 53-62

Lee, S.S.; Liu, H. 2007: Cardiovascular determinants of survival in cirrhosis. Gut 56(6): 746-748

Lorandeau, C.G.; Hakkinen, L.A.; Moore, C.S. 2011: Cardiovascular development and survival during gestation in the Ts65Dn mouse model for down syndrome. Anatomical Record 294(1): 93-101

Nakajima, Y. 2009: Cardiovascular development: structure and molecular mechanism. Anatomical Science International 84(3): 65-66

Mucke, H.A.M. 2007: Cardiovascular developments: patent highlights July to December 2006. Current Opinion in Investigational Drugs 8(3): 193-200

Dean, L.S. 2011: Cardiovascular device technology and health care cost. Archives of Internal Medicine 171(18): 1689; Author's Reply 1689

Rowley, J.W.; Finn, A.V.; French, P.A.; Jennings, L.K.; Bluestein, D.; Gross, P.L.; Freedman, J.E.; Steinhubl, S.R.; Zimmerman, G.A.; Becker, R.C.; Dauerman, H.L.; Smyth, S.S.; Becker, R.C.; Bluestein, D.; Cannon, C.P.; Consigny, M.; Cutlip, D.E.; Dauerman, H.L.; Eppihimer, M.J.; Farb, A.; Finn, A.; Freedman, J.E.; French, P.A.; Girdhar, G.; Granada, J.F.; Gross, P.L.; Hochholzer, W.; Jacoski, M.V.; Jasuja, R.; Jennings, L.K.; Kurane, A.; Lynch, D.R.; Melder, R.; Prats, J.; Price, M.J.; Rowley, J.W.; Rozek, M.; Rusconi, C.P.; Sheehy, A.; Smyth, S.S.; Steinhubl, S.R.; Yang, F.; Zimmerman, G.A. 2012: Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. CIRCULATION. Cardiovascular Interventions 5(2): 296-304

Abramczuk, E.żb.; Heretyk-Grabowska, H.; Grabowski, M.; Demkow, M.; Witkowski, A.; Konka, M.; Hryniewiecki, T. 2011: Rare complication after mitral valve replacement due to infective endocarditis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 17(6): Cq1-Cq2

Durand, J. 2010: The Peruvian diaspora: portrait of a migratory process. Latin American Perspectives 37(5): 12-28

Anonymous 2013: Cardiovascular devices; reclassification of external counter-pulsating devices for treatment of chronic stable angina; effective date of requirement for premarket approval for external counter-pulsating devices for other specified intended uses. Final order. Federal register 78(250): 79304-79308

Rees, J. 2013: PSA in men in their 40s predicts risk of prostate cancer death. Practitioner 257(1764): 5

Wagner, S.; Grin, I.; Malmsheimer, S.; Singh, N.; Torres-Vargas, C.E.; Westerhausen, S. 2018: Bacterial type IIi secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells. Fems Microbiology Letters 365(19)

Suzuki, T. 2009: Cardiovascular diagnostic biomarkers: the past, present and future. Circulation Journal: Official Journal of the Japanese Circulation Society 73(5): 806-809

Patrick, T.H.H.; Fong, A.Y.Y.; Sebastian, Y.; Raman, V.; Wong, Y.H.Colin.; Sim, K.H. 2009: Cardiovascular diagnostics mining on Borneo island: from labour-intensive to prototype. Informatics for Health and Social Care 34(1): 1-9

Heyen, J.R.; Hu, W.; Jamieson, J.; Thibault, S.; Batugo, M.; Loi, C.-M.; Burns-Naas, L.A.; McHarg, A.D.; Jessen, B. 2013: Cardiovascular differentiation of imatinib and bosutinib in the rat. International Journal of Hematology 98(5): 597-607

Sommerkamp, S.K.; Gibson, A. 2012: Cardiovascular disasters in pregnancy. Emergency Medicine Clinics of North America 30(4): 949-959

Le, N-Anh. 2007: Cardiovascular disease. Current Opinion in Lipidology 18(6): 692-695

Brown, A.; Kritharides, L. 2010: Cardiovascular disease. HeartLungandCirculation 19(5-6): 263

Mooney, T. 2012: Cardiovascular disease. Nursing Standard: 1987) 26(39): 59

Risérus, U. 2015: Cardiovascular disease. World Review of Nutrition and Dietetics 111: 94-99

Norum, J. 2010: Cardiovascular disease (CVD) in the Norwegian Arctic. Air ambulance operations 1999-2009 and future challenges in the region. International maritime health 62(3): 117-122

Maahs, D.M. 2012: Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?. Diabetes Technology and Therapeutics 14(6): 449-452

Chen, G.; Lai, X.; Jiang, Q.; Chen, F.; Chen, N.; Huang, H.; Liang, J.; Li, L.; Wen, J.; Lin, L.; Yao, J. 2011: Cardiovascular disease (CVD) risk, insulin resistance and β-cell function in prehypertension population of China. Atherosclerosis 217(1): 279-285

Armenian, S.H.; Bhatia, S. 2008: Cardiovascular disease after hematopoietic cell transplantation--lessons learned. Haematologica 93(8): 1132-1136

Lee, H.; Kershaw, K.N.; Hicken, M.T.; Abdou, C.M.; Williams, E.S.; Rivera-O'Reilly, N.; Jackson, J.S. 2013: Cardiovascular disease among Black Americans: comparisons between the U.S. Virgin Islands and the 50 U.S. states. Public Health Reports 128(3): 170-178

Garg, A.K.; Verma, P. 2010: Cardiovascular disease among South Asians. Cmaj: Canadian Medical Association Journal 182(12): 1334; Author Reply 1334

Jones, L.M.; Stoner, L.; Brown, C.; Baldi, C.; McLaren, B. 2013: Cardiovascular disease among breast cancer survivors: the call for a clinical vascular health toolbox. Breast Cancer Research and Treatment 142(3): 645-653

Ferguson, T.S.; Tulloch-Reid, M.K.; Younger, N.O.; Boyne, M.S.; Wright-Pascoe, R.A.; Elliott, V.E.; Van den Broeck, J.; Wilks, R.J. 2010: Cardiovascular disease among diabetic in-patients at a tertiary hospital in Jamaica. Diabetes and Vascular Disease Research 7(3): 241-242

Ricardo, A.C.; Lash, J.P.; Fischer, M.J.; Lora, C.M.; Budoff, M.; Keane, M.G.; Kusek, J.W.; Martinez, M.; Nessel, L.; Stamos, T.; Ojo, A.; Rahman, M.; Soliman, E.Z.; Yang, W.; Feldman, H.I.; Go, A.S.; Feldman, H.I.; Richard Landis, J.; Appleby, D.H.; Ballard, S.; Cifelli, D.; Curley, R.M.; Dickson, J.; Durborow, M.; Durborow, S.; Glenn, M.; Hanish, A.; Helker, C.; Helker, E.S.; Hyre Anderson, A.; Joffe, M.; Kasner, S.; Kimmel, S.E.; Kumanyika, S.; Nessel, L.; Mohler, E.R.; Messe, S.R.; Robinson, N.; Rosen, L.; Sanford Schwartz, J.; Smith, S.; Stahl, J.; Tao, K.; Teal, V.L.; Wang, X.; Xie, D.; Yang, P.; Zhang, X.; Townsend, R.R.; Cohen, D.; Cuevas, M.; Duckworth, M.J.; Dries, D.L.; Ford, V.; Gorman, C.M.; Grunwald, J.; Hannah, H.M.; Kanetsky 2011: Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clinical Journal of the American Society of Nephrology: Cjasn 6(9): 2121-2131

Traum, A.H.; Wilcox, B.B. 1946: Cardiovascular disease among veterans of World War II; a survey of 19,870 cases. New England Journal of Medicine 234: 82-86

Ferdinand, K.C. 2007: Cardiovascular disease and African Americans: why determination of race is inadequate for research and practice. Journal of the National Medical Association 99(6): 686-689

Shastri, S.; Sarnak, M.J. 2010: Cardiovascular disease and CKD: core curriculum 2010. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 56(2): 399-417

Havlik, R. 2007: Cardiovascular disease and HIV. Gmhc Treatment Issues: the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 21(2): 5-7

Triant, V.A. 2013: Cardiovascular disease and HIV infection. Current Hiv/Aids Reports 10(3): 199-206

Martínez, E.; Larrousse, M.ía.; Gatell, J.é M. 2009: Cardiovascular disease and HIV infection: host, virus, or drugs?. Current Opinion in Infectious Diseases 22(1): 28-34

Adar, S.D.; Kaufman, J.D. 2007: Cardiovascular disease and air pollutants: evaluating and improving epidemiological data implicating traffic exposure. Inhalation Toxicology 19 Suppl. 1: 135-149

Touze, J.-Ét.; Métais, P.; Zawieja, P. 2012: Cardiovascular disease and aircraft transportation: specificities and issues. Presse Medicale 41(2): 109-115

Joy, M. 2007: Cardiovascular disease and airline travel. Heart 93(12): 1507-1509

Mueller, U.R. 2007: Cardiovascular disease and anaphylaxis. Current Opinion in Allergy and Clinical Immunology 7(4): 337-341

Kaushik, M.; Sontineni, S.P.; Hunter, C. 2010: Cardiovascular disease and androgens: a review. International Journal of Cardiology 142(1): 8-14

Swartz, H.A.; Fagiolini, A. 2012: Cardiovascular disease and bipolar disorder: risk and clinical implications. Journal of Clinical Psychiatry 73(12): 1563-1565

Eastell, R.; Newman, C.; Crossman, D.C. 2010: Cardiovascular disease and bone. Archives of Biochemistry and Biophysics 503(1): 78-83

Reyes-García, R.; Rozas-Moreno, P.; Muñoz-Torres, M. 2011: Cardiovascular disease and bone metabolism. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 58(7): 353-359

Wachira, J.K.; Stys, T.P. 2013: Cardiovascular disease and bridging the diagnostic gap. South Dakota Medicine: the Journal of the South Dakota State Medical Association 66(9): 366-369

Irving, G. 2014: Cardiovascular disease and cancer compete for the outcome of death. Bmj 349: G5227

Strandberg, T.E. 2008: Cardiovascular disease and cancer in very old age. Bmj 337: A2521

Van der Zee, S.; Fuster, V. 2009: Cardiovascular disease and chronic kidney disease: from treatment to promoting health. Medicina Clinica 132(Suppl 1): 33-37

Sata, M. 2010: Cardiovascular disease and chronic obstructive pulmonary disease. Circulation Journal: Official Journal of the Japanese Circulation Society 74(2): 254-255

Bayés, B.; Romero, R.ón. 2008: Cardiovascular disease and chronic renal failure or vice versa. Medicina Clinica 131(2): 60-62

Kimball, A.B.; Wu, Y. 2009: Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. International Journal of Dermatology 48(11): 1147-1156

Haring, B.; Leng, X.; Robinson, J.; Johnson, K.C.; Jackson, R.D.; Beyth, R.; Wactawski-Wende, J.; von Ballmoos, M.W.; Goveas, J.S.; Kuller, L.H.; Wassertheil-Smoller, S. 2013: Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study. Journal of the American Heart Association 2(6): E000369

Atlantis, E.; Grayson, D.A.; Browning, C.; Sims, J.; Kendig, H. 2011: Cardiovascular disease and death associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). International Journal of Geriatric Psychiatry 26(4): 341-350

Mehta, L.S. 2011: Cardiovascular disease and depression in women. Heart Failure Clinics 7(1): 39-45

Puri, B.K. 2008: Cardiovascular disease and depression: the PUFA connection. International Journal of Clinical Practice 62(3): 355-357

Hert, M.D.; Dekker, J.M.; Wood, D.; Kahl, K.G.; Möller, H.-J.ür. 2009: Cardiovascular disease and diabetes in people with severe mental illness. Revista de Psiquiatria y Salud Mental 2(1): 49-59

De Hert, M.; Dekker, J.M.; Wood, D.; Kahl, K.G.; Holt, R.I.G.; Möller, H-J. 2009: Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European psychiatry: the journal of the Association of European Psychiatrists 24(6): 412-424

Basa, A.L.; Garber, A.J. 2001: Cardiovascular disease and diabetes: modifying risk factors other than glucose control. Ochsner Journal 3(3): 132-137

Papadodima, S.A.; Sakelliadis, E.I.; Kotretsos, P.S.; Athanaselis, S.A.; Spiliopoulou, C.A. 2007: Cardiovascular disease and drowning: autopsy and laboratory findings. Hellenic Journal of Cardiology: Hjc 48(4): 198-205

Mehta, P.K.; Bairey Merz, C.N. 2012: Cardiovascular disease and endometrial cancer. Gynecologic Oncology 126(2): 171-173

Bukhman, G.; Kidder, A. 2008: Cardiovascular disease and global health equity: lessons from tuberculosis control then and now. American Journal of Public Health 98(1): 44-54

Bloomgarden, Z.T. 2010: Cardiovascular disease and glycemic treatment. Diabetes Care 33(11): E134-E139

Katsi, V.; Felekos, I.; Skevofilax, S.; Aggeli, C.; Tousoulis, D.; Stefanadis, C.; Kallikazaros, I. 2015: Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship?. Cardiology in Review 23(1): 11-17

Ajjan, R.A.; Ariëns, R.A.S. 2009: Cardiovascular disease and heritability of the prothrombotic state. Blood Reviews 23(2): 67-78

Xu, B.; Han, L.; Liu, H.; Wang, J.; Bao, X.-Y.; Xi, H.-X.; Zhao, L.; Yu, G.-P. 2013: Cardiovascular disease and hip fracture among older inpatients in Beijing, China. Biomed Research International 2013: 493696

Goldstein, B.I.; Fagiolini, A.; Houck, P.; Kupfer, D.J. 2009: Cardiovascular disease and hypertension among adults with bipolar i disorder in the United States. Bipolar Disorders 11(6): 657-662

Meier, M.; Hummel, M. 2009: Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies. Vascular Health and Risk Management 5: 859-871

Younis, N.; Soran, H.; Hassanein, M. 2009: Cardiovascular disease and intensive glucose lowering in type 2 diabetes. Qjm: Monthly Journal of the Association of Physicians 102(4): 293-296

Wood, A.; Docimo, S.; Elkowitz, D.E. 2010: Cardiovascular disease and its association with histological changes of the left stellate ganglion. Clinical Medicine Insights. Pathology 3: 19-24

Liu, M.; Li, X.-C.; Lu, L.; Cao, Y.; Sun, R.-R.; Chen, S.; Zhang, P.-Y. 2014: Cardiovascular disease and its relationship with chronic kidney disease. European Review for Medical and Pharmacological Sciences 18(19): 2918-2926

Małyszko, J.; Bachorzewska-Gajewska, H.; Tomaszuk-Kazberuk, A.; Matuszkiewicz-Rowińska, J.; Durlik, M.; Dobrzycki, S.ła. 2014: Cardiovascular disease and kidney transplantation‑evaluation of potential transplant recipient. Polskie Archiwum Medycyny Wewnetrznej 124(11): 608-616

Dosi, R.; Bhatt, N.; Shah, P.; Patell, R. 2014: Cardiovascular disease and menopause. Journal of Clinical and Diagnostic Research: Jcdr 8(2): 62-64

Kilbourne, A.M.; Brar, J.S.; Drayer, R.A.; Xu, X.; Post, E.P. 2007: Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics 48(5): 412-417

Cannon, C.P. 2007: Cardiovascular disease and modifiable cardiometabolic risk factors. Clinical Cornerstone 8(3): 11-28

Prior, J.A.; Kadam, U.T. 2011: Cardiovascular disease and musculoskeletal disorder labels in family practice acted as markers of physical health severity. Journal of Clinical Epidemiology 64(5): 547-555

Pham, T.T.; Miller, M.J.; Harrison, D.L.; Lloyd, A.E.; Crosby, K.M.; Johnson, J.L. 2013: Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines. Journal of Evaluation in Clinical Practice 19(6): 1026-1034

Domanski, J.P.; Park, S.J.; Harrison, S.A. 2012: Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?. Journal of Clinical Gastroenterology 46(5): 427-430

Cantwell, J.D. 2008: Cardiovascular disease and olympic games in China. American Journal of Cardiology 101(4): 542-543

Home, P. 2012: Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes. Diabetes Technology and Therapeutics 14(Suppl 1): S33-S42

Warburton, D.E.R.; Nicol, C.W.; Gatto, S.N.; Bredin, S.S.D. 2007: Cardiovascular disease and osteoporosis: balancing risk management. Vascular Health and Risk Management 3(5): 673-689

Kallen, A.N.; Pal, L. 2011: Cardiovascular disease and ovarian function. Current Opinion in Obstetrics and Gynecology 23(4): 258-267

Persson, Gösta.Rutger.; Persson, R.Elisabeth. 2008: Cardiovascular disease and periodontitis: an update on the associations and risk. Journal of Clinical Periodontology 35(8 Suppl): 362-379

Tenenbaum, A.; Morad, M.; Merrick, J. 2014: Cardiovascular disease and prevention. International Journal of Adolescent Medicine and Health 26(4): 457-458

Gamberale, D.; Pecora, A.; Ardù, M. 2010: Cardiovascular disease and professional activities. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 32(4 Suppl): 150-152

Larsen, B.A.; Christenfeld, N.J.S. 2009: Cardiovascular disease and psychiatric comorbidity: the potential role of perseverative cognition. Cardiovascular Psychiatry and Neurology 2009: 791017

Charles-Schoeman, C. 2012: Cardiovascular disease and rheumatoid arthritis: an update. Current Rheumatology Reports 14(5): 455-462

Ueshima, H.; Sekikawa, A.; Miura, K.; Turin, T.Chowdhury.; Takashima, N.; Kita, Y.; Watanabe, M.; Kadota, A.; Okuda, N.; Kadowaki, T.; Nakamura, Y.; Okamura, T. 2008: Cardiovascular disease and risk factors in Asia: a selected review. Circulation 118(25): 2702-2709

McGorrian, C.; Daly, L.; Fitzpatrick, P.; Moore, R.G.; Turner, J.; Kelleher, C.C.; Abdalla, S.; Cronin, F.; Drummond, A.; Frazer, K.; Hamid, N.A.; Kelly, C.; Kilroe, J.; Lotya, J.; Murnane, S.; Nic Chárthaigh, R.ói.ín.; O'Mahony, D.; O'Shea, B.íd.; Quirke, B.; Staines, A.; Staines, D.; Sweeney, M.R.; Ward, A.; Whelan, J. 2012: Cardiovascular disease and risk factors in an indigenous minority population. the All-Ireland Traveller Health Study. European Journal of Preventive Cardiology 19(6): 1444-1453

Zimmerman, F.H. 2012: Cardiovascular disease and risk factors in law enforcement personnel: a comprehensive review. Cardiology in Review 20(4): 159-166

Tobin, A.-M.; Veale, D.J.; Fitzgerald, O.; Rogers, S.; Collins, P.; O'Shea, D.; Kirby, B. 2010: Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. Journal of Rheumatology 37(7): 1386-1394

Bonakdaran, S.; Ebrahimzadeh, S.; Noghabi, S.H. 2011: Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. Eastern Mediterranean Health Journal 17(9): 640-646

Bexelius, T.S.öb.; Ljung, R.; Mattsson, F.; Lagergren, J. 2013: Cardiovascular disease and risk of acute pancreatitis in a population-based study. Pancreas 42(6): 1011-1015

Vordenbäumen, S.; Sander, O.; Bleck, E.; Schneider, M.; Fischer-Betz, R. 2012: Cardiovascular disease and serum defensin levels in systemic lupus erythematosus. Clinical and Experimental Rheumatology 30(3): 364-370

Pfister, O. 2010: Cardiovascular disease and sexuality. Therapeutische Umschau. Revue Therapeutique 67(3): 139-143

Bhattacharjee, R.; Gozal, D. 2009: Cardiovascular disease and sleep disordered breathing: are children vulnerable?. Sleep 32(10): 1251-1252

Cragg, J.J.; Noonan, V.K.; Krassioukov, A.; Borisoff, J. 2013: Cardiovascular disease and spinal cord injury: results from a national population health survey. Neurology 81(8): 723-728

Campbell, A.W. 2014: Cardiovascular disease and statin drugs. Alternative Therapies in Health and Medicine 20(5): 8-9

Cury, R.C.; Techasith, T.; Feuchtner, G.; Dabus, G. 2011: Cardiovascular disease and stroke in women: role of radiology. AJR. American Journal of Roentgenology 196(2): 265-273

Foley, R.N. 1999: Cardiovascular disease and survival in ESRD. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 10(4): 455-463

Peterson, P.N.; Masoudi, F.A. 2007: Cardiovascular disease and the elderly: can the evidence base avoid irrelevance?. European Heart Journal 28(11): 1277-1278

Marx, J.L. 1976: Cardiovascular disease and the forms it takes. Science 194(4264): 511

Leishman, S.J.; Do, H.L.; Ford, P.J. 2010: Cardiovascular disease and the role of oral bacteria. Journal of Oral Microbiology 2

Drebes Dörr, N.ál.C.; Blokesch, M. 2018: Bacterial type Vi secretion system facilitates niche domination. Proceedings of the National Academy of Sciences of the United States of America 115(36): 8855-8857

Kramer, C.K.; Zinman, B. 2013: Cardiovascular disease and the use of insulin. Diabetes Technology and Therapeutics 15(10): 789-791

Fisher, S.D.; Kanda, B.S.; Miller, T.L.; Lipshultz, S.E. 2011: Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 11(6): 383-394

Faber, J.; Selmer, C. 2014: Cardiovascular disease and thyroid function. Frontiers of Hormone Research 43: 45-56

Gore, M.O.; McGuire, D.K. 2009: Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugs. Current Cardiology Reports 11(4): 258-263

Ageno, W.; Dentali, F.; Romualdi, E.; Squizzato, A. 2008: Cardiovascular disease and venous thromboembolism. Different disorders or possible intriguing association?. Recenti Progressi in Medicina 99(11): 572-577

Ford, J.A.; MacLennan, G.S.; Avenell, A.; Bolland, M.; Grey, A.; Witham, M.; Grant, A.M.; Avenell, A.; Campbell, M.K.; McDonald, A.M.; MacLennan, G.S.; McPherson, G.C.; Anderson, F.H.; Cooper, C.; Francis, R.M.; Donaldson, C.; Gillespie, W.J.; Robinson, C.M.; Torgerson, D.J.; Wallace, W.A. 2014: Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. American Journal of Clinical Nutrition 100(3): 746-755

Sola-Visner, M. 2011: Cardiovascular disease and weight ... at birth. Blood 118(6): 1439-1441

Zárate, A.; Saucedo, R.; Basurto, L.; Martínez, C. 2007: Cardiovascular disease as a current threat of older women. Relation to estrogens. Ginecologia y Obstetricia de Mexico 75(5): 286-292

Semb, A.G.; Rollefstad, S.; van Riel, P.; Kitas, G.D.; Matteson, E.L.; Gabriel, S.E. 2014: Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice. Annals of the Rheumatic Diseases 73(7): 1284-1288

Halle, M.; Hall, P.; Tornvall, P. 2011: Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B. Journal of Internal Medicine 269(5): 469-477

Metkus, T.S.; Brown, T.T.; Post, W.S. 2014: Cardiovascular disease associated with the human immunodeficiency virus: an update. Current Treatment Options in Cardiovascular Medicine 16(11): 346

Coca, A. 2012: Cardiovascular disease based on gender: myths and evidence. Revista Clinica Espanola 212(2): 81-83

Boyle, R.; Field, S.; Sparrow, N.; Howe, A.; Rafi, I. 2010: Cardiovascular disease beyond the QOF. British Journal of General Practice: the Journal of the Royal College of General Practitioners 60(577): 558-560

Karam, P.E.; Majdalani, M.N.; Daher, R.T.; Barhoumi, A.; Yazbeck, N. 2015: Cardiovascular disease biomarkers in patients with inborn errors of protein metabolism: a pilot study. Journal of Human Nutrition and Dietetics: the Official Journal of the British Dietetic Association 28(4): 344-349

Keddis, M.T.; Bhutani, G.; El-Zoghby, Z.M. 2014: Cardiovascular disease burden and risk factors before and after kidney transplant. Cardiovascular and Hematological Disorders Drug Targets 14(3): 185-194

Alonge, V.O.; Grant, T.; Drummond, A.; Sugrue, D.; Codd, M. 2013: Cardiovascular disease burden in acute public hospitals in Ireland: estimates for 2021 and 2031. Irish Journal of Medical Science 182(2): 245-253

Ahmed, A.; Ekundayo, O.J. 2009: Cardiovascular disease care in the nursing home: the need for better evidence for outcomes of care and better quality for processes of care. Journal of the American Medical Directors Association 10(1): 1-3

Hata, S. 2009: Cardiovascular disease caused by earthquake-induced stress: psychological stress and cardiovascular disease. Circulation Journal: Official Journal of the Japanese Circulation Society 73(7): 1195-1196

Patnaik, J.L.; Byers, T.; DiGuiseppi, C.; Dabelea, D.; Denberg, T.D. 2011: Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Research: Bcr 13(3): R64

Torres, A.; Askari, A.D.; Malemud, C.J. 2009: Cardiovascular disease complications in systemic lupus erythematosus. Biomarkers in Medicine 3(3): 239-252

Liu, G.; Yao, L.; Liu, J.; Jiang, Y.; Ma, G.; Chen, Z.; Zhao, B.; Li, K.; Harold, D.; Abraham, R.; Hollingworth, P.; Sims, R.; Gerrish, A.; Chapman, J.; Russo, G.; Hamshere, M.; Pahwa, J.Singh.; Moskvina, V.; Dowzell, K.; Williams, A.; Jones, N.; Thomas, C.; Stretton, A.; Morgan, A.; Lovestone, S.; Powell, J.; Proitsi, P.; Lupton, M.K.; Brayne, C.; Rubinsztein, D.C.; Gill, M.; Lawlor, B.; Morgan, K.; Brown, K.; Passmore, P.; Craig, D.; McGuinness, B.; Todd, S.; Johnston, J.; Holmes, C.; Mann, D.; Smith, A..David.; Love, S.; Keh 2014: Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies. Neurobiology of Aging 35(4): 786-792

Releford, B.J.; Frencher, S.K.; Yancey, A.K.; Norris, K. 2010: Cardiovascular disease control through barbershops: design of a nationwide outreach program. Journal of the National Medical Association 102(4): 336-345

Taylor, J. 2013: Vegetarian diet cuts risk of heart disease by one-third. European Heart Journal 34(21): 1531

Altintas, Z.; Fakanya, W.M.; Tothill, I.E. 2014: Cardiovascular disease detection using bio-sensing techniques. Talanta 128: 177-186

Aluli, N.E.; Reyes, P.W.; Tsark, J.'U. 2007: Cardiovascular disease disparities in native Hawaiians. Journal of the Cardiometabolic Syndrome 2(4): 250-253

Kaul, U. 2012: Cardiovascular disease epidemic in India--a continuing problem. Journal of the Association of Physicians of India 60: 9

Ohira, T.; Iso, H. 2013: Cardiovascular disease epidemiology in Asia: an overview. Circulation Journal: Official Journal of the Japanese Circulation Society 77(7): 1646-1652

Jordan, H.T.; Stellman, S.D.; Morabia, A.; Miller-Archie, S.A.; Alper, H.; Laskaris, Z.; Brackbill, R.M.; Cone, J.E. 2013: Cardiovascular disease hospitalizations in relation to exposure to the September 11, 2001 World Trade Center disaster and posttraumatic stress disorder. Journal of the American Heart Association 2(5): E000431

Livesay, J.J. 2007: Cardiovascular disease in Africa. Texas Heart Institute Journal 34(1): 6-7

Williams, R.Allen. 2009: Cardiovascular disease in African American women: a health care disparities issue. Journal of the National Medical Association 101(6): 536-540

MacDonald, I. 2009: Cardiovascular disease in Australia and new Zealand: early origins, ethnic disparities, opportunities. European Heart Journal 30(7): 746-747

Wilson, A.C.; Mitsnefes, M.M. 2009: Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 54(2): 345-360

Bhatt, S.P.; Wells, J.M.; Dransfield, M.T. 2014: Cardiovascular disease in COPD: a call for action. LANCET. Respiratory Medicine 2(10): 783-785

Maclay, J.D.; MacNee, W. 2013: Cardiovascular disease in COPD: mechanisms. Chest 143(3): 798-807

Cao, Y.; Davidson, P.M.; DiGiacomo, M. 2009: Cardiovascular disease in China: an urgent need to enhance the nursing role to improve health outcomes. Journal of Clinical Nursing 18(5): 687-693

Zhao, D.; Liu, J. 2012: Cardiovascular disease in China: increasing burden ahead for prevention. Zhonghua Xin Xue Guan Bing Za Zhi 40(3): 177-178

Cao, Y.; DiGiacomo, M.; Du, H.Y.; Ollerton, E.; Davidson, P. 2008: Cardiovascular disease in Chinese women: an emerging high-risk population and implications for nursing practice. Journal of Cardiovascular Nursing 23(5): 386-394; Quiz: 395-396

De Leo, M.; Pivonello, R.; Auriemma, R.S.; Cozzolino, A.; Vitale, P.; Simeoli, C.; De Martino, M.C.; Lombardi, G.; Colao, A. 2010: Cardiovascular disease in Cushing's syndrome: heart versus vasculature. Neuroendocrinology 92(Suppl 1): 50-54

Rayner, M.; Allender, S.; Scarborough, P. 2009: Cardiovascular disease in Europe. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 16(Suppl 2): S43-S47

Nichols, M.; Townsend, N.; Scarborough, P.; Rayner, M. 2014: Cardiovascular disease in Europe 2014: epidemiological update. European Heart Journal 35(42): 2929

Perk, J. 2012: Cardiovascular disease in Europe is not only a success story. Lakartidningen 109(47): 2143

Nichols, M.; Townsend, N.; Scarborough, P.; Rayner, M. 2013: Cardiovascular disease in Europe: epidemiological update. European Heart Journal 34(39): 3028-3034

Palella, F.J.; Phair, J.P. 2011: Cardiovascular disease in HIV infection. Current Opinion in HIV and Aids 6(4): 266-271

Lo, J.; Grinspoon, S. 2008: Cardiovascular disease in HIV-infected patients: does HIV infection in and of itself increase cardiovascular risk?. Current Opinion in HIV and Aids 3(3): 207-213

Grinspoon, S.K. 2014: Cardiovascular disease in HIV: traditional and nontraditional risk factors. Topics in Antiviral Medicine 22(4): 676-679

Al Shimemeri, A. 2012: Cardiovascular disease in Hajj pilgrims. Journal of the Saudi Heart Association 24(2): 123-127

Ashavaid, T.F.; Ponde, C.K.; Shah, S.; Jawanjal, M. 2012: Cardiovascular disease in India. Clinics in Laboratory Medicine 32(2): 217-230

Prabhakaran, D.; Yusuf, S. 2010: Cardiovascular disease in India: lessons learnt and challenges ahead. Indian Journal of Medical Research 132: 529-530

Tejero, M.E. 2010: Cardiovascular disease in Latin American women. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 20(6): 405-411

Shara, N.M. 2010: Cardiovascular disease in Middle Eastern women. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 20(6): 412-418

Prendiville, T.W.; Gauvreau, K.; Tworog-Dube, E.; Patkin, L.; Kucherlapati, R.S.; Roberts, A.E.; Lacro, R.V. 2014: Cardiovascular disease in Noonan syndrome. Archives of Disease in Childhood 99(7): 629-634

Avezum, A.; Braga, J.; Santos, I.; Guimarães, H.P.; Marin-Neto, J.A.; Piegas, L.S. 2009: Cardiovascular disease in South America: current status and opportunities for prevention. Heart 95(18): 1475-1482

Soteriades, E.S.; Smith, D.L.; Tsismenakis, A.J.; Baur, D.M.; Kales, S.N. 2011: Cardiovascular disease in US firefighters: a systematic review. Cardiology in Review 19(4): 202-215

Collins, R.Thomas. 2013: Cardiovascular disease in Williams syndrome. Circulation 127(21): 2125-2134

Head, R.F.; Gilthorpe, M.S.; Byrom, A.; Ellison, G.T.H. 2008: Cardiovascular disease in a cohort exposed to the 1940-45 Channel Islands occupation. Bmc Public Health 8: 303

Sullenberger, L.; Gentlesk, P.J. 2008: Cardiovascular disease in a forward military hospital during operation iraqi freedom: a report from deployed cardiologists. Military medicine 173(2): 193-197

McDonald, C.L.; Kaltman, J.R. 2009: Cardiovascular disease in adult and pediatric HIV/AIDS. Journal of the American College of Cardiology 54(13): 1185-1188

Shobeiri, N.; Pang, J.; Adams, M.A.; Holden, R.M. 2013: Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences. Journal of Hypertension 31(1): 160-168

Tseng, C.-H. 2008: Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 199(1): 12-18

Hollan, I.; Meroni, P.L.; Ahearn, J.M.; Cohen Tervaert, J.W.; Curran, S.; Goodyear, C.S.; Hestad, K.A.; Kahaleh, B.; Riggio, M.; Shields, K.; Wasko, M.C. 2013: Cardiovascular disease in autoimmune rheumatic diseases. Autoimmunity Reviews 12(10): 1004-1015

Ferdinand, K.C. 2008: Cardiovascular disease in blacks: can we stop the clock?. Journal of Clinical Hypertension 10(5): 382-389

Maisch, B. 2011: Cardiovascular disease in cancer patients… only the tip of the iceberg?. Herz 36(4): 287-289

Herouvi, D.; Karanasios, E.; Karayianni, C.; Karavanaki, K. 2013: Cardiovascular disease in childhood: the role of obesity. European Journal of Pediatrics 172(6): 721-732

Truong, U.T.; Maahs, D.M.; Daniels, S.R. 2012: Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?. Diabetes Technology and Therapeutics 14(Suppl 1): S11-S21

Massoure, P.-L.; Roche, N.-C.; Lamblin, G.; Dehan, C.; Kaiser, E.; Fourcade, L. 2013: Cardiovascular disease in children in Djibouti: a single-centre study. Pan African Medical Journal 14: 141

Mitsnefes, M.M. 2012: Cardiovascular disease in children with chronic kidney disease. Journal of the American Society of Nephrology: Jasn 23(4): 578-585

Saran, A.M.; DuBose, T.D. 2008: Cardiovascular disease in chronic kidney disease. Therapeutic Advances in Cardiovascular Disease 2(6): 425-434

McCullough, P.A.; Steigerwalt, S.; Tolia, K.; Chen, S-Cheng.; Li, S.; Norris, K.C.; Whaley-Connell, A. 2011: Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Current Diabetes Reports 11(1): 47-55

Ardhanari, S.; Alpert, M.A.; Aggarwal, K. 2014: Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention. Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 30: 40-53

Os, I. 2008: Cardiovascular disease in chronic kidney failure. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(11): 1297

Iliou, M.C.; Fumeron, C. 2005: Cardiovascular disease in chronic renal failure patients. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 16(2): 129-139

Bloomgarden, Z.T. 2008: Cardiovascular disease in diabetes. Diabetes Care 31(6): 1260-1266

Bloomgarden, Z.T. 2010: Cardiovascular disease in diabetes. Diabetes Care 33(4): E49-E54

Siqueira, A.F.A.; Almeida-Pititto, B.d.; Ferreira, S.R.G. 2007: Cardiovascular disease in diabetes mellitus: classical and non-classical risk factors. Arquivos Brasileiros de Endocrinologia e Metabologia 51(2): 257-267

Szuszkiewicz-Garcia, M.M.; Davidson, J.A. 2014: Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. Endocrinology and Metabolism Clinics of North America 43(1): 25-40

Smanio, P. 2007: Cardiovascular disease in diabetic women without cardiac symptoms. Arquivos Brasileiros de Endocrinologia e Metabologia 51(2): 305-311

Aslam, S. 2008: Cardiovascular disease in dialysis patients: do some antihypertensive drugs have specific antioxidant effects or is it just blood pressure reduction? Does antioxidant treatment reduce the risk for cardiovascular disease?. Current Opinion in Nephrology and Hypertension 17(1): 99-105

Miller, L.M.; Sood, M.M.; Sood, A.R.; Reslerova, M.; Komenda, P.; Rigatto, C.; Bueti, J. 2010: Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients. International Urology and Nephrology 42(4): 1007-1014

Belcastro, V.; Striano, P. 2009: Cardiovascular disease in epileptic patients: how to assess the clinical risk?. Annals of Neurology 66(6): 868

Alonso, R.; Mata, N.; Castillo, S.; Fuentes, F.; Saenz, P.; Muñiz, O.; Galiana, J.; Figueras, R.; Diaz, J.L.; Gomez-Enterría, P.; Mauri, M.; Piedecausa, M.; Irigoyen, L.; Aguado, R.; Mata, P. 2008: Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 200(2): 315-321

Mannucci, P.M.; Mauser-Bunschoten, E.P. 2010: Cardiovascular disease in haemophilia patients: a contemporary issue. Haemophilia: the Official Journal of the World Federation of Hemophilia 16(Suppl 3): 58-66

Cheruvu, S.; Holloway, C.J. 2014: Cardiovascular disease in human immunodeficiency virus. Internal Medicine Journal 44(4): 315-324

Gijón-Conde, T.; Banegas, J.R. 2012: Cardiovascular disease in hypertension: gender differences in 100,000 clinical records. Revista Clinica Espanola 212(2): 55-62

Kaufman, J.G. 1946: Cardiovascular disease in industry. Industrial Nursing 5(12): 27-30

Garg, A.X.; Meirambayeva, A.; Huang, A.; Kim, J.; Prasad, G.V.R.; Knoll, G.; Boudville, N.; Lok, C.; McFarlane, P.; Karpinski, M.; Storsley, L.; Klarenbach, S.; Lam, N.; Thomas, S.M.; Dipchand, C.; Reese, P.; Doshi, M.; Gibney, E.; Taub, K.; Young, A.; Arnold, J.; Boudville, N.; Bugeya, A.; Dipchand, C.; Dosh, M.; Feldman, L.; Garg, A.; Geddes, C.; Gibney, E.; Gill, J.; Karpinski, M.; Kim, J.; Klarenbach, S.; Knoll, G.; Lam, N.; Lok, C.; McFarlane, P.; Monroy-Cuadros, M.; Muirhead, N.; Nevis, I.; Nguan, C.Y.; Parikh, C.; Poggio, E.; Ramesh Prasad, G.V.; Sontrop, J.; Storsle, L.; Taub, K.; Thomas, S.; Treleaven, D.; Young, A. 2012: Cardiovascular disease in kidney donors: matched cohort study. Bmj 344: E1203

La Manna, G.; Cappuccilli, M.L.; Cianciolo, G.; Conte, D.; Comai, G.; Carretta, E.; Scolari, M.P.; Stefoni, S. 2010: Cardiovascular disease in kidney transplant recipients: the prognostic value of inflammatory cytokine genotypes. Transplantation 89(8): 1001-1008

Bradley, E.; Parker, J.; Novak, E.; Ludbrook, P.; Billadello, J.; Cedars, A. 2013: Cardiovascular disease in late survivors of tetralogy of fallot: a tertiary care center experience. Texas Heart Institute Journal 40(4): 418-423

Willson, D.M. 1949: Cardiovascular disease in later life. Canadian Nurse 45(8): 587-589

Amaya-Amaya, J.; Sarmiento-Monroy, J.Camilo.; Caro-Moreno, Ján.; Molano-González, Nás.; Mantilla, Rén.D.; Rojas-Villarraga, A.; Anaya, J-Manuel. 2013: Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. Autoimmune Diseases 2013: 794383

Kaul, A.; Sharm, R.K.; Gupta, A.; Sinha, N.; Singh, U. 2011: Cardiovascular disease in live related renal transplantation. Journal of the Association of Physicians of India 59: 715-718

Wurie, H.R.; Cappuccio, F.P. 2012: Cardiovascular disease in low- and middle-income countries: an urgent priority. Ethnicity and Health 17(6): 543-550

Knight, J.S.; Kaplan, M.J. 2013: Cardiovascular disease in lupus: insights and updates. Current Opinion in Rheumatology 25(5): 597-605

Mahendru, A.A.; Morris, E. 2013: Cardiovascular disease in menopause: does the obstetric history have any bearing?. Menopause International 19(3): 115-120

Aronne, L.J.; Brown, W.V.; Isoldi, K.K. 2007: Cardiovascular disease in obesity: a review of related risk factors and risk-reduction strategies. Journal of Clinical Lipidology 1(6): 575-582

Garvey, J.F.; Taylor, C.T.; McNicholas, W.T. 2009: Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. European Respiratory Journal 33(5): 1195-1205

Mankad, R.; Best, P.J.M. 2008: Cardiovascular disease in older women: a challenge in diagnosis and treatment. Women's Health 4(5): 449-464

Escárcega, R.O.; Franco, J.J.; Mani, B.C.; Vyas, A.; Tedaldi, E.M.; Bove, A.A. 2014: Cardiovascular disease in patients with chronic human immunodeficiency virus infection. International Journal of Cardiology 175(1): 1-7

Pilmore, H.; Dogra, G.; Roberts, M.; Lambers Heerspink, H.J.; Ninomiya, T.; Huxley, R.; Perkovic, V. 2014: Cardiovascular disease in patients with chronic kidney disease. Nephrology 19(1): 3-10

Kaisar, M.; Isbel, N.; Johnson, D.W. 2007: Cardiovascular disease in patients with chronic kidney disease. a clinical review. Minerva Urologica e Nefrologica 59(3): 281-297

Vanderheyden, M.; Bartunek, J.; Filippatos, G.; Goethals, M.; Vlem, B.V.; Maisel, A. 2008: Cardiovascular disease in patients with chronic renal impairment: role of natriuretic peptides. Congestive Heart Failure 14(4 Suppl 1: 38-42

Silva, L.S.V.; Oliveira, R.A.; Silva, G.B.; Lima, J.W.O.; Silva, R.P.; Liborio, A.B.; Daher, E.F.; Sobrinho, C.R.R.M. 2012: Cardiovascular disease in patients with end-stage renal disease on hemodialysis in a developing country. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 23(2): 262-266

Tuinenburg, A.; Mauser-Bunschoten, E.P.; Verhaar, M.C.; Biesma, D.H.; Schutgens, R.E.G. 2009: Cardiovascular disease in patients with hemophilia. Journal of Thrombosis and Haemostasis: Jth 7(2): 247-254

Grundtman, C.; Hollan, I.; Førre, O.T.; Saatvedt, K.; Mikkelsen, K.; Lundberg, I.E. 2010: Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes. Arthritis and Rheumatism 62(3): 667-673

Kantartzis, K.; Stefan, N. 2012: Cardiovascular disease in patients with non-alcoholic fatty liver disease. Annals of Gastroenterology 25(3): 276-277

Fellström, B.; Holdaas, H.; Jardine, A.G.; Svensson, M.K.; Gottlow, M.; Schmieder, R.E.; Zannad, F.; Fellström, B.; Zannad, F.; Schmieder, R.; Holdaas, H.; Jardine, A. 2009: Cardiovascular disease in patients with renal disease: the role of statins. Current Medical Research and Opinion 25(1): 271-285

Naranjo, A.; Sokka, T.; Descalzo, M.A.; Calvo-Alén, J.; Hørslev-Petersen, K.; Luukkainen, R.K.; Combe, B.; Burmester, G.R.; Devlin, J.; Ferraccioli, G.; Morelli, A.; Hoekstra, M.; Majdan, M.; Sadkiewicz, S.; Belmonte, M.; Holmqvist, A.-C.; Choy, E.; Tunc, R.; Dimic, A.; Bergman, M.; Toloza, S.; Pincus, T.; Hetland, M.L.; Linde, L.; Hørslev-Petersen, K.; Hansen, T.M.ør.; Knudsen, L.S.; Mäkinen, H.; Immonen, K.; Forsberg, S.; Lähteenmäki, J.; Luukkainen, R.; Gossec, L.; Dougados, M.; Maillefert, J.F.; Combe, B.; Sibilia, J.; Herborn, G.; Rau, R.; Alten, R.; Pohl, C.; Burmester, G.R.; Marsmann, B.; Bresnihan, B.; Minnock, P.; Murphy, E.; Sheehy, C.; Quirke, E.; Devlin, J.; Alraqi, S.; Cazzato, M.; Bombardieri, S.; Ferraccioli, G.; Morel 2008: Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Research and Therapy 10(2): R30

Vinsonneau, U.; Brondex, A.; Mansourati, J.; Saraux, A.; Cornily, J.C.; Arlès, F.; Godon, P.; Quiniou, G. 2008: Cardiovascular disease in patients with spondyloarthropathies. Joint Bone Spine 75(1): 18-21

Fassett, R.G.; Driver, R.; Healy, H.; Coombes, J.S. 2009: Cardiovascular disease in peritoneal dialysis patients. Panminerva Medica 51(3): 151-161

Vogelzangs, N.; Seldenrijk, A.; Beekman, A.T.F.; van Hout, H.P.J.; de Jonge, P.; Penninx, B.W.J.H. 2010: Cardiovascular disease in persons with depressive and anxiety disorders. Journal of Affective Disorders 125(1-3): 241-248

Svircev, J.N. 2009: Cardiovascular disease in persons with spinal cord dysfunction-an update on select topics. Physical Medicine and Rehabilitation Clinics of North America 20(4): 737-747

Lees, G.E. 1996: Bacterial urinary tract infections. Veterinary Clinics of North America. Small Animal Practice 26(2): 297-304

Patterson, J.E.; Andriole, V.T. 1997: Bacterial urinary tract infections in diabetes. Infectious Disease Clinics of North America 11(3): 735-750

Nickens, M.A.; Long, R.C.; Geraci, S.A. 2013: Cardiovascular disease in pregnancy: (women's health series). Southern Medical Journal 106(11): 624-630

Knapton, M. 2012: Cardiovascular disease in primary care: concordance and risk reduction. British Journal of General Practice: the Journal of the Royal College of General Practitioners 62(599): 284-285

Pietrzak, A.; Czuczwar, P.; Mosiewicz, J.; Paszkowski, T.; Chodorowska, G.; Bartosinska, J.; Gerkowicz, A.; Paluszkiewicz, P.; Freud, T.; Cohen, A.D. 2015: Cardiovascular disease in psoriatic post-menopausal women. Journal of the European Academy of Dermatology and Venereology: Jeadv 29(6): 1231-1234

Yamagishi, S. 2011: Cardiovascular disease in recent onset diabetes mellitus. Journal of Cardiology 57(3): 257-262

Bennet, L.; Agardh, C-David.; Lindblad, U. 2013: Cardiovascular disease in relation to diabetes status in immigrants from the Middle East compared to native Swedes: a cross-sectional study. BMC public health 13: 1133

McQuarrie, E.P.; Fellström, B.C.; Holdaas, H.; Jardine, A.G. 2010: Cardiovascular disease in renal transplant recipients. Journal of Renal Care 36(Suppl 1): 136-145

Sen, D.; González-Mayda, M.ía.; Brasington, R.D. 2014: Cardiovascular disease in rheumatoid arthritis. Rheumatic Diseases Clinics of North America 40(1): 27-49

González-Gay, M.A.; González-Juanatey, C. 2009: Cardiovascular disease in rheumatoid arthritis. Importance and clinical management. Reumatologia Clinica 5(3): 95-97

Myasoedova, E.; Gabriel, S.E. 2010: Cardiovascular disease in rheumatoid arthritis: a step forward. Current Opinion in Rheumatology 22(3): 342-347

Sanders, S.; Geraci, S.A. 2010: Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. Journal of the Mississippi State Medical Association 51(3): 75-80

Kitas, G.D.; Gabriel, S.E. 2011: Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Annals of the Rheumatic Diseases 70(1): 8-14

Liebson, P.R. 2010: Cardiovascular disease in special populations III: stroke. Preventive Cardiology 13(1): 1-7

Rugbjerg, K.; Mellemkjaer, L.; Boice, J.D.; Køber, L.; Ewertz, M.; Olsen, Jørgen.H. 2014: Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009. Journal of the National Cancer Institute 106(6): dju 110

Armenian, S.H.; Chow, E.J. 2014: Cardiovascular disease in survivors of hematopoietic cell transplantation. Cancer 120(4): 469-479

Ngian, G-Siew.; Sahhar, J.; Wicks, I.P.; Van Doornum, S. 2011: Cardiovascular disease in systemic sclerosis--an emerging association?. Arthritis Research and Therapy 13(4): 237

Gillum, D.R.; Staffileno, B.A.; Schwartz, K.S.; Coke, L.; Fogg, L.; Reiling, D. 2011: Cardiovascular disease in the Amish: an exploratory study of knowledge, beliefs, and health care practices. Holistic Nursing Practice 25(6): 289-297

Ramahi, T.M. 2010: Cardiovascular disease in the Asia Middle East region: global trends and local implications. Asia-Pacific Journal of Public Health 22(3 Suppl): 83s-89s

Amaya-Amaya, J.; Rojas-Villarraga, A.; Anaya, J.-M. 2014: Cardiovascular disease in the antiphospholipid syndrome. Lupus 23(12): 1288-1291

Jackson, C.F.; Wenger, N.K. 2011: Cardiovascular disease in the elderly. Revista Espanola de Cardiologia 64(8): 697-712

Assayag, P. 2009: Cardiovascular disease in the elderly. a new public health challenge and new medical training needs. La Revue du Praticien 59(10): 1355-1358

Doi, Y.; Furuno, T.; Kubo, T.; Yamasaki, N.; Kitaoka, H. 2014: Cardiovascular disease in the elderly: Management of atrial fibrillation and chronic heart failure. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 51(3): 218-221

Carro, A.; Bastiaenen, R.; Kaski, J.Carlos. 2012: Cardiovascular disease in the elderly: comment. Revista Espanola de Cardiologia 65(2): 196

Gill, J.S. 2008: Cardiovascular disease in transplant recipients: current and future treatment strategies. Clinical Journal of the American Society of Nephrology: Cjasn 3(Suppl 2): S29-S37

Gooren, L.J.; Wierckx, K.; Giltay, E.J. 2014: Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. European Journal of Endocrinology 170(6): 809-819

Wajchenberg, B.L.éo.; Rassi, N.; Feitosa, A.C.R.; Lerário, A.C.; Betti, R.T.B. 2008: Cardiovascular disease in type 1 diabetes mellitus. Arquivos Brasileiros de Endocrinologia e Metabologia 52(2): 387-397

Conget Donlo, I.; Giménez Donlo, M. 2013: Cardiovascular disease in type 1 diabetes mellitus. more than single chance. Medicina Clinica 141(11): 482-483

Laakso, M. 2010: Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes care 33(2): 442-449

Zeber, J.; Parchman, M.L. 2010: Cardiovascular disease in type 2 diabetes: Attributable risk due to modifiable risk factors. Canadian Family Physician Medecin de Famille Canadien 56(8): E302-E307

Nicholson, C. 2007: Cardiovascular disease in women. Nursing Standard: 21(38): 43-47

Stevenson, J.C. 2008: Cardiovascular disease in women. Menopause International 14(1): 5

Weiss, A.M. 2009: Cardiovascular disease in women. Primary Care 36(1): 73

Redberg, R.F. 2010: Cardiovascular disease in women. Expert Review of Cardiovascular Therapy 8(2): 141-142

Bhakta, M.D.; Mookadam, F.; Wilansky, S. 2011: Cardiovascular disease in women. Future Cardiology 7(5): 613-627

Lee, J.S.; Bertakis, K.; Meyers, F.J.; Chedin, E.; Tarantal, A.; Anderson, K.; Berglund, L. 2009: Cardiovascular disease in women--challenges deserving a comprehensive translational approach. Journal of Cardiovascular Translational Research 2(3): 251-255

Anonymous 2011: Cardiovascular disease in women--often silent and fatal. Lancet 378(9787): 200

Piña, I.L. 2011: Cardiovascular disease in women: challenge of the middle years. Cardiology in Review 19(2): 71-75

Moran, B.; Walsh, T. 2013: Cardiovascular disease in women: how nurses can promote awareness and prevention. Nursing for Women's Health 17(1): 63-68

Naderi, S.; Cho, L.S. 2013: Cardiovascular disease in women: prevention, symptoms, diagnosis, pathogenesis. Cleveland Clinic Journal of Medicine 80(9): 577-587

Lind, J.M.; Hennessy, A.; McLean, M. 2014: Cardiovascular disease in women: the significance of hypertension and gestational diabetes during pregnancy. Current Opinion in Cardiology 29(5): 447-453

Levit, R.D.; Reynolds, H.R.; Hochman, J.S. 2011: Cardiovascular disease in young women: a population at risk. Cardiology in Review 19(2): 60-65

Bae, J.C.; Cho, N.H.; Suh, S.; Kim, J.H.; Hur, K.Y.; Jin, S.-M.; Lee, M.-K. 2015: Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: a community-based prospective study (Ansung-Ansan cohort 2001-12). Journal of Diabetes 7(6): 791-799

Stenvinkel, P. 2007: Cardiovascular disease increases the risk of renal failure. Lakartidningen 104(36): 2495

Anonymous 2010: Cardiovascular disease is a prevalent condition treated by Medicare home health services and is strongly associated with depression. American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry 18(6): A11

Black-Shinn, J.L.; Kinney, G.L.; Wise, A.L.; Regan, E.A.; Make, B.; Krantz, M.J.; Barr, R.G.; Murphy, J.R.; Lynch, D.; Silverman, E.K.; Crapo, J.D.; Hokanson, J.E. 2014: Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. Copd 11(5): 546-551

Ortega-Hernandez, O.-D.; Pineda-Tamayo, R.; Pardo, A.L.; Rojas-Villarraga, A.; Anaya, J.-M. 2009: Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clinical Rheumatology 28(7): 767-775

Sanders, J.L.; Boudreau, R.M.; Cappola, A.R.; Arnold, A.M.; Robbins, J.; Cushman, M.; Newman, A.B. 2010: Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old: the cardiovascular health study all stars study. Journal of the American Geriatrics Society 58(3): 421-426

Burgueño, A.L.; Gianotti, T.F.; Mansilla, N.G.; Pirola, C.J.; Sookoian, S. 2013: Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model. Clinical Science 124(1): 53-63

Pahau, H.; Brown, M.A.; Paul, S.; Thomas, R.; Videm, V. 2014: Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT). Arthritis Research and Therapy 16(2): R85

Kuller, L.H. 2010: Cardiovascular disease is preventable among women. Expert Review of Cardiovascular Therapy 8(2): 175-187

Serelis, J.; Panagiotakos, D.B.; Mavrommati, M.; Skopouli, F.N. 2011: Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a greek cohort study. Journal of Rheumatology 38(2): 236-241

Homko, C.J.; Santamore, W.P.; Zamora, L.; Shirk, G.; Gaughan, J.; Cross, R.; Kashem, A.; Petersen, S.; Bove, A.A. 2008: Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease. Journal of Cardiovascular Nursing 23(4): 332-337

Giardina, E.-G.V.; Sciacca, R.R.; Flink, L.E.; Bier, M.L.; Paul, T.K.; Moise, N. 2013: Cardiovascular disease knowledge and weight perception among Hispanic and non-Hispanic white women. Journal of Women's Health 22(12): 1009-1015

Mochari, H.; Ferris, A.; Adigopula, S.; Henry, G.; Mosca, L. 2007: Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Preventive Cardiology 10(4): 190-195

Peters, M.J.L.; Nurmohamed, M. 2013: Cardiovascular disease management in RA. Arthritis and Rheumatism 2013

Ricotta, J.J.; Pagan, J.; Xenos, M.; Alemu, Y.; Einav, S.; Bluestein, D. 2008: Cardiovascular disease management: the need for better diagnostics. Medical and Biological Engineering and Computing 46(11): 1059-1068

Halcomb, E.J.; Davidson, P.M.; Griffiths, R.; Daly, J. 2008: Cardiovascular disease management: time to advance the practice nurse role?. Australian Health Review: a Publication of the Australian Hospital Association 32(1): 44-53

Scheede-Bergdahl, C.; Benee Olsen, D.; Reving, D.; Boushel, R.; Dela, F. 2009: Cardiovascular disease markers in type 2 diabetes: the effects of a moderate home-based exercise training programme. Diabetes and Vascular Disease Research 6(4): 291-296

Mohamadin, A.M.; Habib, F.A.; Al-Saggaf, A.A. 2010: Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine. Annals of Saudi Medicine 30(4): 278-283

Ma, Y.; Yang, Z. 2009: Cardiovascular disease may lead to female sexual dysfunction. Medical Hypotheses 72(4): 482

Crengle, S.; Smylie, J.; Kelaher, M.; Lambert, M.; Reid, S.; Luke, J.; Anderson, I.; Harré Hindmarsh, J.; Harwood, M. 2014: Cardiovascular disease medication health literacy among Indigenous peoples: design and protocol of an intervention trial in Indigenous primary care services. Bmc Public Health 14: 714

Pilmore, H.L.; Skeans, M.A.; Snyder, J.J.; Israni, A.K.; Kasiske, B.L. 2011: Cardiovascular disease medications after renal transplantation: results from the Patient Outcomes in Renal Transplantation study. Transplantation 91(5): 542-551

Harding, A-Helen.; Darnton, A.; Osman, J. 2012: Cardiovascular disease mortality among British asbestos workers (1971-2005). Occupational and environmental medicine 69(6): 417-421

Tjepkema, M.; Wilkins, R.; Goedhuis, N.; Pennock, J. 2012: Cardiovascular disease mortality among First Nations people in Canada, 1991-2001. Chronic diseases and injuries in Canada 32(4): 200-207

Girard, S.A.; Leroux, T.; Verreault, R.é; Courteau, M.èn.; Picard, M.; Turcotte, F.; Baril, J.; Richer, O. 2015: Cardiovascular disease mortality among retired workers chronically exposed to intense occupational noise. International Archives of Occupational and Environmental Health 88(1): 123-130

Huang, T.; Yang, B.; Zheng, J.; Li, G.; Wahlqvist, M.L.; Li, D. 2012: Cardiovascular disease mortality and cancer incidence in vegetarians: a meta-analysis and systematic review. Annals of Nutrition and Metabolism 60(4): 233-240

Roberts, S.E.; Jaremin, B. 2010: Cardiovascular disease mortality in British merchant shipping and among British seafarers ashore in Britain. International Maritime Health 62(3): 107-116

Ning, F.; Tuomilehto, J.; Pyörälä, K.; Onat, A.; Söderberg, S.; Qiao, Q. 2010: Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 33(10): 2211-2216

Ayinde, H.; Gillum, R.F. 2014: Cardiovascular disease mortality in Sub-Saharan Africa and the Caribbean. Ethnicity and Disease 24(4): 495-501

Sunder-Plassmann, G.; Födinger, M.; Säemann, M.D. 2012: Cardiovascular disease mortality in kidney transplant recipients: no light at the end of the tunnel?. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 59(6): 754-757

Kelly, D.L.; McMahon, R.P.; Liu, F.; Love, R.C.; Wehring, H.J.; Shim, J-Cheol.; Warren, K.R.; Conley, R.R. 2010: Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. Journal of Clinical Psychiatry 71(3): 304-311

de Fatima Marinho de Souza, M.; Gawryszewski, V.Pinheiro.; Orduñez, P.; Sanhueza, A.; Espinal, M.A. 2012: Cardiovascular disease mortality in the Americas: current trends and disparities. Heart 98(16): 1207-1212

Oshchepkova, E.V. 2009: Cardiovascular disease mortality of population in Russian Federation in 2001-2006 and ways of its lowering. Kardiologiia 49(2): 67-72

Wennerholm, C.; Grip, B.ör.; Johansson, A.; Nilsson, H.; Honkasalo, M.-L.; Faresjö, T. 2011: Cardiovascular disease occurrence in two close but different social environments. International Journal of Health Geographics 10: 5

Balsam, A.; El Kossi, M.M.; Lord, R.; El Nahas, A.M. 2009: Cardiovascular disease on hemodialysis: predictors of atherosclerosis and survival. Hemodialysis International. International Symposium on Home Hemodialysis 13(3): 278-285

Yancy, C.W. 2012: Cardiovascular disease outcomes: priorities today, priorities tomorrow for research and community health. Ethnicity and Disease 22(3 Suppl 1: S1

Monteiro, A.éa.M.; Jardini, M.A.N.; Alves, S.; Giampaoli, V.; Aubin, E.C.Q.; Figueiredo Neto, A.ôn.M.; Gidlund, M. 2009: Cardiovascular disease parameters in periodontitis. Journal of Periodontology 80(3): 378-388

Pham, P-Thu.T.; Pham, P-Chi.T.; Danovitch, G.M. 2007: Cardiovascular disease posttransplant. Seminars in Nephrology 27(4): 430-444

Howard, B.V.; Comuzzie, A.; Devereux, R.B.; Ebbesson, S.O.E.; Fabsitz, R.R.; Howard, W.J.; Laston, S.; MacCluer, J.W.; Silverman, A.; Umans, J.G.; Wang, H.; Weissman, N.J.; Wenger, C.R. 2010: Cardiovascular disease prevalence and its relation to risk factors in Alaska Eskimos. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 20(5): 350-358

Rizwan, I.; Minuk, L.; Jackson, S.; Iorio, A. 2015: Cardiovascular disease prevalence and relevance in haemophilia: a scoping review. Haemophilia: the Official Journal of the World Federation of Hemophilia 21(3): E156-E166

Mata-Cases, M.; Fernández-Bertolín, E.; García-Durán, M.; Cos-Claramunt, X.; Pareja-Rossell, C.; Pujol-Ribera, E. 2009: Cardiovascular disease prevalence in recent diagnosed type 2 diabetic patients. Gaceta Sanitaria 23(2): 133-138

Magno, C.P.; Araneta, M.Rosario.G.; Macera, C.A.; Anderson, G.W. 2008: Cardiovascular disease prevalence, associated risk factors, and plasma adiponectin levels among Filipino American women. Ethnicity and Disease 18(4): 458-463

Van Camp, G. 2014: Cardiovascular disease prevention. Acta Clinica Belgica 69(6): 407-411

Davidson, J.A.; Moreno, P.R.; Badimon, J.J.; Lopez-Candales, A.; Maisonet Giachello, A.L.; Ovalle, F.; Rodriguez, C.Jose.; Rosenson, R.S.; Rodbard, H.W.; Kannel, W.B. 2007: Cardiovascular disease prevention and care in Latino and Hispanic subjects. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 13(1): 77-85

Coppieters, Y.; Béduwé, C.; Collignon, J.L.; Hubens, V.; Levêque, A. 2010: Cardiovascular disease prevention and health promotion in the French speaking community of Belgium. Revue Medicale de Bruxelles 31(3): 161-170

Cipriano, G.; Neves, L.Maria.Tomazi.; Cipriano, G.França.Bernardelli.; Chiappa, G.R.; Borghi-Silva, A. 2014: Cardiovascular disease prevention and implications for worksite health promotion programs in Brazil. Progress in Cardiovascular Diseases 56(5): 493-500

Baudet, M.; Daugareil, C.; Ferrieres, J. 2012: Cardiovascular disease prevention and life style modifications. Annales de Cardiologie et d'Angeiologie 61(2): 93-98

Thompson, G.R. 2012: Cardiovascular disease prevention and the rise in dementia. Qjm: Monthly Journal of the Association of Physicians 105(1): 93-97

von Schacky, C. 2009: Cardiovascular disease prevention and treatment. Prostaglandins Leukotrienes and Essential Fatty Acids 81(2-3): 193-198

Hallan, S.Ivar. 2014: Cardiovascular disease prevention in CKD. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 64(3): 326-328

Abanilla, P.Karen.A.; Huang, K-Yen.; Shinners, D.; Levy, A.; Ayernor, K.; Aikins, A.de-Graft.; Ogedegbe, O. 2011: Cardiovascular disease prevention in Ghana: feasibility of a faith-based organizational approach. Bulletin of the World Health Organization 89(9): 648-656

Hendriks, M.; Brewster, L.; Wit, F.; Bolarinwa, O.Akeem.; Odusola, A.Olufemi.; Redekop, W.; Bindraban, N.; Vollaard, A.; Alli, S.; Adenusi, P.; Agbede, K.; Akande, T.; Lange, J.; Schultsz, C. 2011: Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I). Bmc Public Health 11: 186

Ganiats, T.G.; Campos-Outcalt, D. 2007: Cardiovascular disease prevention in women. American Family Physician 75(7): 984 987

Hoekstra, T.; Beulens, J.W.J.; van der Schouw, Y.T. 2009: Cardiovascular disease prevention in women: Impact of dietary interventions. Maturitas 63(1): 20-27

Stranges, S.; Guallar, E. 2012: Cardiovascular disease prevention in women: a rapidly evolving scenario. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 22(12): 1013-1018

Rapeport, N. 2011: Cardiovascular disease prevention in women: are we up to date?. Cardiovascular Journal of Africa 22(3): 119-121

Hoebeke, R.E. 2008: Cardiovascular disease prevention in women: the role of the nurse practitioner in primary care. Critical Care Nursing Clinics of North America 20(3): 297-304

Engberding, N.; Wenger, N.K. 2008: Cardiovascular disease prevention tailored for women. Expert Review of Cardiovascular Therapy 6(8): 1123-1134

Sepanlou, S.G.; Farzadfar, F.; Jafari, E.; Danaei, G. 2012: Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation. Archives of Iranian Medicine 15(9): 531-537

Carrington, M.J.; Stewart, S. 2015: Cardiovascular disease prevention via a nurse-facilitated intervention clinic in a regional setting: the Protecting Healthy Hearts Program. European Journal of Cardiovascular Nursing: Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 14(4): 352-361

Kirby, M.G. 2010: Cardiovascular disease prevention, screening and early detection in Turkey. Cardiology 115(4): 294-296

Bogart, D.B. 2011: Cardiovascular disease prevention: a basic but evolving goal for medicine. Missouri Medicine 108(6): 428 430

Donghi, R.; Amendola, P.; Pellicciotta, G.; Bertuzzi, P. 2011: Cardiovascular disease prevention: results from Programma FASEN - H San Raffaele. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 33(2 Suppl): 48-50

Bailén Almorox, R. 2013: Cardiovascular disease primary prevention with a Mediterranean diet. Revista Clinica Espanola 213(7): 355-356

Poesen, R.; Viaene, L.; Verbeke, K.; Augustijns, P.; Bammens, B.; Claes, K.; Kuypers, D.; Evenepoel, P.; Meijers, B.ör. 2014: Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease. Bmc Nephrology 15: 87

Jahangir, E.; Comandé, D.; Rubinstein, A. 2011: Cardiovascular disease research in Latin America: a comparative bibliometric analysis. World Journal of Cardiology 3(12): 383-387

Myers, L.; Mendis, S. 2014: Cardiovascular disease research output in WHO priority areas between 2002 and 2011. Journal of Epidemiology and Global Health 4(1): 23-28

Dimmeler, S. 2011: Cardiovascular disease review series. Embo Molecular Medicine 3(12): 697

Salinas, J.J.; Abdelbary, B.; Rentfro, A.; Fisher-Hoch, S.; McCormick, J. 2014: Cardiovascular disease risk among the Mexican American population in the Texas-Mexico border region, by age and length of residence in United States. Preventing chronic disease 11: E58

Solomon, A.; Tsang, L.; Woodiwiss, A.J.; Millen, A.M.E.; Norton, G.R.; Dessein, P.H. 2014: Cardiovascular disease risk amongst African black patients with rheumatoid arthritis: the need for population specific stratification. Biomed Research International 2014: 826095

Pase, M.P.; Grima, N.A.; Stough, C.K.; Scholey, A.; Pipingas, A. 2012: Cardiovascular disease risk and cerebral blood flow velocity. Stroke 43(10): 2803-2805

Wahman, K.; Nash, M.S.; Lewis, J.E.; Seiger, A.; Levi, R. 2011: Cardiovascular disease risk and the need for prevention after paraplegia determined by conventional multifactorial risk models: the Stockholm spinal cord injury study. Journal of Rehabilitation Medicine 43(3): 237-242

Huang, F.; Zhu, P.-l.; Xiao, H.-z.; Lin, F.; Yuan, Y.; Gao, Z.-h.; Li, J.-w.; Chen, F.-l. 2013: Cardiovascular disease risk and vascular damage status in pre- and hypertension population in coastal areas of Fujian province. Zhonghua Xin Xue Guan Bing Za Zhi 41(10): 876-881

Horwood, F.; Gruber, A.; Sithole, J.; Ali, N.; Idris, I. 2008: Cardiovascular disease risk assessment in patients with obstructive sleep apnoea: clinical utility of the Framingham risk equation for initiating statins. Diabetes Obesity and Metabolism 10(2): 181-182

Paredes, S.; Rocha, T.; de Carvalho, P.; Henriques, J.; Morais, J.; Ferreira, J.; Mendes, M. 2013: Cardiovascular disease risk assessment innovative approaches developed in HeartCycle project. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013: 6980-6983

Appleton, S.L.; Ruffin, R.E.; Wilson, D.H.; Taylor, A.W.; Adams, R.J. 2009: Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists. Journal of Allergy and Clinical Immunology 123(1): 124-130.E1

Curtis, P.J.; Kroon, P.A.; Hollands, W.J.; Walls, R.; Jenkins, G.; Kay, C.D.; Cassidy, A.ín. 2009: Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. Journal of Nutrition 139(12): 2266-2271

Dilbaz, B.; Ozkaya, E.; Cinar, M.; Cakir, E.; Dilbaz, S. 2011: Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Endocrine 39(3): 272-277

Leibowitz, K.L.; Moore, Ré.H.; Stunkard, A.J.; Stallings, V.A.; Berkowitz, R.I.; Stettler, N.; Chittams, J.L.; Faith, M.S. 2009: Cardiovascular disease risk factor (CVDRF) associated waist circumference patterns in obese-prone children. International Journal of Pediatric Obesity: Ijpo: An Official Journal of the International Association for the Study of Obesity 4(3): 150-159

Colvine, K.; Kerr, A.J.; McLachlan, A.; Gow, P.; Kumar, S.; Ly, J.; Wiltshire, C.; Robinson, E.; Dalbeth, N. 2008: Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support. New Zealand Medical Journal 121(1285): 73-81

Baruth, M.; Wilcox, S.; Egan, B.M.; Dowda, M.; Laken, M.; Warren, T.Y. 2011: Cardiovascular disease risk factor clustering among African American adults. Ethnicity and Disease 21(2): 129-134

Nguyen, Q.N.; Pham, S.T.; Do, L.D.; Nguyen, V.L.; Wall, S.; Weinehall, L.; Bonita, R.; Byass, P. 2012: Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam. International Journal of Hypertension 2012: 560397

Norsa, L.; Shamir, R.; Zevit, N.; Verduci, E.; Hartman, C.; Ghisleni, D.; Riva, E.; Giovannini, M. 2013: Cardiovascular disease risk factor profiles in children with celiac disease on gluten-free diets. World Journal of Gastroenterology 19(34): 5658-5664

Hiratsuka, V.Y.; Loo, R.; Will, J.C.; Oberrecht, R.; Poindexter, P. 2007: Cardiovascular disease risk factor screening among Alaska Native women: the traditions of the heart project. International Journal of Circumpolar Health 66(Suppl 1): 39-44

Muhammad, S.; Sani, M.U.; Okeahialam, B.N. 2013: Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Nigerian Medical Journal: Journal of the Nigeria Medical Association 54(3): 185-190

Kulkayeva, G.; Harun-Or-Rashid, M.; Yoshida, Y.; Tulebayev, K.; Sakamoto, J. 2012: Cardiovascular disease risk factors among rural Kazakh population. Nagoya Journal of Medical Science 74(1-2): 51-61

Vimalananda, V.G.; Miller, D.R.; Christiansen, C.L.; Wang, W.; Tremblay, P.; Fincke, B.G. 2013: Cardiovascular disease risk factors among women veterans at VA medical facilities. Journal of General Internal Medicine 28(Suppl 2): S517-S523

Cash, H.L.; McGarvey, S.T.; Houseman, E.A.és.; Marsit, C.J.; Hawley, N.L.; Lambert-Messerlian, G.M.; Viali, S.; Tuitele, J.; Kelsey, K.T. 2011: Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders. Epigenetics 6(10): 1257-1264

Lee, J.A.; Yeo, G.; Gallagher-Thompson, D. 1993: Cardiovascular disease risk factors and attitudes towards prevention among Korean-American elders. Journal of Cross-Cultural Gerontology 8(1): 17-33

Møller, N.C.; Grøntved, A.; Wedderkopp, N.; Ried-Larsen, M.; Kristensen, P.L.; Andersen, L.B.; Froberg, K. 2010: Cardiovascular disease risk factors and blood pressure response during exercise in healthy children and adolescents: the European Youth Heart Study. Journal of Applied Physiology 109(4): 1125-1132

Park, J.Eun.; Lee, J.Eun. 2011: Cardiovascular disease risk factors and depression in Korean women: results from the fourth Korean National Health and Nutrition Examination Survey. Psychiatry Research 190(2-3): 232-239

Vardavas, C.I.; Linardakis, M.K.; Hatzis, C.M.; Saris, W.H.M.; Kafatos, A.G. 2010: Cardiovascular disease risk factors and dietary habits of farmers from Crete 45 years after the first description of the Mediterranean diet. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 17(4): 440-446

Abellan van Kan, G.; Rolland, Y.; Nourhashémi, F.; Coley, N.; Andrieu, S.; Vellas, B. 2009: Cardiovascular disease risk factors and progression of Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 27(3): 240-246

Rasiah, R.; Yusoff, K.; Mohammadreza, A.; Manikam, R.; Tumin, M.; Chandrasekaran, S.K.; Khademi, S.; Bakar, N.A. 2013: Cardiovascular disease risk factors and socioeconomic variables in a nation undergoing epidemiologic transition. Bmc Public Health 13: 886

Darke, S.; Torok, M.; Kaye, S.; Duflou, J. 2010: Cardiovascular disease risk factors and symptoms among regular psychostimulant users. Drug and Alcohol Review 29(4): 371-377

Buffart, L.M.; van den Berg-Emons, R.J.; Burdorf, A.; Janssen, W.G.; Stam, H.J.; Roebroeck, M.E. 2008: Cardiovascular disease risk factors and the relationships with physical activity, aerobic fitness, and body fat in adolescents and young adults with myelomeningocele. Archives of Physical Medicine and Rehabilitation 89(11): 2167-2173

Plugge, E.H.; Foster, C.E.; Yudkin, P.L.; Douglas, N. 2009: Cardiovascular disease risk factors and women prisoners in the UK: the impact of imprisonment. Health Promotion International 24(4): 334-343

Brogan, K.; Danford, C.; Yeh, Y.; Jen, K.-L.C. 2014: Cardiovascular disease risk factors are elevated in urban minority children enrolled in head start. Childhood Obesity 10(3): 207-213

Ouyang, X.; Lou, Q.; Gu, L.; Mo, Y.; Nan, J.H.; Kong, A.P.; So, W-Yee.; Ko, G.T.; Ma, R.C.; Chan, J.C.; Chow, C-Chung.; Bian, R. 2012: Cardiovascular disease risk factors are highly prevalent in the office-working population of Nanjing in China. International Journal of Cardiology 155(2): 212-216

So, E.S. 2015: Cardiovascular disease risk factors associated with depression among Korean adults with coronary artery disease and cerebrovascular disease. Asia-Pacific Psychiatry: Official Journal of the Pacific Rim College of Psychiatrists 7(2): 173-181

Lwow, F.; Jedrzejuk, D.; Dunajska, K.; Milewicz, A.; Szmigiero, L. 2013: Cardiovascular disease risk factors associated with low level of physical activity in postmenopausal Polish women. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 29(7): 683-686

Nag, T.; Ghosh, A. 2013: Cardiovascular disease risk factors in Asian Indian population: A systematic review. Journal of Cardiovascular Disease Research 4(4): 222-228

Shaffer, D.; Hughes, M.D.; Sawe, F.; Bao, Y.; Moses, A.; Hogg, E.; Lockman, S.; Currier, J. 2014: Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE). Journal of Acquired Immune Deficiency Syndromes 66(2): 155-163

Steene-Johannessen, J.; Kolle, E.; Anderssen, S.Alfred.; Andersen, L.Bo. 2009: Cardiovascular disease risk factors in a population-based sample of Norwegian children and adolescents. Scandinavian Journal of Clinical and Laboratory Investigation 69(3): 380-386

Hemmings, S.; Conner, A.; Maffulli, N.; Morrissey, D. 2011: Cardiovascular disease risk factors in adolescent British South Asians and whites: a pilot study. Postgraduate Medicine 123(2): 104-111

Kaldmäe, M.; Zilmer, M.; Viigimaa, M.; Zemtsovskaja, G.; Tomberg, K.; Kaart, T.; Annuk, M. 2011: Cardiovascular disease risk factors in homeless people. Upsala Journal of Medical Sciences 116(3): 200-207

Fletcher, H.M.; Bennett, F.; Simms-Stewart, D.; Reid, M.; Williams, N.P.; Wharfe, G.H.; Wilks, R.J.; Mitchell, S.; Scott, P. 2010: Cardiovascular disease risk factors in menopausal Jamaican black women after hysterectomy and bilateral oophorectomy: an observational study. West Indian Medical Journal 59(6): 625-632

Novaković, T.; Inić Kostić, B.; Milinić, S.; Jovićević, L.; Dzeletović, G. 2013: Cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease. Medicinski Pregled 66(1-2): 24-31

Díaz-Realpe, Jús.E.; Muñoz-Martínez, J.; Sierra-Torres, C.H. 2007: Cardiovascular disease risk factors in people working at a Colombian health institution. Revista de Salud Publica 9(1): 64-75

Wahman, K.; Nash, M.S.; Westgren, N.; Lewis, J.E.; Seiger, A.; Levi, R. 2010: Cardiovascular disease risk factors in persons with paraplegia: the Stockholm spinal cord injury study. Journal of Rehabilitation Medicine 42(3): 272-278

Daviglus, M.L.; Pirzada, A.; Talavera, G.A. 2014: Cardiovascular disease risk factors in the Hispanic/Latino population: lessons from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Progress in Cardiovascular Diseases 57(3): 230-236

Elkum, N.; Al-Arouj, M.; Sharifi, M.; Behbehani, K.; Bennakhi, A. 2014: Cardiovascular disease risk factors in the South Asian population living in Kuwait: a cross-sectional study. Diabetic Medicine: a Journal of the British Diabetic Association 31(5): 531-539

Van Rijn, B.B.; Nijdam, M.-E.; Bruinse, H.W.; Roest, M.; Uiterwaal, C.S.; Grobbee, D.E.; Bots, M.L.; Franx, A. 2013: Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstetrics and Gynecology 121(5): 1040-1048

Spisak, S.N.; Zabula, A.V.; Alkan, M.; Filatov, A.S.; Rogachev, A.Y.; Petrukhina, M.A. 2018: Site-Directed Dimerization of Bowl-Shaped Radical Anions to Form a σ-Bonded Dibenzocorannulene Dimer. Angewandte Chemie 57(21): 6171-6175

Mayer-Davis, E.J.; Ma, B.; Lawson, A.; D'Agostino, R.B.; Liese, A.D.; Bell, R.A.; Dabelea, D.; Dolan, L.; Pettitt, D.J.; Rodriguez, B.L.; Williams, D. 2009: Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metabolic Syndrome and Related Disorders 7(2): 89-95

Teramoto, T.; Sasaki, J.; Ishibashi, S.; Birou, S.; Daida, H.; Dohi, S.; Egusa, G.; Hiro, T.; Hirobe, K.; Iida, M.; Kihara, S.; Kinoshita, M.; Maruyama, C.; Ohta, T.; Okamura, T.; Yamashita, S.; Yokode, M.; Yokote, K. 2013: Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. Journal of atherosclerosis and thrombosis 20(10): 733-742

Rubin, R.R.; Gaussoin, S.A.; Peyrot, M.; DiLillo, V.; Miller, K.; Wadden, T.A.; West, D.S.; Wing, R.R.; Knowler, W.C. 2010: Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia 53(8): 1581-1589

Kelishadi, R.; Gharipour, M.; Sadri, G.H.; Tavasoli, A.A.; Amani, A. 2008: Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population. Eastern Mediterranean Health Journal 14(5): 1070-1079

Fox, C.S. 2010: Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study. Trends in Cardiovascular Medicine 20(3): 90-95

Dahlöf, B.ör. 2010: Cardiovascular disease risk factors: epidemiology and risk assessment. American Journal of Cardiology 105(1 Suppl): 3a-9a

Lim, M.Y.; Pruthi, R.K. 2011: Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 22(5): 402-406

López, M.; Román, Jús.San.; Estrada, V.; Vispo, E.; Soriano, V. 2012: Cardiovascular disease risk in HIV infection and endothelial progenitor cells. Journal of infectious diseases 206(9): 1479-80; author reply 1480-1

Chin, C.Y.; Pengal, S. 2009: Cardiovascular disease risk in a semirural community in Malaysia. Asia-Pacific Journal of Public Health 21(4): 410-420

Flouris, A.D.; Faught, B.E.; Klentrou, P. 2008: Cardiovascular disease risk in adolescent smokers: evidence of a 'smoker lifestyle'. Journal of Child Health Care: for Professionals Working with Children in the Hospital and Community 12(3): 221-231

Van der Slot, W.M.A.; Roebroeck, M.E.; Nieuwenhuijsen, C.; Bergen, M.P.; Stam, H.J.; Burdorf, A.; van den Berg-Emons, R.J.G.; Janssen, W.G.M.; Pangalila, R.F.; Buijs, H.J.R.; Terburg, M.; Nieuwstraten, W.; van der Heijden-Maessen, H.; Arendzen, J.H.; Ras, B. 2013: Cardiovascular disease risk in adults with spastic bilateral cerebral palsy. Journal of Rehabilitation Medicine 45(9): 866-872

So-Armah, K.; Freiberg, M.S. 2014: Cardiovascular disease risk in an aging HIV population: not just a question of biology. Current Opinion in HIV and Aids 9(4): 346-354

Olsen, M.; Schmidt, M.; Lash, T.L.; Sørensen, K.; Pedersen, L.; Sørensen, H.T. 2014: Cardiovascular disease risk in childhood cancer survivors. American Journal of Epidemiology 180(1): 120-123

Friedemann, C.; Heneghan, C.; Mahtani, K.; Thompson, M.; Perera, R.; Ward, A.M. 2012: Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. Bmj 345: E4759

Ross, A.C.; McComsey, G.A. 2011: Cardiovascular disease risk in pediatric HIV: the need for population-specific guidelines. Journal of Acquired Immune Deficiency Syndromes 57(5): 351-354

Kramer, H.R.; Giles, J.T. 2011: Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity. Arthritis Care and Research 63(4): 484-499

Joshi, K.B.; Nillawar, A.; Thorat, A.P. 2013: Cardiovascular disease risk in schizophrenia patients: a case control study. Journal of Clinical and Diagnostic Research: Jcdr 7(12): 2694-2696

Pereira, S. 2009: Cardiovascular disease risk in white-coat hypertension. European Journal of Internal Medicine 20(1): E23

Rockett, F.C.; Perla, A.d.S.; Perry, I.D.S.; Chaves, M.ár.L.F. 2013: Cardiovascular disease risk in women with migraine. Journal of Headache and Pain 14: 75

Roeters van Lennep, J.E.; Heida, K.Y.; Bots, M.L.; Hoek, A. 2016: Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. European Journal of Preventive Cardiology 23(2): 178-186

Guleria, A.K.; Syal, S.K.; Kapoor, A.; Kumar, S.; Tiwari, P.; Dabadghao, P. 2014: Cardiovascular disease risk in young Indian women with polycystic ovary syndrome. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(1): 26-29

Breetveld, N.M.; Ghossein-Doha, C.; van Kuijk, S.; van Dijk, A.P.; van der Vlugt, M.J.; Heidema, W.M.; Scholten, R.R.; Spaanderman, M.E.A. 2015: Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women. Bjog: An International Journal of Obstetrics and Gynaecology 122(8): 1092-1100

Peiris, D.P.; Patel, A.A.; Cass, A.; Howard, M.P.; Tchan, M.L.; Brady, J.P.; De Vries, J.; Rickards, B.A.; Yarnold, D.J.; Hayman, N.E.; Brown, A.D. 2009: Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Medical Journal of Australia 191(6): 304-309

Mallewa, J.E.; Higgins, S.P.; Garbett, S.; Saxena, N.; Vilar, F.J. 2009: Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester. International Journal of Std and Aids 20(6): 425-426

Kar, S.S.; Thakur, J.S.; Jain, S.; Kumar, R. 2008: Cardiovascular disease risk management in a primary health care setting of north India. Indian Heart Journal 60(1): 19-25

Shin, S.Y.; Lee, C.G.; Song, H.S.; Kim, S.H.; Lee, H.S.; Jung, M.S.; Yoo, S.K. 2013: Cardiovascular disease risk of bus drivers in a city of Korea. Annals of Occupational and Environmental Medicine 25(1): 34

Maxwell, J.; Lie, J. 2008: Cardiovascular disease risk of homeless patients. British Journal of General Practice: the Journal of the Royal College of General Practitioners 58(554): 648-649

Williams, K.; Monroe, H.M. 2012: Cardiovascular disease risk prediction factors. JAMA 308(19): 1969-70; Author Reply 1970-1

Paynter, N.P.; Everett, B.M.; Cook, N.R. 2014: Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?. Clinical Chemistry 60(1): 88-97

Stein, J.H. 2012: Cardiovascular disease risk prediction measures. JAMA 308(23): 2455; Author Reply 2455-6

Paynter, N.P.; Chasman, D.I.; Buring, J.E.; Shiffman, D.; Cook, N.R.; Ridker, P.M. 2009: Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Annals of Internal Medicine 150(2): 65-72

Oguoma, V.Maduabuchi.; Nwose, E.Uba.; Bwititi, P.Taderera. 2014: Cardiovascular disease risk prevention: preliminary survey of baseline knowledge, attitude and practices of a nigerian rural community. North American Journal of Medical Sciences 6(9): 466-471

Wells, S.; Riddell, T.; Jackson, R. 2010: Cardiovascular disease risk profile tools and new Zealand--absolutely the best way forward. Journal of Primary Health Care 2(2): 168-169

Boland, P.; Moriarty, H. 2009: Cardiovascular disease risk profile tools and new zealand--the best way forward?. Journal of Primary Health Care 1(4): 328-331

Day, T.E.; Goldlust, E. 2010: Cardiovascular disease risk profiles. American Heart Journal 160(1): E3

Horan, P.G.; Kamaruddin, M.S.; Moore, M.J.; McCarty, D.; Spence, M.S.; McGlinchey, P.G.; Murphy, G.; Jardine, T.C.L.; Patterson, C.C.; McKeown, P.P. 2007: Cardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology Working Groups on Epidemiology and Prevention and Cardiac Rehabilitation and Exercise Physiology 14(4): 521-525

Kim, C.; Cheng, Y.J.; Beckles, G.L. 2008: Cardiovascular disease risk profiles in women with histories of gestational diabetes but without current diabetes. Obstetrics and Gynecology 112(4): 875-883

Mahdy Ali, K.; Wonnerth, A.; Huber, K.; Wojta, J. 2012: Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities. British Journal of Pharmacology 167(6): 1177-1194

Wei, X.; Zou, G.; Gong, W.; Yin, J.; Yu, Y.; Walley, J.; Zhang, Z.; King, R.; Chen, K.; Chong, M.K.C.; Zee, B.C.Y.; Liu, S.; Tang, J.; Griffiths, S.; Yu, M. 2013: Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang. Trials 14: 354

Jean-Louis, G.; Brown, C.D.; Zizi, F.; Ogedegbe, G.; Boutin-Foster, C.; Gorga, J.; McFarlane, S.I. 2010: Cardiovascular disease risk reduction with sleep apnea treatment. Expert Review of Cardiovascular Therapy 8(7): 995-1005

Goh, L.G.; Dhaliwal, S.S.; Welborn, T.A.; Thompson, P.L.; Maycock, B.R.; Kerr, D.A.; Lee, A.H.; Bertolatti, D.; Clark, K.M.; Naheed, R.; Coorey, R.; Della, P.R. 2014: Cardiovascular disease risk score prediction models for women and its applicability to Asians. International Journal of Women's Health 6: 259-267

Culhane-Pera, K.A.; Moua, M.; DeFor, T.A.; Desai, J. 2009: Cardiovascular disease risks in Hmong refugees from Wat Tham Krabok, Thailand. Journal of Immigrant and Minority Health 11(5): 372-379

Dickson, V.V.; Nocella, J.; Yoon, H.-W.; Hammer, M.; Melkus, G.D.'E.; Chyun, D. 2013: Cardiovascular disease self-care interventions. Nursing Research and Practice 2013: 407608

Durazo-Arvizu, Rón.Angel.; Barquera, S.; Lazo-Elizondo, M.; Franco, M.; Cooper, R.S. 2008: Cardiovascular disease surveillance in Mexicans and Mexican Americans: a tale of two countries. Revista Panamericana de Salud Publica 23(2): 119-124

Roger, V.ér.L. 2009: Cardiovascular disease surveillance in the comparative effectiveness landscape. CIRCULATION. Cardiovascular Quality and Outcomes 2(5): 404-406

Kelley, W.E.; Lockwood, C.M.; Cervelli, D.R.; Sterner, J.; Scott, M.G.; Duh, S.-H.; Christenson, R.H. 2009: Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes. Clinical Biochemistry 42(13-14): 1444-1451

Després, J.-P. 2007: Cardiovascular disease under the influence of excess visceral fat. Critical Pathways in Cardiology 6(2): 51-59

Aragon-Ching, J.B. 2009: Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27(35): e261; author reply e262

Cowan, R.E.; Nash, M.S. 2010: Cardiovascular disease, SCi and exercise: unique risks and focused countermeasures. Disability and Rehabilitation 32(26): 2228-2236

Danaei, G.; Lu, Y.; Singh, G.M.; Carnahan, E.; Stevens, G.A.; Cowan, M.J.; Farzadfar, F.; Lin, J.K.; Finucane, M.M.; Rao, M.; Khang, Y.-H.; Riley, L.M.; Mozaffarian, D.; Lim, S.S.; Ezzati, M.; Aamodt, G.; Abdeen, Z.; Abdella, N.A.; Rahim, H.F.A.; Addo, J.; Aekplakorn, W.; Afifi, M.M.; Agabiti-Rosei, E.; Salinas, C.A.A.; Agyemang, C.; Ali, M.K.; Ali, M.M.; Al-Nsour, M.; Al-Nuaim, A.R.; Ambady, R.; Di Angelantonio, E.; Aro, P.; Azizi, F.; Babu, B.V.; Bahalim, A.N.; Barbagallo, C.M.; Barbieri, M.A.; Barceló, A.; Barreto, S.M.; Barros, H.; Bautista, L.E.; Benetos, A.; Bjerregaard, P.; Björkelund, C.; Bo, S.; Bobak, M.; Bonora, E.; Botana, M.A.; Bovet, P.; Breckenkamp, J.; Breteler, M.M.; Broda, G.; Brown, I.J.; Bursztyn, M.; de León, A.C.; C 2014: Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. LANCET. Diabetes and Endocrinology 2(8): 634-647

Kanda, T.; Wakino, S.; Hayashi, K.; Plutzky, J. 2008: Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection. Journal of the American Society of Nephrology: Jasn 19(1): 4-7

Takeda, N.; Maemura, K. 2010: Cardiovascular disease, chronopharmacotherapy, and the molecular clock. Advanced Drug Delivery Reviews 62(9-10): 956-966

Almeida, O.P.; Alfonso, H.; Flicker, L.; Hankey, G.J.; Norman, P.E. 2012: Cardiovascular disease, depression and mortality: the Health in Men Study. American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry 20(5): 433-440

Agyemang, C.; Addo, J.; Bhopal, R.; Aikins, A.de.Graft.; Stronks, K. 2009: Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review. Globalization and Health 5: 7

Nichols, G.A.; Moler, E.J. 2011: Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes. Diabetologia 54(3): 523-526

Strandberg, T.E. 2010: Cardiovascular disease, hypertension, and risk of hip fracture. JAMA 303(8): 731; Author Reply 731-2

Deepak, D.; Furlong, N.J.; Wilding, J.P.H.; MacFarlane, I.A. 2007: Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease. Postgraduate Medical Journal 83(978): 277-280

Paquette, D.W.; Brodala, N.; Nichols, T.C. 2007: Cardiovascular disease, inflammation, and periodontal infection. Periodontology 2000 44: 113-126

Feke, G.T. 2007: Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: women's health initiative sight exam ancillary study. American Journal of Ophthalmology 144(3): 482

Bloomgarden, Z.T. 2009: Cardiovascular disease, neuropathy, and retinopathy. Diabetes Care 32(6): E64-E68

Reyes-García, R.; Rozas-Moreno, P.; Muñoz-Torres, M. 2012: Cardiovascular disease, osteoporosis and risk of fracture. Revista Clinica Espanola 212(4): 188-192

Martín de Francisco, Án.L.; Aguilera García, L.; Fuster Carulla, V.í 2009: Cardiovascular disease, renal disease and other chronic diseases. Earlier intervention is needed in chronic renal disease. Atencion Primaria 41(9): 511-514

Premaor, M.O.; Vanacour, R.; Furlanetto, T.W. 2008: Cardiovascular disease, sodium intake, and urinary calcium loss. Archives of Internal Medicine 168(3): 332; Author Reply 332-333

Wilding, P.M. 2012: Cardiovascular disease, statins and vitamin D. British Journal of Nursing 21(4): 214-220

Kumar, N.; Armstrong, D.J. 2008: Cardiovascular disease--the silent killer in rheumatoid arthritis. Clinical Medicine 8(4): 384-387

Vanden Heuvel, J.P. 2009: Cardiovascular disease-related genes and regulation by diet. Current Atherosclerosis Reports 11(6): 448-455

Chrysohoou, C.; Stefanadis, C.; Pitsavos, C.; Panagiotakos, D.; Das, U.N.; Giugliano, D. 2011: Cardiovascular disease-related lifestyle factors and longevity. Cardiology Research and Practice 2011: 386892

Molinar-Toribio, E.; Pérez-Jiménez, J.; Ramos-Romero, S.; Lluís, L.; Sánchez-Martos, V.; Taltavull, N.úr.; Romeu, M.; Pazos, M.; Méndez, L.ía.; Miranda, A.íb.; Cascante, M.; Medina, I.; Torres, J.L.ís. 2014: Cardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndrome. Plos one 9(8): E104637

Rosas-Peralta, M.ín.; Attie, F. 2007: Cardiovascular disease. first cause of death in adults in Mexico and worldwide. Archivos de Cardiologia de Mexico 77(2): 91-93

Johnson, C. 2007: Former EN is grateful for support. Nursing New Zealand 13(2): 3

Couzin-Frankel, J. 2012: Cardiovascular disease. Massive trials to test inflammation hypothesis. Science 337(6099): 1158

Haddad, L.B.; Wall, K.M.; Kilembe, W.; Vwalika, B.; Khu, N.H.; Brill, I.; Chomba, E.; Tichacek, A.; Allen, S. 2018: Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition. Aids 32(5): 595-604

Aje, T.O.; Miller, M. 2009: Cardiovascular disease: a global problem extending into the developing world. World Journal of Cardiology 1(1): 3-10

Salinas Botrán, A.; Ramos Rincón, J.é M.; de Górgolas Hernández-Mora, M. 2013: Cardiovascular disease: a view from global health perspective. Medicina Clinica 141(5): 210-216

Lazzini, A.; Lazzini, S. 2009: Cardiovascular disease: an economical perspective. Current Pharmaceutical Design 15(10): 1142-1156

Peters, R.J.G. 2013: Cardiovascular disease: big problems require big solutions. Nederlands Tijdschrift Voor Geneeskunde 157(20): A6047

Chen, M.H.; Colan, S.D.; Diller, L. 2011: Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circulation Research 108(5): 619-628

Rolley, J.X.; Thompson, D.R. 2012: Cardiovascular disease: is it time to finally recognise it as a complex, chronic life-span illness?. European Journal of Cardiovascular Nursing 11(2): 135-137

Kownator, S. 2010: Cardiovascular disease: pay attention to differences in women!. Presse Medicale 39(2): 232-233

Gondrie, M.J.A.; Mali, W.P.T.M.; Jacobs, P.C.; Oen, A.L.; van der Graaf, Y. 2010: Cardiovascular disease: prediction with ancillary aortic findings on chest CT scans in routine practice. Radiology 257(2): 549-559

Sultan, S.; Hynes, N. 2012: Cardiovascular disease: primary prevention, disease modulation and regenerative therapy. Vascular 20(5): 243-250

Luepker, R.V. 2011: Cardiovascular disease: rise, fall, and future prospects. Annual Review of Public Health 32: 1-3

Wenger, N.K. 2012: Cardiovascular disease: the female heart is vulnerable: a call to action from the 10Q report. Clinical Cardiology 35(3): 134-135

Ge, Y.; Van Eyk, J. 2014: Cardiovascular disease: the leap towards translational and clinical proteomics. Proteomics. Clinical Applications 8(7-8): 473-475

Ikem, I.; Sumpio, B.E. 2011: Cardiovascular disease: the new epidemic in sub-Saharan Africa. Vascular 19(6): 301-307

Barlovic, D.P.; Thomas, M.C.; Jandeleit-Dahm, K. 2010: Cardiovascular disease: what's all the AGE/RAGE about?. Cardiovascular and Hematological Disorders Drug Targets 10(1): 7-15

Kostka, T.; Para, J.; Kostka, B. 2009: Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly. Archives of Gerontology and Geriatrics 48(3): 300-305

Jeong, J.C.; Ro, H.; Hwang, Y.-H.; Lee, H.K.; Ha, J.; Ahn, C.; Yang, J. 2010: Cardiovascular diseases after kidney transplantation in Korea. Journal of Korean Medical Science 25(11): 1589-1594

Petta, S.; Macaluso, F.Salvatore.; Craxì, A. 2014: Cardiovascular diseases and HCV infection: a simple association or more?. Gut 63(3): 369-375

Jevtić, M.; Dragić, N.ša.; Bijelović, S.; Popović, M. 2014: Cardiovascular diseases and air pollution in Novi Sad, Serbia. International Journal of Occupational Medicine and Environmental Health 27(2): 153-164

Umnikova, M.V.; Gubernatorova, E.V.; Cheremkhin, K.Iu.; Vlasov, A.A.; Shkliar, T.F.; Bliakhman, F.A. 2009: Cardiovascular diseases and capabilities of transcutaneous electric nerve stimulation (review of literature). Voenno-Meditsinskii Zhurnal 330(1): 60-64

Kengne, A.P.; June-Rose McHiza, Z.; Amoah, A.G.B.; Mbanya, J.-C. 2013: Cardiovascular diseases and diabetes as economic and developmental challenges in Africa. Progress in Cardiovascular Diseases 56(3): 302-313

Vallé, B.; Camelot, D.; Bounes, V.; Parant, M.; Battefort, F.; Ducassé, J-Louis.; Pujos, M. 2010: Cardiovascular diseases and electrocardiogram teletransmission aboard ships: the French TMAS experience. International Maritime Health 62(3): 129-136

Pomeshkina, S.A.; Pomeshkin, E.V.; Barbarash, O.L.; Neĭmark, A.I. 2010: Cardiovascular diseases and erectile dysfunction. Terapevticheskii Arkhiv 82(10): 37-40

Yassin, A.A.; Akhras, F.; El-Sakka, A.I.; Saad, F. 2011: Cardiovascular diseases and erectile dysfunction: the two faces of the coin of androgen deficiency. Andrologia 43(1): 1-8

Sennerby, U.; Farahmand, B.; Ahlbom, A.; Ljunghall, S.; Michaëlsson, K. 2007: Cardiovascular diseases and future risk of hip fracture in women. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 18(10): 1355-1362

Rauramaa, T.; Pikkarainen, M.; Englund, E.; Ince, P.G.; Jellinger, K.; Paetau, A.; Parkkinen, L.; Alafuzoff, I. 2011: Cardiovascular diseases and hippocampal infarcts. Hippocampus 21(3): 281-287

Nakaya, H. 2011: Cardiovascular diseases and inflammation. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 138(5): 177

Cutini, V. 1949: Cardiovascular diseases and major operations of gynecology. Ginecologia 15(5): 223-238

Losin, I.E.; Shakhnovich, R.M.; Zykov, K.A.; Ruda, M.I. 2014: Cardiovascular diseases and mannose-binding lectin. Kardiologiia 54(3): 64-70

Fedorchenko, I.L.; Nebieridze, D.V.; Safarian, A.S.; Skripnikova, I.A.; Sobchenko, K.E. 2014: Cardiovascular diseases and osteoporosis: what is common?. Terapevticheskii Arkhiv 86(5): 116-119

Bowman, M.A.; Neale, A.V. 2012: Cardiovascular diseases and other evidence for primary care clinical practice. Journal of the American Board of Family Medicine: Jabfm 25(4): 403-405

Morović-Vergles, J. 2010: Cardiovascular diseases and rheumatoid arthritis. Reumatizam 57(2): 11-15

Sennerby, U.; Melhus, H.åk.; Gedeborg, R.; Byberg, L.; Garmo, H.; Ahlbom, A.; Pedersen, N.L.; Michaëlsson, K. 2009: Cardiovascular diseases and risk of hip fracture. JAMA 302(15): 1666-1673

Javaheri, S.; Somers, V.K. 2011: Cardiovascular diseases and sleep apnea. Handbook of Clinical Neurology 98: 327-345

Touze, J.E. 2007: Cardiovascular diseases and the epidemiological transition in tropical regions. Medecine Tropicale: Revue du Corps de Sante Colonial 67(6): 541-542

Weisberg, I.S.; Jacobson, I.M. 2011: Cardiovascular diseases and the liver. Clinics in Liver Disease 15(1): 1-20

Yang, C.-C.; Kao, C.-C. 2007: Cardiovascular diseases and the risk of venous thromboembolism: a hospital-based case-control study. Journal of the Chinese Medical Association: Jcma 70(3): 103-109

Low, W.-Y.; Kaewboonchoo, O.; Nilvarangkul, K. 2013: Cardiovascular diseases and the work environment. Asia-Pacific Journal of Public Health 25(4): 296-297

Andersen-Ranberg, K.; Fjederholt, K.T.; Madzak, A.; Nybo, M.; Jeune, B. 2013: Cardiovascular diseases are largely underreported in Danish centenarians. Age and Ageing 42(2): 249-253

Ishcheĭkina, I.O. 2012: Cardiovascular diseases as a problem of preventive medicine (review of the literature and our own research). Likars'ka Sprava 2012(5): 15-26

Rawdanowicz, J.; Pikto-Pietkiewicz, W.; Marczyńska, M. 2013: Cardiovascular diseases associated with HIV infection and their management. Kardiologia Polska 71(11): 1183-1187

Kharazmi, E.; Fallah, M.; Luoto, R. 2007: Cardiovascular diseases attributable to hysterectomy: a population-based study. Acta Obstetricia et Gynecologica Scandinavica 86(12): 1476-1483

Stajić, Z.; Mijailović, Z.; Bogavac, M.; Lazović, B.; Stojanović, M. 2013: Cardiovascular diseases during pregnancy and delivery. Medicinski Pregled 66(11-12): 507-513

Zhang, Y. 2010: Cardiovascular diseases in American women. Nutrition Metabolism and Cardiovascular Diseases: Nmcd 20(6): 386-393

Civeira, F. 2013: Cardiovascular diseases in Spain: conclusions and final comments. Clinica e investigacion en arteriosclerosis: publicacion oficial de la Sociedad Espanola de Arteriosclerosis 25(5): 231-232

Margaix Muñoz, M.ía.; Jiménez Soriano, Y.; Poveda Roda, R.; Sarrión, G. 2008: Cardiovascular diseases in dental practice. Practical considerations. Medicina Oral Patologia Oral y Cirugia Bucal 13(5): E296-E302

Wijnands, K.P.J.; Obermann-Borst, S.A.; Sijbrands, E.J.G.; Wildhagen, M.F.; Helbing, W.A.; Steegers-Theunissen, R.P.M. 2014: Cardiovascular diseases in grandparents and the risk of congenital heart diseases in grandchildren. Journal of Developmental Origins of Health and Disease 5(2): 152-158

Oldenburg, M.; Baur, X.; Schlaich, C. 2010: Cardiovascular diseases in modern maritime industry. International Maritime Health 62(3): 101-106

Fisher, A.; Srikusalanukul, W.; Davis, M.; Smith, P. 2013: Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links. Clinical Interventions in Aging 8: 239-256

Dimković, N. 2008: Cardiovascular diseases in patients with chronic renal diseases. Srpski Arhiv Za Celokupno Lekarstvo 136(Suppl 2): 135-141

Koivuniemi, R.; Paimela, L.; Suomalainen, R.; Leirisalo-Repo, M. 2013: Cardiovascular diseases in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology 42(2): 131-135

Gerasimova, E.V.; Popkova, T.V.; Novikova, D.S.; Nasonov, E.L. 2014: Cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy. Terapevticheskii Arkhiv 86(5): 26-31

Abdullateef, R.M.; Ijaiya, M.A.; Abayomi, F.; Adeniran, A.S.; Idris, H. 2017: Bacterial vaginosis: Prevalence and associated risk factors among non-pregnant women of reproductive age attending a Nigerian tertiary hospital. Malawi Medical Journal: the Journal of Medical Association of Malawi 29(4): 290-293

Regitz-Zagrosek, V.; Seeland, U.; Geibel-Zehender, A.; Gohlke-Bärwolf, C.; Kruck, I.; Schaefer, C. 2011: Cardiovascular diseases in pregnancy. Deutsches Arzteblatt International 108(16): 267-273

Rott, H. 2011: Cardiovascular diseases in pregnancy. Not helpful. Deutsches Arzteblatt International 108(37): 621; Author Reply 621-2

Cossio, P. 1950: Cardiovascular diseases in relation to odontology. Revista Odontologica 38(7): 271-275

Popkova, T.V.; Khelkovskaia, A.N.; Mach, E.S.; Aleksandrova, E.N.; Novikov, A.A.; Novikova, D.S.; Nasonov, E.L. 2007: Cardiovascular diseases in rheumatoid arthritis. Terapevticheskii Arkhiv 79(5): 9-14

Moir, R.A.; Smith, K.S. 1946: Cardiovascular diseases in the British Army overseas. British Heart Journal 8: 110-114

Krivoshapkin, V.G.; Alexeev, V.P.; Klimova, T.M. 2007: Cardiovascular diseases in the Republic of Sakha (Yakutia): status of the problem in the light of scientific research results. Alaska Medicine 49(2 Suppl): 48-50

Azizova, T.V.; Muirhead, C.R.; Druzhinina, M.B.; Grigoryeva, E.S.; Vlasenko, E.V.; Sumina, M.V.; O'Hagan, J.A.; Zhang, W.; Haylock, R.G.E.; Hunter, N. 2010: Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948-1958. Radiation Research 174(2): 155-168

Antonelli, D.; Suleiman, K.; Turgeman, Y. 2009: Cardiovascular diseases in the elderly in a consultant outpatient cardiac clinic. Israel Medical Association Journal: Imaj 11(4): 235-237

Reinhold, T.; Müller-Riemenschneider, F.; McBride, D.; Brüggenjürgen, B.; Willich, S.N. 2012: Cardiovascular diseases in the focus of health economics. the example of drug-eluting vascular stents in coronary heart disease. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(5): 693-699

Sancini, A.; Caciari, T.; De Sio, S.; Fiaschetti, M.; Di Giorgio, V.; Samperi, I.; Gioffrè, P.; Giubilati, R.; Vitarelli, A.; Tomei, G.; Tomei, F. 2010: Cardiovascular diseases in workers at risk. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 32(4 Suppl): 163-165

Benda, T. 2011: Cardiovascular diseases occurrence in patients with pseudoexfoliative syndrome and pseudoexfoliative glaucoma. Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 67(1): 12-15

Purohit, P. 2012: Cardiovascular diseases risk evaluation in newly diagnosed type-2 diabetics: An association of novel biomarkers apo proteins and C-peptide. Indian Journal of Endocrinology and Metabolism 16(6): 1061-1062

Olszewski, R.; Grabysa, R.ła.; Kwasiborski, P.ła.J.; Makowski, T.; Warmiński, J.; Szczechowicz, R.; Kubik, L. 2009: Cardiovascular diseases risk factors knowledge among soldiers of the Polish army. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 27(160): 273-278

Eusébio, J.; Reny, J.-L.; Fontana, P.; Nendaz, M. 2010: Cardiovascular diseases, antiplatelet agents, anticoagulants and hemorrhagic risk. Revue Medicale Suisse 6(267): 1942; 1944-1946; 1948-1950

Husseini, A.; Abu-Rmeileh, N.M.E.; Mikki, N.; Ramahi, T.M.; Ghosh, H.A.; Barghuthi, N.; Khalili, M.; Bjertness, E.; Holmboe-Ottesen, G.; Jervell, J. 2009: Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet 373(9668): 1041-1049

Dzakula, A.; Sogorić, S.; Polasek, O.; Jurisa, A.; Andrić, A.; Radaković, N.; Todorović, G. 2009: Cardiovascular diseases, risk factors and barriers in their prevention in Croatia. Collegium Antropologicum 33 Suppl. 1: 87-92

Greiser, K.Halina.; Kluttig, A.; Schumann, B.; Swenne, C.A.; Kors, J.A.; Kuss, O.; Haerting, J.; Schmidt, H.; Thiery, J.; Werdan, K. 2009: Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006. European journal of epidemiology 24(3): 123-142

Chapman, M.John. 2010: Cardiovascular diseases. Introduction. Atherosclerosis. Supplements 11(3): 1-2

Gómez, L.A. 2011: Cardiovascular diseases: a public health problem and a global challenge. Biomedica: Revista del Instituto Nacional de Salud 31(4): 469-473

Zhang, P.-Y.; Xu, X.; Li, X.-C. 2014: Cardiovascular diseases: oxidative damage and antioxidant protection. European Review for Medical and Pharmacological Sciences 18(20): 3091-3096

Paul, O.; Bland, E.F.; White, P.D. 1948: Cardiovascular diseases; a review of significant publications from January 1944 to June 1947. Archives of Internal Medicine (1908) 81(2): 209; Passim

Péter, L.ás.ó; Döme, P.ét.; Rihmer, Z.án.; Kovács, G.áb.; Faludi, G.áb. 2008: Cardiovascular disorders and depression: a review of epidemiological and possible etiological data. Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 10(2): 81-90

Onuchin, S.G.; Elsukova, O.S.; Solov'ev, O.V.; Onuchina, E.L. 2010: Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy. Klinicheskaia Meditsina 88(1): 32-37

Villa-Forte, A.; Mandell, B.F. 2011: Cardiovascular disorders and rheumatic disease. Revista Espanola de Cardiologia 64(9): 809-817

Anonymous 2011: Cardiovascular disorders associated with obstructive sleep apnea. Advances in cardiology 46: 197-266

Suárez-Moro, R.; Castaño-García, B. 2010: Cardiovascular disorders in Parkinson's disease. Revista de Neurologia 50(Suppl 2): S59-S63

Di Cola, G.; Jacoangeli, F.; Jacoangeli, F.; Lombardo, M.; Iellamo, F. 2014: Cardiovascular disorders in anorexia nervosa and potential therapeutic targets. Internal and Emergency Medicine 9(7): 717-721

Takeda, N.; Shikata, C.; Sekikawa, T.; Kimura, N.; Nishiyama, A. 2006: Cardiovascular disorders in patients with diabetes mellitus. Experimental and Clinical Cardiology 11(3): 237-238

Morović-Vergles, J. 2008: Cardiovascular disorders in rheumatoid arthritis. Reumatizam 55(2): 53-56

Klein, G.L.; Enkhbaatar, P.; Traber, D.L.; Buja, L.M.; Jonkam, C.C.; Poindexter, B.J.; Bick, R.J. 2008: Cardiovascular distribution of the calcium sensing receptor before and after burns. Burns: Journal of the International Society for Burn Injuries 34(3): 370-375

Sokolow, M.; Garland, L.H. 1945: Cardiovascular disturbances in Tsutsugamushi disease. United States Naval Medical Bulletin 45: 1054-1068

Fedrizzi, D.; Czepielewski, M.A. 2008: Cardiovascular disturbances in acromegaly. Arquivos Brasileiros de Endocrinologia e Metabologia 52(9): 1416-1429

Wingo, J.E.; Salaga, L.J.; Newlin, M.K.; Cureton, K.J. 2012: Cardiovascular drift and Vo2max during cycling and walking in a temperate environment. Aviation Space and Environmental Medicine 83(7): 660-666

Kounalakis, S.N.; Geladas, N.D. 2012: Cardiovascular drift and cerebral and muscle tissue oxygenation during prolonged cycling at different pedalling cadences. Applied Physiology Nutrition and Metabolism 37(3): 407-417

Wingo, J.E.; Ganio, M.S.; Cureton, K.J. 2012: Cardiovascular drift during heat stress: implications for exercise prescription. Exercise and Sport Sciences Reviews 40(2): 88-94

Rowland, T.; Pober, D.; Garrison, A. 2008: Cardiovascular drift in euhydrated prepubertal boys. Applied Physiology Nutrition and Metabolism 33(4): 690-695

Unger, E.; Porter, T.; Lindner, J.; Grayburn, P. 2014: Cardiovascular drug delivery with ultrasound and microbubbles. Advanced Drug Delivery Reviews 72: 110-126

Gardell, S.J.; Roth, G.P.; Kelly, D.P. 2010: Cardiovascular drug discovery in the academic setting: building infrastructure, harnessing strengths, and seeking synergies. Journal of Cardiovascular Translational Research 3(5): 431-437

Gromo, G.; Mann, J.; Fitzgerald, J.D. 2014: Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company. Cold Spring Harbor Perspectives in Medicine 4(6)

Aronow, W.S.; Frishman, W.H.; Cheng-Lai, A. 2007: Cardiovascular drug therapy in the elderly. Cardiology in Review 15(4): 195-215

Cleophas, T.J.; Zwinderman, A.H.; van Ouwerkerk, B.; Sobh, M. 2007: Cardiovascular drug trials: how to examine interaction, and why so. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 15(2): 61-66

Laursen, T.M.; Mortensen, P.B.; MacCabe, J.H.; Cohen, D.; Gasse, C. 2014: Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study. Psychological Medicine 44(8): 1625-1637

Simoens, S.; De Coster, S.; Dethier, M.; Lenie, J.; Meuwissen, P.; Laekeman, G. 2009: Cardiovascular drug use prior to diagnosis of diabetes: a pilot study in community pharmacy. International Journal of Pharmacy Practice 17(2): 127-129

Rejnmark, L. 2008: Cardiovascular drugs and bone. Current Drug Safety 3(3): 178-184

Messerli, F.H.; Bangalore, S.; Torp-Pedersen, C.; Staessen, J.A.; Kostis, J.B. 2013: Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert. European Heart Journal 34(15): 1095-1098

Eto, M. 2011: Cardiovascular drugs and cognitive impairment. Nihon Rinsho. Japanese Journal of Clinical Medicine 69 Suppl 10 Pt 2: 166-169

Dandona, S. 2014: Cardiovascular drugs and the genetic response. Methodist Debakey Cardiovascular Journal 10(1): 13-17

Macfarlane, D.P.; Paterson, K.R.; Fisher, M. 2008: Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes. Diabetes Obesity and Metabolism 10(7): 533-544

Jurković, D.; Stimac, D.; Bajramović, D.; Tiljak, H.; Stevanović, R. 2014: Cardiovascular drugs consumption--comparison between two Croatian regions, City of Zagreb and Lika-Senj County. Collegium Antropologicum 38(2): 645-652

Jauković, Z.D.; Grujić, S.D.; Vasiljević, T.M.; Petrović, S.D.; Lausević, M.D. 2014: Cardiovascular drugs in environmental waters and wastewaters: method optimization and real sample analysis. Journal - Association of Official Analytical Chemists 97(4): 1167-1174

Del Giaccio, A.; Eblen-Zajjur, A. 2010: Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol. Investigacion Clinica 51(1): 77-86

Frishman, W.H.; Elkayam, U.; Aronow, W.S. 2012: Cardiovascular drugs in pregnancy. Cardiology Clinics 30(3): 463-491

Ong, K.L.; Barter, P.J.; Waters, D.D. 2014: Cardiovascular drugs that increase the risk of new-onset diabetes. American Heart Journal 167(4): 421-428

Becker, D.E. 2007: Cardiovascular drugs: implications for dental practice part 1 - cardiotonics, diuretics, and vasodilators. Anesthesia Progress 54(4): 178-185; Quiz: 186-187

Becker, D.E. 2008: Cardiovascular drugs: implications for dental practice. Part 2--antihyperlipidemics and antithrombotics. Anesthesia Progress 55(2): 49-55; Quiz: 56-57

Bastarrika, G.; De Cecco, C.N.; Bastero, P.; Arraiza, M.; Barba, J.ín.; Anselmi, A.; Alzina, V. 2008: Cardiovascular dual source computed tomography for aortic coarctation in a neonate: one-second scan with ultra-low radiation dose. Annals of Thoracic Surgery 86(5): E4

Simmonds, M.J.; Tripette, J.; Sabapathy, S.; Marshall-Gradisnik, S.M.; Connes, P. 2011: Cardiovascular dynamics during exercise are related to blood rheology. Clinical Hemorheology and Microcirculation 49(1-4): 231-241

Sarlo, M.; Buodo, G.; Munafò, M.; Stegagno, L.; Palomba, D. 2008: Cardiovascular dynamics in blood phobia: evidence for a key role of sympathetic activity in vulnerability to syncope. Psychophysiology 45(6): 1038-1045

Smith, J.R.; Hara, M. 1948: Cardiovascular dynamics in experimental embolism of restricted portions of the lungs. Journal of Clinical Investigation 27(4): 556

Ramirez-Marrero, F.A.; Charkoudian, N.; Hart, E.C.; Schroeder, D.; Zhong, L.; Eisenach, J.H.; Joyner, M.J. 2008: Cardiovascular dynamics in healthy subjects with differing heart rate responses to tilt. Journal of Applied Physiology 105(5): 1448-1453

Goto, Y. 2007: Cardiovascular dynamics in heart failure. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 4): 307-315

Van der Wall, E.E.; Bax, J.J.; Swenne, C.A.; Steendijk, P.; Schalij, M.J. 2010: Cardiovascular dynamics in ischemic cardiomyopathy during exercise. International Journal of Cardiovascular Imaging 26(2): 161-164

Oka, H.; Toyoda, C.; Yogo, M.; Mochio, S. 2011: Cardiovascular dysautonomia in de novo Parkinson's disease without orthostatic hypotension. European Journal of Neurology 18(2): 286-292

Izquierdo, L.María.; Rodríguez Buitrago, J.R. 2012: Cardiovascular dysfunction and pulmonary edema secondary to severe envenoming by Tityus pachyurus sting. Case report. Toxicon: official journal of the International Society on Toxinology 60(4): 603-606

Abu-Sittah, G.S.; Sarhane, K.A.; Dibo, S.A.; Ibrahim, A. 2012: Cardiovascular dysfunction in burns: review of the literature. Annals of Burns and Fire Disasters 25(1): 26-37

Barbosa, J.é A.A.; Rodrigues, A.B.; Mota, C.C.C.; Barbosa, M.ár.M.; Simões e Silva, A.C. 2011: Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods. Vascular Health and Risk Management 7: 287-295

Xu, G-Feng.; Zhang, J-Yu.; Pan, H-Tao.; Tian, S.; Liu, M-E.; Yu, T-Tian.; Li, J-Yi.; Ying, W-Wen.; Yao, W-Miao.; Lin, X-Hua.; Lv, Y.; Su, W-Wen.; Ye, X-Qun.; Zhang, F-Hong.; Pan, J-Xue.; Liu, Y.; Zhou, C-Liang.; Zhang, D.; Liu, X-Mei.; Zhu, Y-Min.; Sheng, J-Zhong.; Huang, H-Feng. 2014: Cardiovascular dysfunction in offspring of ovarian-hyperstimulated women and effects of estradiol and progesterone: a retrospective cohort study and proteomics analysis. Journal of Clinical Endocrinology and Metabolism 99(12): E2494-E2503

Mandell, M.S.; Tsou, M.-Y. 2008: Cardiovascular dysfunction in patients with end-stage liver disease. Journal of the Chinese Medical Association: Jcma 71(7): 331-335

Liaudet, L. 2013: Cardiovascular dysfunction in sepsis: from basic mechanisms to clinical management. Current Vascular Pharmacology 11(2): 121-122

Agarwal, G.; Nanda, G.; Kapoor, A.; Singh, K.R.; Chand, G.; Mishra, A.; Agarwal, A.; Verma, A.K.; Mishra, S.K.; Syal, S.K. 2013: Cardiovascular dysfunction in symptomatic primary hyperparathyroidism and its reversal after curative parathyroidectomy: results of a prospective case control study. Surgery 154(6): 1394-1403; Discussion: 1403-1404

Miwa, K.; Fujita, M. 2009: Cardiovascular dysfunction with low cardiac output due to a small heart in patients with chronic fatigue syndrome. Internal Medicine 48(21): 1849-1854

Pal, G.K.; Pal, P.; Nanda, N.; Amudharaj, D.; Adithan, C. 2013: Cardiovascular dysfunctions and sympathovagal imbalance in hypertension and prehypertension: physiological perspectives. Future Cardiology 9(1): 53-69

Semeraro, L.; Lénaud, A-Valérie.; McLin, Vérie.A. 2012: Cardiovascular dysphagia. Journal of Pediatric Gastroenterology and Nutrition 55(1): 1

Yuan, S.-M. 2014: Cardiovascular dysphagia - anatomical and clinical implications. Folia Morphologica 73(2): 113-121

Danielson, L.S.; Park, D.S.; Rotllan, N.; Chamorro-Jorganes, A.; Guijarro, M.V.; Fernandez-Hernando, C.; Fishman, G.I.; Phoon, C.K.L.; Hernando, E. 2013: Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 27(4): 1460-1467

John, H.; Carroll, D.; Kitas, G.D. 2011: Cardiovascular education for people with rheumatoid arthritis: what can existing patient education programmes teach us?. Rheumatology 50(10): 1751-1759

Liang, X.; Beilei, W.; Ying, L.; Qianqian, W.; Sihua, L.; Yang, W.; Guoyan, L.; Jia, L.; Xuting, Y.; Liming, Z. 2012: Cardiovascular effect is independent of hemolytic toxicity of tentacle-only extract from the jellyfish Cyanea capillata. Plos one 7(8): E43096

Zeggwagh, N.-A.; Farid, O.; Michel, J.B.; Eddouks, M. 2008: Cardiovascular effect of Artemisia herba alba aqueous extract in spontaneously hypertensive rats. Methods and Findings in Experimental and Clinical Pharmacology 30(5): 375-381

Kawabe, T.; Kawabe, K.; Sapru, H.N. 2014: Cardiovascular effect of angiotensin-(1-12) in the caudal ventrolateral medullary depressor area of the rat. American Journal of Physiology. Heart and Circulatory Physiology 306(3): H438-H449

Meyers, D.G.; Neuberger, J.S. 2008: Cardiovascular effect of bans on smoking in public places. American Journal of Cardiology 102(10): 1421-1424

Meyers, D.G.; Neuberger, J.S.; He, J. 2009: Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. Journal of the American College of Cardiology 54(14): 1249-1255

Torres-Lagares, D.; Serrera-Figallo, M.ía.-Án.; Machuca-Portillo, G.; Corcuera-Flores, J.é-R.ón.; Machuca-Portillo, C.; Castillo-Oyagüe, R.; Gutiérrez-Pérez, J.é-L. 2012: Cardiovascular effect of dental anesthesia with articaine (40 mg with epinefrine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30 mg and 20 mg with epinefrine 1 mg%) in medically compromised cardiac patients: a cross-over, randomized, single blinded study. Medicina Oral Patologia Oral y Cirugia Bucal 17(4): E655-E660

Jang, Y.; Kim, E. 2013: Cardiovascular effect of epinephrine in endodontic microsurgery: a review. Restorative Dentistry and Endodontics 38(4): 187-193

Guo, B.-Q.; Jia, M.; Liu, J.-X.; Zhang, Z. 2010: Cardiovascular effect of intracerebroventricular injection of orexin-1 receptor antagonist in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 26(3): 278-283

Joukar, S.; Sheibani, M.; Joukar, F. 2012: Cardiovascular effect of nifedipine in morphine dependent rats: hemodynamic, histopathological, and biochemical evidence. Croatian Medical Journal 53(4): 343-349

Yalcin, M.; Aydin, C.; Savci, V. 2009: Cardiovascular effect of peripheral injected melittin in normotensive conscious rats: Mediation of the central cholinergic system. Prostaglandins Leukotrienes and Essential Fatty Acids 81(5-6): 341-347

Francomano, D.; Bruzziches, R.; Natali, M.; Aversa, A.; Spera, G. 2010: Cardiovascular effect of testosterone replacement therapy in aging male. Acta Bio-Medica: Atenei Parmensis 81(Suppl 1): 101-106

Roziaková, L.; Mladosievicová, B. 2010: Cardiovascular effects after hematopoietic stem cell transplantation. Vnitrni Lekarstvi 56(3): 233-239

Wondergem, J.; Boerma, M.; Kodama, K.; Stewart, F.A.; Trott, K.R. 2013: Cardiovascular effects after low-dose exposure and radiotherapy: what research is needed?. Radiation and Environmental Biophysics 52(4): 425-434

Fachko, M.J.; Xiao, C.; Bowles, K.H.; Robinson, K.M.; Libonati, J.R. 2013: Cardiovascular effects and enjoyment of exercise gaming in older adults. Journal of Gerontological Nursing 39(12): 43-54

Lu, W.-W.; Qi, Y.-F. 2013: Cardiovascular effects and pathophysiological significance of adrenomedullin family peptides. Sheng Li Ke Xue Jin Zhan 44(3): 177-182

Cui, X.-J.; Meng, L.; Ding, W.-H. 2013: Cardiovascular effects and pathophysiological significance of vasostatins. Sheng Li Ke Xue Jin Zhan 44(6): 429-432

Shin, B.S.; Do, Y.S.; Cho, H.S.; Hahm, T.S.; Kim, C.S.; Sim, W.S.; Lee, C.J.; Lee, S.H.; Jin, H.S.; Song, H.G.; Park, K.B.; Park, H.S.; Kim, S.T. 2010: Cardiovascular effects and predictability of cardiovascular collapse after repeated intravenous bolus injections of absolute ethanol in anesthetized pigs. Journal of Vascular and Interventional Radiology: Jvir 21(12): 1867-1872

Masmiquel, L. 2014: Cardiovascular effects and safety of glucose-lowering drugs: current situation. Semergen 40(2): 80-88

Tong, H.; Rappold, A.G.; Caughey, M.; Hinderliter, A.L.; Graff, D.W.; Berntsen, J.H.; Cascio, W.E.; Devlin, R.B.; Samet, J.M. 2014: Cardiovascular effects caused by increasing concentrations of diesel exhaust in middle-aged healthy GSTM1 null human volunteers. Inhalation Toxicology 26(6): 319-326

Cavalcante, H.M.M.; Ribeiro, T.ís.P.; Silva, D.íz.F.; Nunes, X.P.; Barbosa-Filho, J.é M.; Diniz, M.F.F.M.; Correia, N.A.; Braga, V.A.; Medeiros, I.A. 2011: Cardiovascular effects elicited by milonine, a new 8,14-dihydromorphinandienone alkaloid. Basic and Clinical Pharmacology and Toxicology 108(2): 122-130

Franco, V.I.; Henkel, J.M.; Miller, T.L.; Lipshultz, S.E. 2011: Cardiovascular effects in childhood cancer survivors treated with anthracyclines. Cardiology Research and Practice 2011: 134679

Aguirre, S.A.; Heyen, J.R.; Collette, W.; Bobrowski, W.; Blasi, E.R. 2010: Cardiovascular effects in rats following exposure to a receptor tyrosine kinase inhibitor. Toxicologic Pathology 38(3): 416-428

de Menezes, I.Alexandre.Côrtes.; Moreira, I.José.Alves.; de Paula, Jé.Welton.Azevedo.; Blank, A.Fitzgerald.; Antoniolli, A.Roberto.; Quintans-Júnior, L.José.; Santos, Márcio.Roberto.Viana. 2010: Cardiovascular effects induced by Cymbopogon winterianus essential oil in rats: involvement of calcium channels and vagal pathway. Journal of Pharmacy and Pharmacology 62(2): 215-221

Araújo, J.ão.X.; Ribeiro, E.A.él.N.; Fraga, C.A.M.; Lima, L.íd.M.; Barreiro, E.J.; de Medeiros, I.A. 2010: Cardiovascular effects induced by N-(4'-dihydro)-piperoylthiomorpholine in normotensive rats. Journal of Pharmacy and Pharmacology 62(12): 1794-1800

Anjos, P.J.C.; Lima, A.O.; Cunha, P.íc.S.; De Sousa, D.ão.P.; Onofre, A.S.C.; Ribeiro, T.P.; Medeiros, I.A.; Antoniolli, A.R.; Quintans-Júnior, L.J.; Santosa, M.ár.R.V. 2013: Cardiovascular effects induced by linalool in normotensive and hypertensive rats. Zeitschrift für Naturforschung. C Journal of Biosciences 68(5-6): 181-190

Fujimoto, N.; Hastings, J.L.; Carrick-Ranson, G.; Shafer, K.M.; Shibata, S.; Bhella, P.S.; Abdullah, S.M.; Barkley, K.W.; Adams-Huet, B.; Boyd, K.N.; Livingston, S.A.; Palmer, D.; Levine, B.D. 2013: Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals. CIRCULATION. Heart Failure 6(6): 1155-1164

Fujimoto, N.; Prasad, A.; Hastings, J.L.; Arbab-Zadeh, A.; Bhella, P.S.; Shibata, S.; Palmer, D.; Levine, B.D. 2010: Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation 122(18): 1797-1805

Interaminense, L.d.F.át.L.; de Siqueira, R.J.é B.; Xavier, F.E.; Duarte, G.P.; Magalhães, P.J.C.; da Silva, J.K.; Maia, J.é G.S.; Sousa, P.J.é d.C.; Leal-Cardoso, J.é H.; Lahlou, S. 2011: Cardiovascular effects of 1-nitro-2-phenylethane, the main constituent of the essential oil of Aniba canelilla, in spontaneously hypertensive rats. Fundamental and Clinical Pharmacology 25(6): 661-669

Hansen, P.Riis.; Andersen, L.Juel.; Rebelo, Aónio.Natal.; Brito, J.; Hornstrup, T.; Schmidt, J.Friis.; Jackman, S.R.; Mota, J.; Rêgo, C.; Oliveira, J.; Seabra, Aé.; Krustrup, P. 2013: Cardiovascular effects of 3 months of football training in overweight children examined by comprehensive echocardiography: a pilot study. Journal of Sports Sciences 31(13): 1432-1440

Fadini, G.P.; Avogaro, A. 2011: Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vascular Pharmacology 55(1-3): 10-16

Kamadyaapa, D.R.; Gondwe, M.M.; Moodley, K.; Ojewole, J.A.O.; Musabayane, C.T. 2009: Cardiovascular effects of Ekebergia capensis Sparrm (Meliaceae) ethanolic leaf extract in experimental animal paradigms. Cardiovascular Journal of Africa 20(3): 162-167; 169

Khan, M.; Khan, A.-U.; Najeeb-ur-Rehman; Zafar, M.A.; Hazrat, A.; Gilani, A.-H. 2012: Cardiovascular effects of Juniperus excelsa are mediated through multiple pathways. Clinical and Experimental Hypertension 34(3): 209-216

Mokra, D.; Tonhajzerova, I.; Pistekova, H.; Visnovcova, Z.; Drgova, A.; Mokry, J.; Calkovska, A. 2015: Cardiovascular effects of N-acetylcysteine in meconium-induced acute lung injury. Advances in Experimental Medicine and Biology 832: 35-43

Sherve, K.; Gerard, C.J.; Neher, J.O.; St Anna, L. 2014: Cardiovascular effects of NSAIDs. American Family Physician 90(4): Online

Ojewole, J.A.O.; Kamadyaapa, D.R.; Gondwe, M.M.; Moodley, K.; Musabayane, C.T. 2007: Cardiovascular effects of Persea americana Mill (Lauraceae) (avocado) aqueous leaf extract in experimental animals. Cardiovascular Journal of Africa 18(2): 69-76

Anggadiredja, K.; Tjandrawinata, R.R. 2015: Cardiovascular effects of Phaleria macrocarpa extracts combined with mainstay FAC regimen for breast cancer. Cardiovascular Toxicology 15(1): 90-99

Niazmand, S.; Esparham, M.; Hassannia, T.; Derakhshan, M. 2011: Cardiovascular effects of Teucrium polium L. extract in rabbit. Pharmacognosy Magazine 7(27): 260-264

Kardeşoğlu, E.; Uz, O.; Işılak, Z. 2010: Cardiovascular effects of Turkish bath and sauna/The effect of Turkish bath on QT dispersion. Anadolu Kardiyoloji Dergisi: Akd 10(6): 559; Author Reply 559

Brancaccio, D.; Cozzolino, M. 2009: Cardiovascular effects of VDR and CaSR activation. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(Suppl 49): S18-S22

Araújo, M.A.; Dias, B.P.; Bovino, F.; Deschk, M.íc.; Abimussi, C.J.; Oliva, V.ér.N.; Rodrigues, C.A.; Santos, P.S. 2014: Cardiovascular effects of a continuous rate infusion of lidocaine in calves anesthetized with xylazine, midazolam, ketamine and isoflurane. Veterinary Anaesthesia and Analgesia 41(2): 145-152

Scherbaum, W.A.; Nitschmann, S. 2014: Cardiovascular effects of a lifestyle intervention in type 2 diabetes. the look AHEAD (Action for Health in Diabetes) study. Der Internist 55(6): 735-738

De Araújo Júnior, J.ão.X.; Julien, C.; Barrès, C.; de Medeiros, I.A.; Ribeiro, E.A.él.N.; Lima, L.íd.M.; Barreiro, E.J. 2010: Cardiovascular effects of a novel synthetic analogue of naturally occurring piperamides. Journal of Cardiovascular Pharmacology 56(3): 293-299

Canbora, K.; Kose, O.; Gurkan, U.; Polat, A.; Erdem, S.; Haklar, U. 2013: Cardiovascular effects of abduction shoulder sling in elderly patients; is it really safe?. Archives of Orthopaedic and Trauma Surgery 133(11): 1557-1560

Deolindo, M.V.; Pelosi, G.G.; Busnardo, C.; Resstel, L.B.M.; Corrêa, F.M.A. 2011: Cardiovascular effects of acetylcholine microinjection into the ventrolateral and dorsal periaqueductal gray of rats. Brain Research 1371: 74-81

Ceriello, A. 2008: Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings. Diabetes and Vascular Disease Research 5(4): 260-268

Lackner, H.K.; Weiss, E.M.; Hinghofer-Szalkay, H.; Papousek, I. 2014: Cardiovascular effects of acute positive emotional arousal. Applied Psychophysiology and Biofeedback 39(1): 9-18

Leung, J.Y.T.; Pang, C.C.Y.; Procyshyn, R.M.; Barr, A.M. 2014: Cardiovascular effects of acute treatment with the antipsychotic drug olanzapine in rats. Vascular Pharmacology 62(3): 143-149

Scholten, R.R.; Thijssen, D.J.H.; Lotgering, F.K.; Hopman, M.T.E.; Spaanderman, M.E.A. 2014: Cardiovascular effects of aerobic exercise training in formerly preeclamptic women and healthy parous control subjects. American Journal of Obstetrics and Gynecology 211(5): 516.E1-516.E11

Brook, R.D. 2008: Cardiovascular effects of air pollution. Clinical Science 115(6): 175-187

Escoubet, B.; Couffignal, C.; Laisy, J.-P.; Mangin, L.; Chillon, S.; Laouénan, C.éd.; Serfaty, J.-M.; Jeunemaitre, X.; Mentré, F.; Zennaro, M.-C. 2013: Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations. CIRCULATION. Cardiovascular Genetics 6(4): 381-390

Sonne, D.P.; Knop, F.K. 2013: Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1. Experimental Biology and Medicine 238(10): 1116-1117

Sun, Q.; Hong, X.; Wold, L.E. 2010: Cardiovascular effects of ambient particulate air pollution exposure. Circulation 121(25): 2755-2765

Medeiros, I.A.; Pires, S.L.; Almeida, R.N.; Thomas, G. 1998: Cardiovascular effects of an aqueous fraction of the ethanol extract of the leaves of Cissampelos Eichl. in the rat. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 5(2): 97-102

Giraldo, P.T.G.ía. 2014: Cardiovascular effects of an intensive intervention on lifestyle in type 2 diabetes. Revista Clinica Espanola 214(2): 102

Rosa, M.A.; Rosa, M.O.; Marcolin, M.A.; Fregni, F. 2007: Cardiovascular effects of anesthesia in ECT: a randomized, double-blind comparison of etomidate, propofol, and thiopental. Journal of Ect 23(1): 6-8

Dampney, R.A.L.; Tan, P.S.P.; Sheriff, M.J.; Fontes, M.A.P.; Horiuchi, J. 2007: Cardiovascular effects of angiotensin Ii in the rostral ventrolateral medulla: the push-pull hypothesis. Current Hypertension Reports 9(3): 222-227

Tai, D.J.; Lim, T.W.; James, M.T.; Manns, B.J.; Tonelli, M.; Hemmelgarn, B.R. 2010: Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis. Clinical Journal of the American Society of Nephrology: Cjasn 5(4): 623-630

Rosa, G.M.; Bauckneht, M.; Scala, C.; Tafi, E.; Leone Roberti Maggiore, U.; Ferrero, S.; Brunelli, C. 2013: Cardiovascular effects of antimuscarinic agents in overactive bladder. Expert Opinion on Drug Safety 12(6): 815-827

Michelsen, J.W.; Meyer, J.M. 2007: Cardiovascular effects of antipsychotics. Expert Review of Neurotherapeutics 7(7): 829-839

Filardi, P.P.; Paolillo, S.; Marciano, C.; Iorio, A.; Losco, T.; Marsico, F.; Scala, O.; Ruggiero, D.; Ferraro, S.; Chiariello, M. 2008: Cardiovascular effects of antiretroviral drugs: clinical review. Cardiovascular and Hematological Disorders Drug Targets 8(4): 238-244

Bagnost, T.; Ma, L.; da Silva, R.F.; Rezakhaniha, R.; Houdayer, C.; Stergiopulos, N.; André, C.; Guillaume, Y.; Berthelot, A.; Demougeot, C.él. 2010: Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension. Cardiovascular Research 87(3): 569-577

Stea, F.; Bianchi, F.; Cori, L.; Sicari, R. 2014: Cardiovascular effects of arsenic: clinical and epidemiological findings. Environmental Science and Pollution Research International 21(1): 244-251

Ishizaka, T.; Takahara, A.; Iwasaki, H.; Mitsumori, Y.; Kise, H.; Nakamura, Y.; Sugiyama, A. 2010: Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog. Basic and Clinical Pharmacology and Toxicology 106(2): 135-143

Montaudon, E.; Abdelkrim, M.A.; Desfontis, J.-C.; Mallem, M.Y. 2014: Cardiovascular effects of beta1 and beta3-adrenergic receptor autoantibodies in Lewis rat. Annales de Cardiologie et d'Angeiologie 63(3): 128-134

Senkus-Konefka, E.; Jassem, J. 2007: Cardiovascular effects of breast cancer radiotherapy. Cancer Treatment Reviews 33(6): 578-593

Reid, I.R.; Bolland, M.J.; Avenell, A.; Grey, A. 2011: Cardiovascular effects of calcium supplementation. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 22(6): 1649-1658

Reid, I.R. 2013: Cardiovascular effects of calcium supplements. Nutrients 5(7): 2522-2529

Liu, L.; Ding, W.-H.; Tang, C.-S. 2009: Cardiovascular effects of catestatin. Sheng Li Ke Xue Jin Zhan 40(4): 325-328

Yalcin, M.; Aydin, C. 2009: Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism. Clinical and Experimental Pharmacology and Physiology 36(4): 447-453

Yalcin, M.; Savci, V. 2007: Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms. Neuropeptides 41(6): 465-475

Marsh, D.F. 1946: Cardiovascular effects of certain aliphatic sympathomimetic amines. Federation Proceedings 5: 264

Mose, F.H.; Vase, H.; Larsen, T.; Kancir, A.S.P.; Kosierkiewic, R.; Jonczy, B.; Hansen, A.B.; Oczachowska-Kulik, A.E.; Thomsen, I.M.; Bech, J.N.; Pedersen, E.B. 2014: Cardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial. Bmc Nephrology 15: 50

Ballard, K.D. 2011: Cardiovascular effects of chronic and acute whey protein ingestion. British Journal of Nutrition 105(10): 1415-1417

Choucair-Jaafar, N.; Beetz, N.; Gilsbach, R.; Yalcin, I.; Waltisperger, E.; Freund-Mercier, M.-J.é; Monassier, L.; Hein, L.; Barrot, M. 2011: Cardiovascular effects of chronic treatment with a β2-adrenoceptor agonist relieving neuropathic pain in mice. Neuropharmacology 61(1-2): 51-60

Jurado, O.M.; Mosing, M.; Kutter, A.P.N.; Boretti, F.; Bettschart-Wolfensberger, R. 2012: Cardiovascular effects of cis-atracurium overdose in a dog following misplacement of neuromuscular monitoring electrodes. Veterinary Anaesthesia and Analgesia 39(5): 555-557

Schwartz, B.G.; Rezkalla, S.; Kloner, R.A. 2010: Cardiovascular effects of cocaine. Circulation 122(24): 2558-2569

Ong, H.T.; Ong, L.M.; Tan, T.E.; Chean, K.Y. 2013: Cardiovascular effects of common analgesics. Medical Journal of Malaysia 68(2): 189-194

Fitschen, P.J.; Rolfhus, K.R.; Winfrey, M.R.; Allen, B.K.; Manzy, M.; Maher, M.A. 2011: Cardiovascular effects of consumption of black versus English walnuts. Journal of Medicinal Food 14(9): 890-898

Comerma-Steffensen, S.; Grann, M.; Andersen, C.U.; Rungby, J.; Simonsen, U. 2014: Cardiovascular effects of current and future anti-obesity drugs. Current Vascular Pharmacology 12(3): 493-504

Brophy, J.M. 2007: Cardiovascular effects of cyclooxygenase-2 inhibitors. Current Opinion in Gastroenterology 23(6): 617-624

Nissen, S.E. 2012: Cardiovascular effects of diabetes drugs: emerging from the dark ages. Annals of Internal Medicine 157(9): 671-672

Rosenstock, J.; Marx, N.; Johansen, O.-E.; Wörle, H.-J.ür. 2013: Cardiovascular effects of diabetes drugs: making the dark ages brighter with Carolina. Annals of Internal Medicine 158(6): 499

Chetboul, V.ér.; Reynolds, B.S.ép.; Trehiou-Sechi, E.; Nguyen, P.; Concordet, D.; Sampedrano, C.C.; Testault, I.; Elliott, J.; Abadie, J.ér.ôm.; Biourge, V.; Lefebvre, H.é P. 2014: Cardiovascular effects of dietary salt intake in aged healthy cats: a 2-year prospective randomized, blinded, and controlled study. Plos one 9(6): E97862

Scheen, A.é J. 2013: Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes. Postgraduate Medicine 125(3): 7-20

Baumgartner, C.M.; Koenighaus, H.; Ebner, J.K.; Henke, J.; Schuster, T.; Erhardt, W.D. 2009: Cardiovascular effects of dipyrone and propofol on hemodynamic function in rabbits. American Journal of Veterinary Research 70(11): 1407-1415

Ohta, M.; Kurimoto, S.; Ishikawa, Y.; Tokushige, H.; Mae, N.; Nagata, S.-i.; Mamada, M. 2013: Cardiovascular effects of dobutamine and phenylephrine infusion in sevoflurane-anesthetized Thoroughbred horses. Journal of Veterinary Medical Science 75(11): 1443-1448

Howes, L.G. 2014: Cardiovascular effects of drugs used to treat Alzheimer's disease. Drug Safety 37(6): 391-395

Chaudhury, S.; Shekhar, R.; Bhardwaj, P.; John, T.R. 2001: Cardiovascular effects of ect. Indian Journal of Psychiatry 43(3): 287-288

Bester, D.; Esterhuyse, A.J.; Truter, E.J.; van Rooyen, J. 2010: Cardiovascular effects of edible oils: a comparison between four popular edible oils. Nutrition Research Reviews 23(2): 334-348

Bechlioulis, A.; Naka, K.K.; Calis, K.A.; Makrigiannakis, A.; Michalis, L.; Kalantaridou, S.N. 2010: Cardiovascular effects of endogenous estrogen and hormone therapy. Current Vascular Pharmacology 8(2): 249-258

Li, P.; Fu, X.; Lu, Y.; Yin, W.; Ma, L.; Fu, Z. 2014: Cardiovascular effects of endothelin-1₁₋₃₁ microinjected into the nucleus tractus solitarius of anesthetized rats. Neuroreport 25(8): 612-617

Münzel, T.; Gori, T.; Babisch, W.; Basner, M. 2014: Cardiovascular effects of environmental noise exposure. European Heart Journal 35(13): 829-836

Lercher, P.; Botteldooren, D.; Widmann, U.; Uhrner, U.; Kammeringer, E. 2011: Cardiovascular effects of environmental noise: research in Austria. Noise and Health 13(52): 234-250

Maschke, C. 2011: Cardiovascular effects of environmental noise: research in Germany. Noise and Health 13(52): 205-211

Belojevic, G.; Paunovic, K.; Jakovljevic, B.; Stojanov, V.; Ilic, J.; Slepcevic, V.; Saric-Tanaskovic, M. 2011: Cardiovascular effects of environmental noise: research in Serbia. Noise and Health 13(52): 217-220

Bluhm, G.ös.; Eriksson, C. 2011: Cardiovascular effects of environmental noise: research in Sweden. Noise and Health 13(52): 212-216

Kempen, E.v. 2011: Cardiovascular effects of environmental noise: research in the Netherlands. Noise and Health 13(52): 221-228

Stansfeld, S.; Crombie, R. 2011: Cardiovascular effects of environmental noise: research in the United Kingdom. Noise and Health 13(52): 229-233

Rostoff, P.; Gackowski, A.; Konduracka, E.; Latacz, P.; Piwowarska, W. 2008: Cardiovascular effects of ephedrine during cardiopulmonary resuscitation. Resuscitation 76(1): 151-152

Bosmans, T.; Schauvliege, S.; Gasthuys, F.; Duchateau, L.; Marcilla, M.G.; Gadeyne, C.; Polis, I. 2011: Cardiovascular effects of epidural administration of methadone, ropivacaine 0.75% and their combination in isoflurane anaesthetized dogs. Veterinary Anaesthesia and Analgesia 38(2): 146-157

Stegmann, G.F. 2010: Cardiovascular effects of epidural morphine or ropivacaine in isoflurane-anaesthetised pigs during surgical devascularisation of the liver. Journal of the South African Veterinary Association 81(3): 143-147

Santhanam, A.Vijay.R.; d'Uscio, L.V.; Katusic, Z.S. 2010: Cardiovascular effects of erythropoietin an update. Advances in Pharmacology 60: 257-285

Su, X.H.; Duan, R.; Sun, Y.Y.; Wen, J.F.; Kang, D.G.; Lee, H.S.; Cho, K.W.; Jin, S.N. 2014: Cardiovascular effects of ethanol extract of Rubus chingii Hu (Rosaceae) in rats: an in vivo and in vitro approach. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 65(3): 417-424

Gielen, S.; Schuler, G.; Adams, V. 2010: Cardiovascular effects of exercise training: molecular mechanisms. Circulation 122(12): 1221-1238

Hales, S.; Edwards, R. 2011: Cardiovascular effects of exposure to air pollution. Bmj 343: D5814

Baumgartner, C.M.; Koenighaus, H.; Ebner, J.K.; Henke, J.; Schuster, T.; Erhardt, W.D. 2009: Cardiovascular effects of fentanyl and propofol on hemodynamic function in rabbits. American Journal of Veterinary Research 70(3): 409-417

Riediker, M. 2007: Cardiovascular effects of fine particulate matter components in highway patrol officers. Inhalation Toxicology 19 Suppl. 1: 99-105

Behjati, M.; Etemadifar, M.; Abdar Esfahani, M. 2014: Cardiovascular effects of fingolimod: A review article. Iranian Journal of Neurology 13(3): 119-126

Mladenka, P.; Zatloukalová, L.; Filipský, T.ás.; Hrdina, R.ír. 2010: Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radical Biology and Medicine 49(6): 963-975

Cantù, P.; Savojardo, D.; Barelli, M.V.; Buonamici, V.; Bertinieri, G.; Penagini, R. 2008: Cardiovascular effects of gastric intubation and distension in healthy humans. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 20(4): 304-310

Isgaard, J.ör.; Barlind, A.; Johansson, I. 2008: Cardiovascular effects of ghrelin and growth hormone secretagogues. Cardiovascular and Hematological Disorders Drug Targets 8(2): 133-137

Vlasova, M.A.; Järvinen, K.; Herzig, K.-H. 2009: Cardiovascular effects of ghrelin antagonist in conscious rats. Regulatory Peptides 156(1-3): 72-76

Papazafiropoulou, A.; Pappas, S.I.; Papadogiannis, D.; Tentolouris, N. 2011: Cardiovascular effects of glucagon-like peptide 1. Mini Reviews in Medicinal Chemistry 11(1): 97-105

Saraiva, F.K.; Sposito, A.C. 2014: Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists. Cardiovascular Diabetology 13: 142

Kober, L.; Rustom, R.; Wiedmann, J.; Kappelgaard, A.-M.; El Nahas, M.; Feldt-Rasmussen, B. 2010: Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. NEPHRON. Clinical Practice 115(3): C213-C226

Vullaganti, S.; Goldsmith, J.; Teruya, S.; Alvarez, J.; Helmke, S.; Maurer, M.S. 2014: Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction. Journal of Geriatric Cardiology: Jgc 11(2): 100-105

Chan, C.T. 2009: Cardiovascular effects of home intensive hemodialysis. Advances in Chronic Kidney Disease 16(3): 173-178

Dinger, J.; Nitschmann, S. 2013: Cardiovascular effects of hormonal contraception. Der Internist 2013

Kim, J.; Samson, S.L. 2014: Cardiovascular effects of incretin therapy in diabetes care. Metabolic Syndrome and Related Disorders 12(6): 303-310

Advani, A.; Bugyei-Twum, A.; Connelly, K.A. 2013: Cardiovascular effects of incretins in diabetes. Canadian Journal of Diabetes 37(5): 309-314

Susic, D.; Varagic, J.; Frohlich, E.D. 2010: Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess. American Journal of Physiology. Heart and Circulatory Physiology 298(4): H1177-H1181

Johnston, C.A.; Moreno, J.P.; Foreyt, J.P. 2014: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Current Atherosclerosis Reports 16(12): 457

Yang, J.-h.; Qi, Y.-f.; Ma, C.-g.; Tang, C.-s. 2009: Cardiovascular effects of intermedin1-53 and its mechanism. Zhongguo Ying Yong Sheng Li Xue Za Zhi 25(3): 308-311

Fang, Q.; Liu, Q.; Li, N.; Jiang, T.-N.; Li, Y.-L.; Yan, X.; Wang, R. 2009: Cardiovascular effects of intravenous administered 26RFa, a novel RFamide peptide ligand for GPR103, in anaesthetised rats. European Journal of Pharmacology 621(1-3): 61-66

Mair, A.R.; Woolley, J.; Martinez, M. 2010: Cardiovascular effects of intravenous gadolinium administration to anaesthetized dogs undergoing magnetic resonance imaging. Veterinary Anaesthesia and Analgesia 37(4): 337-341

Lippmann, M.; Karnwal, A.; Julka, I.S. 2010: Cardiovascular effects of ketamine in sick patients: should physicians be concerned?. Journal of Clinical Pharmacology 50(4): 482

Vaziri, N.D.; Gonick, H.C. 2008: Cardiovascular effects of lead exposure. Indian Journal of Medical Research 128(4): 426-435

Noack, C.; Schroeder, C.; Heusser, K.; Lipp, A. 2014: Cardiovascular effects of levodopa in Parkinson's disease. Parkinsonism and Related Disorders 20(8): 815-818

Dietrichs, E.S.; Håheim, B.; Kondratiev, T.; Sieck, G.C.; Tveita, T. 2014: Cardiovascular effects of levosimendan during rewarming from hypothermia in rat. Cryobiology 69(3): 402-410

Cunha-Goncalves, D.; Perez-de-Sa, V.; Dahm, P.; Grins, E.; Thörne, J.; Blomquist, S. 2007: Cardiovascular effects of levosimendan in the early stages of endotoxemia. Shock 28(1): 71-77

Conrado, V.C.L.S.; de Andrade, J.ár.; de Angelis, G.A.M.C.; de Andrade, A.C.P.; Timerman, L.; Andrade, M.M.; Moreira, D.R.; Sousa, A.G.M.R.; Sousa, J.E.M.R.; Piegas, L.S. 2007: Cardiovascular effects of local anesthesia with vasoconstrictor during dental extraction in coronary patients. Arquivos Brasileiros de Cardiologia 88(5): 507-513

El Agaty, S.M.T.; Seif, A.A. 2015: Cardiovascular effects of long-term caffeine administration in aged rats. Irish Journal of Medical Science 184(2): 265-272

Hammerness, P.; Wilens, T.; Mick, E.; Spencer, T.; Doyle, R.; McCreary, M.; Becker, J.; Biederman, J. 2009: Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. Journal of Pediatrics 155(1): 84-89; 89.E1

Patrono, C. 2010: Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs. Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 165(1-2): 115-123; Discussion 124

Stegmann, G.F. 2009: Cardiovascular effects of lumbar epidural anaesthesia in isoflurane-anaesthetised pigs during surgical removal of the liver. Journal of the South African Veterinary Association 80(1): 37-40

Saravanan, P.; Davidson, N.C.; Schmidt, E.B.; Calder, P.C. 2010: Cardiovascular effects of marine omega-3 fatty acids. Lancet 376(9740): 540-550

Frazier, S.K. 2008: Cardiovascular effects of mechanical ventilation and weaning. Nursing Clinics of North America 43(1): 1-15; V

Elia, J.; Vetter, V.L. 2010: Cardiovascular effects of medications for the treatment of attention-deficit hyperactivity disorder: what is known and how should it influence prescribing in children?. Paediatric Drugs 12(3): 165-175

Paulis, L.; Simko, F.; Laudon, M. 2012: Cardiovascular effects of melatonin receptor agonists. Expert Opinion on Investigational Drugs 21(11): 1661-1678

Sharman, J.E.; Johns, D.P.; Marrone, J.; Walls, J.; Wood-Baker, R.; Walters, E.H. 2014: Cardiovascular effects of methacholine-induced airway obstruction in man. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 65(3): 401-407

Daniels, S.R. 2009: Cardiovascular effects of methylphenidate. Journal of Pediatrics 155(1): A3

Stiefel, G.; Besag, F.M.C. 2010: Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Safety 33(10): 821-842

Awudu, G.A.H.; Besag, F.M.C. 2014: Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update. Drug Safety 37(9): 661-676

Lazzeri, C.; Sori, A.; Bernardo, P.; Chiostri, M.; Tommasi, E.; Zucchini, M.; Romano, S.M.; Gensini, G.F.; Valente, S. 2014: Cardiovascular effects of mild hypothermia in post-cardiac arrest patients by beat-to-beat monitoring. a single centre pilot study. Acute Cardiac Care 16(2): 67-73

Biondi, B. 2007: Cardiovascular effects of mild hypothyroidism. Thyroid: Official Journal of the American Thyroid Association 17(7): 625-630

Hoenicka, M.; Schmid, C. 2008: Cardiovascular effects of modulators of soluble guanylyl cyclase activity. Cardiovascular and Hematological Agents in Medicinal Chemistry 6(4): 287-301

Ojewole, J.A. 2008: Cardiovascular effects of mollic acid glucoside, a 1alpha-hydroxycycloartenoid saponin extractive from Combretum molle R Br ex G Don (Combretaceae) leaf. Cardiovascular Journal of Africa 19(3): 128-134

Sleight, P. 2013: Cardiovascular effects of music by entraining cardiovascular autonomic rhythms music therapy update: tailored to each person, or does one size fit all?. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 21(2): 99-100

Kryzhanovskiĭ, S.A.; Vititnova, M.B. 2011: Cardiovascular effects of nerve growth factor (analytical literature review) Part I. NGF-indirect intracellular signal pathways. Fiziologiia Cheloveka 37(2): 104-116

Kryzhnovskiĭ, S.A.; Vititnova, M.B. 2011: Cardiovascular effects of nerve growth factor analytical review. Part 2. Fiziologiia Cheloveka 37(3): 109-128

Babisch, W. 2011: Cardiovascular effects of noise. Noise and Health 13(52): 201-204

Raj, S.R.; Stein, C.Michael.; Saavedra, P.J.; Roden, D.M. 2009: Cardiovascular effects of noncardiovascular drugs. Circulation 120(12): 1123-1132

Alves, F.H.F.; Crestani, C.C.; Resstel, L.B.M.; Correa, F.M.A. 2011: Cardiovascular effects of noradrenaline microinjected into the insular cortex of unanesthetized rats. Autonomic Neuroscience: Basic and Clinical 160(1-2): 90-98

Garcia Pelosi, G.; Fiacadori Tavares, R.; Barros Parron Fernandes, K.; Morgan Aguiar Corrêa, F. 2009: Cardiovascular effects of noradrenaline microinjection into the medial part of the superior colliculus of unanesthetized rats. Brain Research 1290: 21-27

Peavy, W.C. 2009: Cardiovascular effects of obesity: implications for critical care. Critical Care Nursing Clinics of North America 21(3): 293-300 V

Riccó, C.H.; Henao-Guerrero, N. 2014: Cardiovascular effects of orotracheal intubation following anesthetic induction with propofol, ketamine-propofol, or ketamine-diazepam in premedicated dogs. Journal of the American Veterinary Medical Association 244(8): 934-939

Authier, S.; Tanguay, J.-F.ço.; Geoffroy, P.; Gauvin, D.; Bichot, S.; Ybarra, N.; Otis, C.; Troncy, E. 2010: Cardiovascular effects of oxytocin infusion in a porcine model of myocardial infarct. Journal of Cardiovascular Pharmacology 55(1): 74-82

Dettoni, J.L.; Consolim-Colombo, F.M.; Drager, L.F.; Rubira, M.C.; Souza, S.B.P.C.d.; Irigoyen, M.C.; Mostarda, C.; Borile, S.; Krieger, E.M.; Moreno, H.; Lorenzi-Filho, G. 2012: Cardiovascular effects of partial sleep deprivation in healthy volunteers. Journal of Applied Physiology 113(2): 232-236

Jordan, J.; Astrup, A.; Engeli, S.; Narkiewicz, K.; Day, W.W.; Finer, N. 2014: Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity. Journal of Hypertension 32(6): 1178-1188

Vlachopoulos, C.; Ioakeimidis, N.; Rokkas, K.; Stefanadis, C. 2009: Cardiovascular effects of phosphodiesterase type 5 inhibitors. Journal of Sexual Medicine 6(3): 658-674

Langrish, J.P.; Mills, N.L.; Bath, L.E.; Warner, P.; Webb, D.J.; Kelnar, C.J.; Critchley, H.O.D.; Newby, D.E.; Wallace, W.H.B. 2009: Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 53(5): 805-811

Holland, M.R.; McIntyre, T.M.; Zimmerman, G.A.; Prescott, S.M. 1991: Cardiovascular effects of platelet-activating factor. Trends in Cardiovascular Medicine 1(3): 117-121

Susic, D.; Zhou, X.; Frohlich, E.D.; Lippton, H.; Knight, M. 2008: Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet. American Journal of Physiology. Heart and Circulatory Physiology 295(3): H1117-H1121

Kovacs, D.; Arora, R. 2008: Cardiovascular effects of psychotropic drugs. American Journal of Therapeutics 15(5): 474-483

Chen, T.; Hu, J.; Chen, C.; Pu, J.; Cui, X.; Jia, G. 2013: Cardiovascular effects of pulmonary exposure to titanium dioxide nanoparticles in ApoE knockout mice. Journal of Nanoscience and Nanotechnology 13(5): 3214-3222

Salvaterra, C.G.; Rubin, L.J. 1991: Cardiovascular effects of pulmonary hypertension. Trends in Cardiovascular Medicine 1(2): 65-69

Zhang, X.-H.; Sui, Y.-B.; Chen, W.-J. 2013: Cardiovascular effects of relaxin. Sheng Li Ke Xue Jin Zhan 44(5): 381-385

Bukarica, L.G.ć; Protić, D.; Kanjuh, V.; Heinle, H.; Novakoviĉ, R.; Sćepanović, R. 2013: Cardiovascular effects of resveratrol. Vojnosanitetski Pregled 70(12): 1145-1150

Soner, B.C.; Sahin, A.şe.S. 2014: Cardiovascular effects of resveratrol and atorvastatin treatments in an H2O2-induced stress model. Experimental and Therapeutic Medicine 8(5): 1660-1664

Saida, Y.; Tanaka, R.; Fukushima, R.; Hoshi, K.; Hira, S.; Soda, A.; Iizuka, T.; Ishikawa, T.; Nishimura, T.; Yamane, Y. 2009: Cardiovascular effects of right ventricle-pulmonary artery valved conduit implantation in experimental pulmonic stenosis. Journal of Veterinary Medical Science 71(4): 477-483

Kamalipour, M.; Akhondzadeh, S. 2011: Cardiovascular effects of saffron: an evidence-based review. Journal of Tehran Heart Center 6(2): 59-61

Gomes, H.L.; Andrich, F.; Mauad, H.él.; Sampaio, K.N.; De Lima, M.E.; Figueiredo, S.G.; Moysés, M.R. 2010: Cardiovascular effects of scorpionfish (Scorpaena plumieri) venom. Toxicon: Official Journal of the International Society on Toxinology 55(2-3): 580-589

Laurent, A.; Mottu, F.; Chapot, R.é; Zhang, J.Q.; Jordan, O.; Rüfenacht, D.A.; Doelker, E.; Merland, J.-J. 2007: Cardiovascular effects of selected water-miscible solvents for pharmaceutical injections and embolization materials: a comparative hemodynamic study using a sheep model. PDA Journal of Pharmaceutical Science and Technology 61(2): 64-74

Chen, X.; Zhang, Q.; Tan, X. 2009: Cardiovascular effects of sexual activity. Indian Journal of Medical Research 130(6): 681-688

Pisarik, P. 2007: Cardiovascular effects of sibutramine. Pediatrics 120(4): 930

Kipple, H.M.; Waldman, M.S.; Hall, V.E. 1947: Cardiovascular effects of sodium caprylate in the cat. Journal of Pharmacology and Experimental Therapeutics 89(4): 313-319

Levkau, B. 2013: Cardiovascular effects of sphingosine-1-phosphate (S1P). Handbook of Experimental Pharmacology 216: 147-170

Schultz, D.M.; Zhou, X.; Singal, A.; Musley, S. 2011: Cardiovascular effects of spinal cord stimulation in hypertensive patients. Pain Physician 14(1): 1-14

Mihos, C.G.; Pineda, A.M.; Santana, O. 2014: Cardiovascular effects of statins, beyond lipid-lowering properties. Pharmacological Research 88: 12-19

Burgan, O.; Smargiassi, A.; Perron, Séphane.; Kosatsky, T. 2010: Cardiovascular effects of sub-daily levels of ambient fine particles: a systematic review. Environmental Health: a Global Access Science Source 9: 26

Senkus, E.żb.; Jassem, J. 2011: Cardiovascular effects of systemic cancer treatment. Cancer Treatment Reviews 37(4): 300-311

Faria-Costa, G.; Leite-Moreira, A.; Henriques-Coelho, T. 2014: Cardiovascular effects of the angiotensin type 2 receptor. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 33(7-8): 439-449

Biala, A.; Finckenberg, P.; Korpi, A.; Loytainen, M.; Martonen, E.; Levijoki, J.; Mervaala, E. 2011: Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 62(3): 275-285

De Siqueira, R.J.é B.; Duarte, G.P.; Magalhães, P.J.C.; Lahlou, S. 2013: Cardiovascular effects of the essential oil of Croton zehntneri leaves in DOCA-salt hypertensive, conscious rats. Natural Product Communications 8(8): 1167-1170

Arnould, P.; Petit, J.; Boulange, M.; Rombach, F. 1961: Cardiovascular effects of the inhalation of pure nitrogen by means of an excluded vascularized lung in the dog treated with chloralose. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 155: 354-356

Cam-Etoz, B.; Isbil-Buyukcoskun, N.; Ozluk, K. 2012: Cardiovascular effects of the intracerebroventricular injection of adrenomedullin: roles of the peripheral vasopressin and central cholinergic systems. Brazilian Journal of Medical and Biological Research 45(3): 250-255

White, W.B. 2007: Cardiovascular effects of the selective cyclooxygenase-2 inhibitors. Sub-Cellular Biochemistry 42: 145-158

Zebrowska, A.; Gasior, Z.; Jastrzebski, D. 2013: Cardiovascular effects of the valsalva maneuver during static arm exercise in elite power lifting athletes. Advances in Experimental Medicine and Biology 755: 335-342

Roberts, B.W.; Trzeciak, S. 2010: Cardiovascular effects of therapeutic hypothermia after resuscitation from cardiac arrest?. Critical Care Medicine 38(11): 2264-2265

Acharya, D.; Falik, R. 2009: Cardiovascular effects of thiazolidinediones: a review of the literature. Southern Medical Journal 102(1): 51-56

Sangster, J.K.; Panciera, D.L.; Abbott, J.A. 2013: Cardiovascular effects of thyroid disease. Compendium 35(7): E5

Campisi, R.; Marengo, F.D. 2007: Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator. Cardiovascular Drug Reviews 25(2): 132-145

Rai, S.; Nandan, N.; Tiwari-Pandey, R.; Pandey, N.R. 2010: Cardiovascular effects of tight versus usual blood-pressure control. Lancet 374(9703): 1741; author reply 1742

Polakowski, J.S.; King, A.J.; Campbell, T.J.; Nelson, R.A.; Preusser, L.C.; Kempf-Grote, A.J.; Marsh, K.C.; Gintant, G.A.; Cox, B.F.; Mittelstadt, S.W. 2009: Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs. Journal of Cardiovascular Pharmacology 54(6): 543-551

Umar, M.A.; Fukui, S.; Kawase, K.; Itami, T.; Yamashita, K. 2015: Cardiovascular effects of total intravenous anesthesia using ketamine-medetomidine-propofol (KMP-TIVA) in horses undergoing surgery. Journal of Veterinary Medical Science 77(3): 281-288

Itami, T.; Tamaru, N.; Kawase, K.; Ishizuka, T.; Tamura, J.; Miyoshi, K.; Umar, M.A.; Inoue, H.; Yamashita, K. 2011: Cardiovascular effects of tramadol in dogs anesthetized with sevoflurane. Journal of Veterinary Medical Science 73(12): 1603-1609

Peroukides, S.; Alexopoulos, A.; Kalofonos, H.; Papadaki, H. 2012: Cardiovascular effects of treatment with taxanes. Journal of Cardiovascular Medicine 13(5): 319-324

Padfield, G.J.; Din, J.N.; Koushiappi, E.; Mills, N.L.; Robinson, S.D.; Cruden, N.L.M.; Lucking, A.J.; Chia, S.; Harding, S.A.; Newby, D.E. 2013: Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study. Heart 99(18): 1330-1335

Villela, N.R.; Nascimento Júnior, P.d.; Carvalho, L.íd.R.d. 2003: Cardiovascular effects of two dexmedetomidine doses: experimental study in dogs. Revista Brasileira de Anestesiologia 53(6): 784-796

Chintalgattu, V.; Patel, S.S.; Khakoo, A.Y. 2009: Cardiovascular effects of tyrosine kinase inhibitors used for gastrointestinal stromal tumors. Hematology/Oncology Clinics of North America 23(1): 97

Bro, S. 2009: Cardiovascular effects of uremia in apolipoprotein E-deficient mice. Danish Medical Bulletin 56(4): 177-192

Capone, M.L.; Tacconelli, S.; Di Francesco, L.; Petrelli, M.; Patrignani, P. 2008: Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs. Expert Opinion on Drug Safety 7(1): 29-42

Schmiedl, S.; Ritter, A.; Szymanski, J.; Schneider, F.; Plecko, T.; Alken, R.G.; Thuermann, P.A. 2012: Cardiovascular effects, pharmacokinetics and cross-reactivity in digitalis glycoside immunoassays of an antidiarrheal uzara root extract. International Journal of Clinical Pharmacology and Therapeutics 50(10): 729-740

Kołodzińska, A.; Kutarski, A.; Grabowski, M.; Opolski, G. 2013: Cardiovascular electronic device infections. Kardiologia Polska 71(6): 623-630